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CHAPTER I

INTRODUCTION AND REVIEW OF THE RELATED LITERATURE
I.

CHOLESTEROL

A. Cholesterol

1. Endogenous Sources of
Cholesterol
Cholesterol shown in figure 1 is formed from two carbon units provided by acetyl CoA.

Cholesterol synthesis begins by the condensation

of two acetyl CoA molecules to acetoacetyl CoA, which is catalyzed by
acetoacetyl CoA thiolase.

The next step for cholesterol synthesis cata-

lyzed by HMG CoA synthase involves the formation of 3-hydroxy-3-methyl
glutaryl CoA from acetoacetyl CoA.

Mevalonic acid is then produced by

hydrolysis of the thiol ester bond which is catalyzed by the enzyme HMG
CoA reductase.

Mevalonic acid in a series of reactions forms farnesyl

pyrophosphate a 15 carbon compound, which fuses with another molecule of
farnesyl pyrophosphate to form squalene a process which is catalyzed by _
squalene synthetase.

A hydroxyl group is added to the squalene molecule

at the C-3 position in the beta stereochemical configuration by squalene
oxidocyclase which also catalyzes the cyclization of squalene to lanesterol.

Lanosterol after a few other modifications becomes the 27 carbon

cholesterol with a hydroxyl group at the 3 beta position and a 5,6 carbon double bond (Bloch, 1965).
1

2

The rate determining step for cholesterol synthesis has been shown
to be the conversion of a hydroxy-a methyl glutaryl coenzyme A to mevalonic acid and the regulatory enzyme responsible for this conversion is
mevalonate:NADP oxidoreductase (acylating CoA), EC 1.1.1.34 (Nomenclature Committee, 1979) better known as HMG CoA reductase.

Feeding rats

high cholesterol diets has been shown to inhibit the conversion of a
hydroxy-a methyl glutaryl coenzyme A to mevalonic acid (Frantz et al.,
1954; Siperstein et al., 1960).

In addition, a pronounced reduction in

HMG CoA reductase activity was also noted when rats were fed cholesterol
(Shefer et al., 1973).

Bile acids appeared to be necessary for the

decrease in HMG CoA reductase activity found in rat liver, but may only
play a secondary role to that of cholesterol concentration.

The mecha-

nism of cholesterol's feedback regulation of HMG CoA reductase activity
appears to be very complex since not only is activity, but also quantity
of HMG CoA reductase affected by increasing sterol concentrations
(Rodwell et al., 1976).

A preference for absorbed cholesterol over that

of endogenous production in the liver has been observed and postulated
to be due to the more ready availability to the liver of chylomicron
remnants containing cholesterol (Nervi et al., 1974).

This may be true

for other tissues as well, since extrahepatic tissue cholesterol synthesis appears to be regulated by cholesterol carried to the tissues "from
the blood by lipoproteins (see section II.C.4.

LDL Catabolism).

The

precise mechanism for cholesterol feedback inhibition on HMG CoA reductase is as yet unknown.
Endogenous sources of cholesterol include almost every cell in the

3

animal,

since virtually every tissue is capable of synthesizing

cholesterol (Dietschy et al., 1967), yet the bulk of endogenous cholesterol of both human and rat is synthesized in the liver (Dietschy et
al., 1971; Turley et al., 1981b). Studies have indicated that 50% of
endogenous cholesterol in the rat is derived from the liver, 24% in the
small bowel, 8% from the skin and 18% from the remaining tissues (Turley
et al., 1981a).

Unfortunately, cholesterol biosynthesis in rat tissues

was determined using the digitonin precipitation method for unesterified
sterols (Sperry, 1950), which was recently found to include methyl sterols that coprecipitated with the unesterified sterols.

The rate of cho-

lesterol biosynthesis determined using the digitonin precipitation technique may appear to be faster than what is actually occurring.

The

inaccuracy of the cholesterol biosynthesis determination would be due to
the inclusion of methyl sterols as well as the desired unesterified
sterol in the assay (Tabicik et al., 1983).

Although the method for

determining the rate and amount of cholesterol biosynthesis for each
tissue may be of uncertain accuracy, the relative percents of cholesterol synthesis for each tissue, should be good rough estimates (Turley
et al., 1981a). Moreover, despite the methodology used to determine tissue cholesterol biosynthesis it has been clearly demonstrated that the
bulk of endogenous cholesterol synthesis occurs in the liver and small
bowel of both rats and humans (Jeske et al., 1980).
Cholesterol is ubiquitous in the mammalian system, but certain
tissues synthesize the cholesterol required for self maintenance while
other tissues receive cholesterol requirements from circulating plasma

4

lipoproteins.

The contribution of many rat tissues to their own

cholesterol content and also the contribution of circulating lipoprotein
cholesterol to tissue cholesterol content have been determined.

Brain,

ovary, skin, muscle and marrow were found to produce greater than 75% of
their own cholesterol content.

The adrenal produced only 4% of its own

sterol content, the spleen 6%, the heart 28%, kidney 26% and lung 17%.
Cholesterol not produced by the tissue is obtained from circulating
plasma lipoproteins (Andersen et al., 1979;

Turley et al.,

1981a;

198lb).
2. Exogenous Sources of
Cholesterol
Diet and bile are the two major sources of cholesterol in the
intestine (Grundy, 1978).

Cholesterol intake from an American diet has

been found to average between 500-750 mg per day while biliary excretion
of cholesterol averages between 750-1250 mg per day (Bennion et al.,
1975; Grundy, 1972).

Other sources of intestinal cholesterol include

degraded intestinal cells and intestinal secretions, although their contributions to the total pool of cholesterol within the intestine have
been difficult to assess (Miettinen et al., 1981). It has been determined that only

30-60~~

of cholesterol present in the human intestine is

absorbed (Quintao et al., 1971).

Moreover, the rat's ability to absorb

cholesterol has also been demonstrated to be between 30-60% of the cholesterol present in the intestine (Cook et al., 1951; Pihl, 1955).
Cholesterol absorption is limited by its solubilization into
micelles (Hofman et al., 1964) and only unesterified cholesterol can be

5

solubilized into these micelles, therefore cholesteryl esters present in
the diet are hydrolyzed in the intestine and converted to unesterif ied
cholesterol and free fatty acids by carboxylic-ester hydro lase, EC
3.1.1.13 (Nomenclature Committee, 1979), a nonspecific lipase secreted
from the pancreas (Lombardo, et al., 1980).

In addition, micelle forma-

tion has been shown to require conjugated bile acids and hydrolytic
products of triglycerides, lecithin (phosphatidyl choline), fatty acids,
monoglycerides and lysolecithin (Hofman et al., 1964).

Therefore, cho-

lesterol absorption has been found to be dependent on the intraluminal
availability of bile acids and hydrolytic products of dietary fat (Pihl,
1955; Swell et al., 1955).
Cholesterol is absorbed by intestinal mucosal cells.

Maximum

absorption has been demonstrated to occur in the upper intestine where
the micelles facilitate transport of cholesterol across the unstirred
water layer adjacent to the surface of the luminal cell (Simmonds et
al., 1967; Westergaard et al., 1976).

Bolar lipids necessary for cho-

lesterol solubilization have also been found to be almost quantitatively
absorbed at the proximal part of the small intestine (Simmonds et al.,
1967), so cholesterol would precipitate within the lumen of the small
intestine when the polar lipid concentration needed to solubilize cholesterol decreases (Simmonds et al., 1967), even though bile acids· are
mainly absorbed in the distil portion of the small intestine (Weiner et
al., 1968).

However, a high fat diet would allow the polar lipids to

remain in the micelle longer, thus increasing cholesterol absorption.
Cholesterol absorption into the intestinal cell is believed to occur

6
when the cholesterol containing micelle collides with the intestinal
cell membrane and disaggregates following which bile salts and cholesterol diffuse across the membrane passively.

The entire micelle would

not be absorbed intact and those portions of the micelle not absorbed
would be excreted in the feces (Chow et al., 1978; Schultz et al.,
1971).
Intraluminal intestinal cholesterol is mostly unesterified, yet
more esterified than unesterified cholesterol has been found in the
intestinal lymph (Gallo et al., 1963).

Microsomal acyl coenzyme A cho-

lesterol acyltransferase, EC 2.3.1.21 (Nomenclature Committee, 1979),
also known as ACAT, has been shown to be responsible for the formation
of cholesteryl esters within the intestinal mucosal cell (Haugen et al.,
1976).

Unesterified cholesterol and cholesteryl esters have been found

to be secreted into the mesenteric lymph after being incorporated into
lipoproteins known as chylomicrons (Sabesin, 1976).

Chylomicrons are

then metabolized by an enzyme known as 1-ipoprotein lipase into chylomicron remnants, which are taken up by the liver (Fielding et al., 1977).
Chylomicron synthesis and catabolism will be covered in greater detail
in a later section (see section II.C. Lipoprotein Synthesis and Metabolism).

7

B.

Cholesterol Distribution

1. Membrane and Intracellular

Cholesterol has three major functions in mammalian organisms:

(1)

It is a required structural component of the plasma membrane of all
cells.

(2) It is the precursor for steroid hormones.

precursor of bile acids (Havel et al., 1980).

(3) It is the

The unesterified choles-

terol of tissues is found exclusively in the cell membrane, whereas
excess intracellular unesterif ied cholesterol is esterif ied by ACAT and
stored within the cell as a liquid cholesterol ester crystal (Brown et
al., 1975c).

Plasma cholesterol on the other hand, is found within sub-

stances known as lipoproteins.
2.

Plasma Lipoprotein
Lipoproteins transport nonpolar lipids through the plasma. Lipo-

proteins are large macromolecular complexes which are pseudomicellar
(Havel, 1975).

Analysis of the correlations between size and chemical

composition of lipoproteins in normal humans indicated lipoproteins are
spherical, surrounded by a monolayer of cholesterol and phospholipids.
Proteins appear to be closely packed with the hydrophilic head groups of
phospholipids at the outer surface of the lipoprotein molecule.

Hydro-

phobic ends of phospholipids and cholesterol surround and seem to be
packed tightly at a liquid core of cholesteryl ester and triglyceride.
The correlations between size and chemical composition of lipoproteins
also indicated that sharply defined boundaries exist between the hydrophobic core and the amphipathic layer surrounding it.

Proteins appear

8

to be at the same surface layer as the phospholipid head groups competing for that surface area.

Also, the location of all unesterified cho-

lesterol may be under the protein layer with the alcohol group in direct
contact with protein and not the surrounding plasma water.

Moreover,

the analysis indicates that all lipoproteins regardless of size, have an
identical structure.

(Shen et al., 1977).

However, studies using

nuclear magnetic resonance suggested that unesterif ied cholesterol rapidly exchanges between the core and surface of lipoproteins (Lund-Katz
et al., 1981).

In addition, 40% of the lipoprotein unesterified choles-

terol appeared to exist in the core of the molecule, while 60% appears
to be present on the surface of the molecule associated with phospholipids.

Moreover, the the nuclear magnetic resonance study implied that

more than 90% of lipoprotein-unesterified cholesterol molecules belong
to a single kinetic pool, from which they could be available for
exchange with cholesterol molecules in cells or other lipoproteins
(Lund-Katz et al., 1984).
C.

Cholesterol Clearance

1. Bile and Sloughed
Intestinal Cells
The main mode of cholesterol excretion has been demonstrated.to be
via the bile and is dependent on bile salt secretion (Hardison et. al.,
1972; Wheeler, 1972).

Unesterified cholesterol is dissolved within the

bile and bile is formed by cholesterol catabolism, therefore cholesterol
is excreted from the liver into the intestine in two forms.

Moreover,
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the bulk of the cholesterol which appears in the bile either in the form
of bile acids or as unesterified cholesterol was found by one study to
be derived from the liver of rats (Turley, et al., 1981b).

However, it

has been suggested that the major source of bile acids in man is from
lipoprotein-cholesterol (Schwartz et al., 1981).

Sloughed cells and

secretions from the intestine as mentioned previously are also involved
in cholesterol excretion, but it has been difficult to determine to what
extent (Miettinen et al., 1981).
2.

Skin
Skin surface sterols are a mixture derived both from local synthe-

sis and from the plasma.

Therefore, cholesterol has been found to be

lost from the hair, desquamated cells, sweat and sebaceous secretions,
which makes skin the second major source for cholesterol excretion in
the human (Nikkari et al., 1974).
3.

Urine
Studies on humans have shown that cholesterol is excreted in the

urine, but in very small amounts of about 1 mg/24 hr, except during
pregnancy where it can go up to 70 mg/24 hr.

(Vela et al., 1969).

Uri-

nary excretion however, was not related to plasma cholesterol levels
(Acevedo et al., 1973) and therefore could not be a major route of" cholesterol excretion.
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4.

Milk
Another form of cholesterol secretion limited to the female of

mammalian species is through the milk.

Human milk cholesterol content

has been determined to be 20 mg/dl (Macy et al., 1953), while rat milk
cholesterol content has been determined to be between 25-65 mg/dl
(Clarenburg et al., 1966; Reiser et al;, 1972).

The sources of choles-

terol in milk may be from the diet, mammary gland synthesis and from
endogenous synthesis other than the mammary gland.

The cholesterol con-

tent of milk in the rat can be increased by cholesterol feeding (Reiser
et al., 1972) and an estimated 11% of milk cholesterol comes from
dietary cholesterol, which was determined in rats on a 0.05% cholesterol
diet (Clarenburg et al., 1966).
5.

Hormone Production
The adrenal glands, ovaries and testes convert cholesterol to

steroid hormones.

As indicated previously, the ovary was found to pro-

duce over 75% of its own cholesterol requirement, whereas the adrenal
gland only produced about 4% (Turley et al., 1981a;1981b).

The addi-

tional cholesterol required was supplied by plasma lipoproteins.

Stud-

ies performed on rats have indicated that when plasma cholesterol
decreases, adrenal gland cholesterol synthesis increases and the intracellular stores of cholesteryl ester decrease (Andersen et al., 1976).
The process can be reversed by raising the plasma cholesterol level
through

the

infusion

of

cholesterol

carrying

lipoproteins

(Balasubramaniam et al., 1977). Therefore, the low adrenal gland cholesterol synthesis activity has been postulated to be due to the.adrenal
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gland receiving its cholesterol requirements from plasma lipoproteins.
Rat high density lipoprotein (see section II.A.1. Methodological Classification) appears to be the principle supplier of cholesterol to the
adrenal gland (Andersen et al., 1976; 1977).

Moreover, high density

lipoprotein binds with high affinity to the rat testes and appears to be
the main exogenous source of cholesterol to that organ (Andersen et al.,
1977;1978; Chen et al., 1980) however, a high amount of HMG CoA reductase activity is also present in the rat testes, so most of the cholesterol needed for steroid hormone synthesis is produced endogenously and
not supplied by high density lipoprotein.

In addition,

low density

lipoprotein appeared to bind with high affinity to human fetal testes
and bovine corpus luteum indicating that high density lipoprotein as a
source of cholesterol to gonadal tissue may be species specific (Brown
etal., 1979).
Cholesterol homeostasis in human steroid hormone producing cells
has been postulated to consist of four stages.

The first stage being

the basal stage, when the cell produces hormone at a steady state.

The

cell has a large storage supply of cholesteryl ester and plasma lipoprotein-cholesterol is received by lipoprotein receptors (see section
II.C.4. LDL Catabolism).
state.

ID1G CoA reductase activity is also at a steady

The second stage occurs when the.gland receives stimulation to

increase steroid output, as when ACTH stimulates the adrenal gland.
Unesterif ied cholesterol is produced by the hydrolysis of esterified
cholesterol present within the cell and HMG CoA reductase is stimulated
into producing more unesterified cholesterol for steroid hormone synthe-
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sis.

The third stage is reached upon prolonged stimulation of hormone

production, when

the intracellular cholesteryl ester

stores are

depleted, the bulk of cholesterol for hormone production is obtained
from the plasma by increasing the number of receptors on the cell surface for plasma lipoproteins.

filtG CoA reductase activity then becomes

inhibited by the increased plasma cholesterol input to the cell and
endogenous synthesis of cholesterol decreases.

The fourth stage occurs

at the end of hormone production stimulation as the cell goes back to
the basal state.

Lipoprotein receptors decrease and cholesteryl esters

accumulate within the cell until the cell is back to the first stage
condition (Brown et al., 1979).

Although hormone production is a major

function of cholesterol, it does not appear to be a major source for
plasma cholesterol clearance, due to the availability of intracellular
stores and intracellular synthesis of cholesterol in steroid hormone
producing cells.
II.
A.

LIPOPROTEINS

Lipoprotein Classification

1. Methodological
Classification
Nomenclature of the various classes of lipoproteins is dependent
on the method of isolation and characterization of the lipoprotein
classes.

Alaupovic (1980) proposed two types of lipoprotein nomencla-

tures (1) operational and (2) chemical.

Operational nomenclature is

dependent on the method of separation of the various lipoprotein
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classes.

The nomenclature for electrophoretic separation would include

lipoproteins remaining at the origin called origin lipoproteins, alpha

1

lipoproteins are those lipoproteins which migrate in the alpha -globulin
1
fraction and alpha

lipoproteins are those which migrate in the

2

alpha -globulin fraction, while beta lipoproteins migrate in the beta2
globulin fraction.
Nomenclature based on hydrated density for human lipoproteins
would include chylomicrons with densities less than 0.94 g/ml, very low
density lipoproteins (VLDL) with density greater than 0.94 g/ml and less
than 1.006 g/ml, low density lipoproteins (LDL) have densities between
1.006-1.063 g/ml, high density lipoproteins (HDL) have a density range
from 1.063-1.210 g/ml and very high density lipoproteins (VHDL) have a
density greater than 1.210 g/ml.
human plasma are HDL

2

and HDL

3

Two subtractions of HDL isolated from

which have densities of 1.063-1.125 and

1.125-1.210 g/ml respectively (Nicoll et al., 1980b). Ultracentrifugation has also allowed for the identification of other subtractions of
the major classes of lipoproteins such as HDL a' HDL b (see section
2
2
II.B.1. Ultracentrifugation), HDL

1

and HDLc (see section II.D. Rat Lipo-

protein) (Lindgren, 1979).
2.

Lipoprotein Families
Chemical nomenclature is based on the concept that plasma lipopro-

teins consist of lipoprotein families or particles which are characterized by distinct apolipoproteins.

Lipoprotein families are present as

free, separable forms or association complexes.

Lipoprotein families

are polydisperse and display antigenic homogeneity.

Apolipoprqteins are
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designated by capital letters; constitutive polypeptides by Roman numerals; and the polymorphic forms of apolipoproteins or polypeptides by
Arabic numbers.

Examples of this nomenclature are as follows:

The apo-

lipoprotein A (apo A) family consists of two polypeptides A-I and A-II
and the apolipoprotein C (apo C) family has three polypeptides C-I, C-II
and C-III, whereas apolipoprotein B (apo B), apolipoprotein D (apo D),
apolipoprotein E (apo E) and apolipoprotein F (apo F) are believed to
consist of only one polypeptide each (Alaupovic, 1980).

Throughout this

dissertation lipoproteins will be referred to primarily by operational
nomenclature with mention of the constitutive substances
B.

1.

as necessary.

Methodologies for Lipoprotein Separation

Ultracentrifugation
Isolation of soluble lipoprotein of constant composition was first

accomplished in 1929 from horse plasma by precipitation using half saturated ammonium sulfate (Macheboeuf, 1929).

Twelve years later, the

lipoprotein fraction isolated by precipitation was found to migrate in
the alpha -globulin region using paper electrophoresis (see section
1
II.B.2.

Electrophoresis), which would indicate the lipoprotein fraction

was equivalent to HDL (Macboeuf et al., 1941). Precipitation by ammonium
sulfate was not an ideal technique for lipoprotein separation, therefore
other techniques for lipoprotein fractionation were devised, one of
which was ultracentrifugation.
Since lipoproteins have densities

lower than other naturally

occuring macromolecules, changes in solvent density has allowed the sep-
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aration of plasma lipoproteins from other macromolecules by floatation
in a high centrifugal field.

The equation for the velocity of sedimen-

tation coefficient of a macromolecule (S) is as follows:
S

s

= (l/w 2x)

is in Svedberg units (l0-

radians/sec =

(2~)/60rpm,

13

(dx/dt)

= M(l-Vp)/3~Nnd.

seconds), w is the angular velocity in

x is the distance (cm) of particle from the

rotation axis, t is the time in seconds, Mis the molecular weight (g),
3
V is the partial specific volume of macromolecules (cm /gm), p is the
3
density of the solvent (g/cm ), N is Avogadro's number,

n is the viscos-

ity of solvent (poise) and dis the diameter of the particle (cm).

The

3
5
S value for chylomicrons is 10 -10 for VLDL is 12-400 and for LDL is
0-12, while HDL is found in the sediment (Hatch et al., 1968).

The

interpretation of analytical ultracentrifugal results obtained for
plasma was the major problem needed to be overcome in order to use this
technique for lipoprotein analysis.

This problem was resolved and

plasma lipoproteins have been characterized by analytical ultracentrifugation (Gofman et al., 1949).

Unfortunately the analytical ultracentri-

fuge is a very costly and complicated piece of equipment and few laboratories in the world have one.

Moreover, the stress forces exerted on

the lipoproteins subjected to analytical ultracentrifugation cause
reversible and irreversible changes in lipoprotein structure and characteristics (Lindgren, 1980).
The most commonly used method in research for lipoprotein analysis
is sequential ultracentrifugation (Chapman, 1980) and the most fre-
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quently used sequential ultracentrifugal technique involved adjusting
the plasma sample to a higher density by the addition of salt, either in
solution or by dry weight.

The sample would then be centrifuged at high

speed for long periods of time, usually from 18-48 hours.

Following

centrifugation the fraction containing lower density lipoproteins would
be at the top of the centrifuge tube separated from the higher density
fraction at the bottom of the tube.

The tube could then be sliced

between the two lipoprotein fractions or the floating lower density
fraction could be removed from the top by pipette (Havel et al., 1955).
Ultracentrifugal techniques appear to be the best way currently available to fractionate human HDL into the subf ractions of HDL a HDL b and
2
2
HDL

3

(Lindgren et al., 1979).

Table 1 demonstrates the results of human

and other species lipoproteins isolated by sequential ultracentrifugation and analyzed for protein, phospholipid, triglyceride and both
esterified and unesterified cholesterol (Havel et al., 1955).
Variations of ultracentrifugal techniques have been developed all
based on the same principle of density adjustment with centrifugal force
used in separating the various density lipoprotein fractions.

Each

technique has advantages over the other, but all suffer from some limitations and differences in lipoprotein constituent values have been
obtained using different ultracentrifugal techniques (Hojnacki et al.,
1978; Shireman et al., 1983).

Ultracentrifugation can lead to lipopro-

tein degradation (Fainaru et al., 1977) and loss of cholesterol from the
various lipoprotein fractions (Marcel et al., 1981).

LDL has been dem-

onstrated to be significantly affected by ultracentrifugation, apo A-I
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is lost from HDL and salt gradients which tend to set up prior to
separation also interfere with lipoprotein resolution (Lindgren et al.,
1979).

Another drawback to ultracentrifugation is the time involved in

separating lipoprotein fractions, which can take up to a week to accomplish (Havel et al., 1955).
2.

Electrophoresis
Apolipoproteins on the surface of lipoprotein molecules display a

net charge which determines electrophoretic mobility and allows separation of lipoprotein classes by electrophoresis.

The lipoprotein net

charge is mostly determined by the balance of charges on terminal and
side-chain amino acid residues of the apolipoproteins.

Additional

charge contributions could be from absorbed metal cations and fatty acid
anions.

Phospholipids contribute little to lipoprotein electrophoretic

mobility, since over 90% of the phospholipids present in lipoproteins
exist in the zwitterionic state at physiological and electrophoretic pH
values (Hatch et al., 1968).
Ultracentrifugal separation of lipoproteins has often been correlated with various other methods for lipoprotein separation.

The lipo-

protein bands obtained by paper electrophoresis have been correlated to
ultracentrifugally isolated lipoproteins.

The density equivalents for

lipoproteins separated by paper electrophoresis has been determined as
follows: alpha
alpha

2

1

lipoprotein corresponds to HDL density 1.063-1.210 g/ml

lipoprotein also known as prebeta lipoprotein corresponds to VLDL

density less than 1.006 g/ml, beta lipoprotein corresponds to LDL with
density between 1.006 and 1.063 g/ml and the band at the origin corre-

18
sponds to chylomicrons (Lees et al., 1965; Levy et al., 1966).

Paper

electrophoresis, because it is less time consuming, easier to run and
correlates well with the ultracentrifugal methodology has been used to
phenotype human lipoprotein disorders previously only definable by
ultracentrifugal techniques (Fredrickson et al., 1965).

Unfortunately,

paper electrophoresis like ultracentrifugation has some problems.

Reso-

lution of lipoprotein bands by paper electrophoresis was poor until it
was improved by substituting a barbital-albumin buffer for the barbital
buffer used previously (Lees et al., 1963), however it still required 16
hours for an electrophoretic run.
Cellulose .acetate used as a support medium for electrophoresis was
found to be capable of excellent resolution of plasma lipoproteins without the requirement of albumin in the buffer within 15-45 minutes (Chin
et al., 1968; Beckering et al., 1970; Fletcher et al., 1970).

The use

of agarose gels and polyacrylamide gels for lipoprotein electrophoresis
does not markedly improve resolution of the lipoprotein fractions over
that of cellulose acetate nor is there any added convenience in the use
of gels (Conlon et al., 1979; Muniz, 1977).

Cellulose acetate electro-

phoresis is a suitable and convenient method for lipoprotein fractionation (Hatch et al., 1968).
Currently, isotachophoresis and isoelectric focusing are used in
lipoprotein research for the identification and characterization of apolipoproteins (Bon et al., 1981; Eggena et al., 1972).

The lipoproteins

are usually first isolated by ultracentrifugation, delipidated then
electrophoresed (Eggena et al., 1972). Delipidation however, does not
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always appear to be necessary (Bon et al., 1981; Bugugnani et al., 1984;
Godolphin et al., 1974), yet with nondelipidated lipoprotein fractions
isolated by high resolution electrophoretic techniques, the number of
subfractions resolved increases tremendously.

However, the increased

number of subfractions observed using high resolution techniques such
as, isoelectric focusing could be due to different distributions of
lipid content within the same class of lipoprotein (Rosseneu-Motreff et
al., 1969) or protein interaction with ampholytes (Hare et al., 1978).
Therefore, the number of subfractions of lipoproteins observed using
high resolution techniques could be due to the techniques and not to the
actual number of subfractions.
Accurate quantitation of

electrophoretically-separated plasma

lipoproteins with non-specific "total" lipid stains has been difficult,
because of each lipoprotein' s differing affinities for such stains
(Fletcher et al., 1970).

Such commonly used lipid stains as Sudan black

B, preferentially stain unsaturated ster-01 esters and unsaturated triglycerides, whereas unesterified cholesterol and phospholipids are
stained negligibly or not at all (Schjeide et al., 1963).

Moreover, the

various cholesterol esters and triglycerides have different staining
affinities for Sudan black B, dependent upon their particular fatty
acids.

Oil red 0, which is another commonly used "total" lipid stain,

stains cholesterol esters more intensely than Sudan black B, but its
staining is also dependent on the cholesterol ester's degree of fatty
acid saturation.

In addition, oil red 0 also stains triglycerides as

well as albumin, but does not stain phospholipids or unesterified cho-

r
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lesterol.

Recently a cellulose acetaxe electrophoretic technique, which

combines an enzymatic staining procedure for total cholesterol (Allain
~al.,

1974) has been developed for determining human plasma lipopro-

tein-cholesterol concentrations which are currently employed as risk
factors for human atherosclerotic disease (Cobb et al.,

1978).

enzymatic assay used cholesterol oxidase, which is specific for

The
3~

ster-

ols and requires a double bond in the delta 5 or delta 4 positions of
the steroid molecule.

Interference from sterols normally occurring in

human plasma using the enzymatic staining technique is less than 0.1%
the total plasma cholesterol concentration indicating the technique has
a high specificity for cholesterol in plasma (Richmond, 1973).

The

method of quantitating human plasma lipoproteins using enzymes specific
for cholesterol is more precise and accurate as opposed to "total" lipid
staining.
3.

Polyanionic Precipitation
Another group of methods used to separate and identify lipopro-

teins is polyanionic precipitation of which the most commonly used are
manganese heparin or dextran sulfate precipitation (Burstein et al.,
1960; 1970; 1973).

Precipitation techniques are usually rapid and can

be adjusted to clear solutions of any particular class of lipoprotein
.

.

merely by titrating the anion concentrations.

.

Lower density lipoprotein

classes are found in the precipitate while higher density lipoproteins
remain in the supernate.

Therefore, a chylomicron free solution can be

achieved by adding a low concentration of a polyanionic precipitating
agent and a VLDL/chylomicron free solution can be achieved by adding a
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higher concentration of precipitating agent.

Precipitation of each

lipoprotein fraction can be done sequentially until the solution is
lipoprotein free.

Recently, precipitation techniques have become more

refined and have been used to separate the HDL subfractions HDL
HDL

3

2

and

(Gidez et al., 1982).
Although HDL subfraction precipitation correlates well with ultra-

centrifugal studies, there is incomplete separation of HDL

3

from HDL ,
2

therefore the technique is only useful if a precise measurement of the
two HDL subfractions is unnecessary (Daerr et al., 1983).

This is indi-

cative of the major problem with precipitation methods, which is that
although the various lipoprotein density classes can be sequentially
precipitated, the resolution between lipoprotein classes is so close
that a portion of the lipoprotein class which is desired in solution may
also occur in the precipitate (Burstein et al., 1970).

In a study com-

paring various precipitation techniques to sequential ultracentrifugation (Warnick et al.,

1979a; 1979b), a good correlation was found

between the methods however,

differing HDL-cholesterol levels were

obtained depending on which method was used.

This would indicate that

the various precipitation techniques are not equivalent and can lead to
significant differences in HDL-cholesterol quantitation.
lem with precipitation techniques is

th~

Another prob-

inadvertent precipitatiori of

HDL containing apolipoprotein E along with the apolipoprotein B-containing lipoproteins (Mahley et al., 1977b).
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4.

Column Techniques
Many column techniques for obtaining pure lipoprotein fractions

require ultracentrifugal separation from the rest of plasma proteins
prior to applying the sample to the column.

Agarose column chromatogra-

phy for example which separates lipoproteins by size requires prior
purification by ultracentrifugation (Rudel, 1974).

Heparin affinity

chromatography is a good technique for isolating beta lipoprotein and
those lipoprotein fractions containing apo E, especially HDL containing
apo E, however purification of the isolated fractions requires further
manipulation, which can affect the nature of the lipoprotein being studied (Bentzen et al., 1982).

A new rapid lipoprotein separation techni-

que coupling high performance liquid chromatography (HPLC) with exclusion chromatography can use plasma volumes of two micro liters, but
sacrifices resolution, due to loss of sensitivity from using small
plasma volumes.

Therefore, only two plasma lipoprotein fractions, HDL

and LDL, could clearly be isolated from-human plasma.
1981).

(Ohno et al.,

Improvement in the HPLC technique will continue to occur and

with the use of larger plasma volumes the resolution between lipoproteins may be enhanced, which would make HPLC an excellent rapid technique for isolating plasma lipoproteins in pure form.
5. Immunoassay of
Apo lipoprote ins
Immunological techniques were developed to quantitate the apolipoprotein concentration within plasma as an easier alternative to ultracentrifugal isolation.

The first methods for apo A-I and apo B, the
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major apolipoproteins of HDL and LDL respectively, involved a double
antibody precipitation procedure which required plasma lipoprotein delipidation and 60 hours of incubation (Schonfeld et al., 1974a; 1974b).

A

radioimmunodiffusion assay was later developed for Apo A-I that correlated well with the double antibody procedure and with the HDL-cholesterol concentration in plasma (Albers et al., 1976).

Moreover, this

method was easier to perform, although, delipidation was still necessary
and the incubation time required 48-72 hours.

Recently, an improved

radioimmunoassay system for ape A-I was developed which used a detergent
that removed the necessity for plasma lipoprotein delipidation.

In

addition, an immunoglobulin absorbent was used which removed the free
from the bound antibody, eliminating the necessity for a second antibody.

This system required only a 10 minute incubation and correlated

well with double antibody techniques (Maciejko et al., 1982).

Moreover,

the new ape A-I radioimmunoassay technique also correlated well with
HDL-cholesterol concentrations (Maciejko et al., 1983).
Apo B quantitation using immunological techniques appears to be
best achieved by electroimmunoassay as demonstrated by its comparison to
radioimmunoassay and radioimmunodiffusion, since the latter two methods
appear to underestimate the amount of ape B present.

Moreover, the

electroimmunoassay appears to be the easiest to perform (Curry et al.,
1978).

A more recent assay has been developed using a competitive

enzyme linked immunoassay for ape B substituting changes in enzyme
activity for radioactivity.

This technique has correlated well with

angiographically described coronary artery disease (Vander Heiden et
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~·' 1984).

Any immunoassay is dependent on the purity of the antigen for
which the antibody is produced.

Apo A-I is a relatively easy apolipo-

protein to isolate and purify, while Apo B appears to be extremely difficult to isolate and purify (Bradley et al., 1980).

Another difficulty

with assays for apolipoproteins are that they may be found within different classes of lipoproteins.

Apo A-I is found in chylomicrons, VLDL

and HDL, although mostly in HDL, whereas apo B is found in VLDL and chylomicrons as well as LDL (Smith et al., 1978).

Epidemiological work is

currently underway to ascertain the significance of apolipoprotein measurement with regard to predicting atherosclerotic disease and the extent
of coronary artery disease with some promising preliminary results (see
section V.C. Lipoproteins and Atherosclerosis).

However, apolipoprotein

immunoassays greatest benefits may be in the explanation of the causes
for atherosclerosis and the further understanding of lipoprotein metabolism (Blackburn, 1983).
C.

Lipoprotein Synthesis and Metabolism

1. Triglyceride Rich
Lipoprotein Synthesis
Triglyceride rich lipoproteins include both chylomicrons and· VLDL
which are produced in the intestine and liver respectively.

The liver

in the fasting state produces about 80% of the plasma's triglyceride
rich lipoproteins (Windmueller et al.,

1968).

The core lipids which

include triglycerides and cholesterol esters are synthesized on the
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cytoplasmic surface of the endoplasmic reticulum (ER) (Coleman et al.,
19 78; Hashimoto et al., 1980; Lichenstein et al., 1980).

ACAT esteri-

fies cholesterol in the rough ER and then esters are transferred to the
smooth ER (Hashimoto,

1980).

Enzymes

responsible for

cholesterol

synthesis are also in the ER and the specific activity of HMG CoA reductase is highest in the smooth ER (Havel et al., 1973b), so the lipid
core and surface lipids of the lipoprotein can all be assembled in the
same area of the cell.
The apolipoproteins are probably synthesized on ribosomes bound to
the rough ER (Alexander et al., 1976).

Exactly where the lipoprotein

particles are packed is still unclear although there is some evidence it
occurs on the smooth ER (Alexander et al., 1976).

It has been proposed

that during synthesis the apolipoprotein is inserted into the lipid
bilayer of the ER.

Apolipoprotein is being synthesized at the same time

the core and surface lipids of the lipoprotein are being synthesized.
The nascent lipoprotein buds off from the ER with the apolipoprotein
attached when an excess amount of lipids are accumulated.

Lipid dro-

plets may bud off without the apolipoprotein and accumulate in the cell
when high cholesterol concentrations are present intracellularly, which
may be reflected by high plasma cholesterol concentrations (Swany,
1980).
The lipoproteins after packaging are transferred into the cisternae and secretory vesicles of the Golgi complex.

It was postulated

that specialized tubules transfer the nascent lipoproteins to the Golgi
apparatus from the ER (Alexander et al., 1976), although it is also pos-
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sible that the lipoproteins are transported via vesicular transport
(Novikoff et al., 1978).

Lipoproteins isolated from the Golgi apparatus

are similar to VLDL found in the plasma except Golgi lipoproteins contain more phospholipids and fewer apolipoproteins (Hamilton, 1980).

The

nascent lipoprotein particles are packaged in secretory vesicles and
transported to the sinusoidal surface of the cell where the vesicles
fuse with the plasma membrane and the lipoproteins are released.

VLDL

is released into Disse' s space of the liver and chylomicrons are
released into the basolateral spaces between intestinal absorptive cells
(Hamilton et al., 1967; Hamilton, 1972).
2. Triglyceride Rich
Lipoprotein CatabO'iiSm
Extrahepatic lipoprotein lipase EC 3.1.1.34 (LPL) (Nomenclature
Committee, 1979) is an enzyme bound to the endothelial luminal surface
of capillaries which supply the tissues that utilize circulating triglycerides (Scow et al., 1972). LPL forms free fatty acids and glycerol
from triglycerides and the rate of the reaction is strongly dependent
upon the particular lipoprotein present (Fielding, 1970).

A protein

cofactor present in VLDL and in chylomicrons was found to be responsible
for increased LPL activity (Havel et al., 1973a). Further investigation
revealed that the protein cofactor responsible for lipoprotein lipase
activity was apo C-II (LaRosa et al., 1970).

Moreover, the amount of

apo C present in VLDL was found to be dependent on the triglyceride concentration of VLDL (Eisenberg et al., 1975).

Chylomicrons have been

demonstrated to receive apo C from HDL (Havel et al., 1973c). In addi-
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tion, apo C was shown to transfer from HDL to VLDL as the triglyceride
concentration of plasma increases, while as lipolysis occurred apo C was
transferred back to HDL (Kashyap et al., 1977).
Two forms of lipoprotein lipase are released into the plasma of
rats and humans upon in vivo administration of heparin (Krauss et al.,
1973; 1974).

One form of lipoprotein lipase was inhibited by protamine,

while the other form was resistant to protamine.

The protamine resis-

tant lipoprotein lipase was found to be hepatic in origin, whereas the
protamine sensitive lipoprotein lipase was found to originate from the
capillary endothelium.

The activity of the hepatic lipoprotein lipase

appeared to be less than that of the extrahepatic lipoprotein lipase,
since VLDL was found to be a poor substrate for hepatic lipoprotein
lipase and an excellent substrate for extrahepatic lipoprotein lipase.
Hepatic lipoprotein lipase has been suggested to have a greater specificity for lipoprotein remnants, which are those lipoproteins that have
already been acted upon by extrahepatic lipoprotein lipase (Krauss et
al., 1973; 1974).

Moreover, hepatic lipoprotein lipase has been found

to have phospholipase activity (Enholm et al., 1975) and appears to be
localized exclusively on the surface of hepatic endothelial cells (Kuusi
et al., 1979).

Hepatic lipoprotein lipase appears to act on smaller

lipoprotein molecules preferring VLDL to chylomicrons and the lower density IDL to VLDL (Nicoll et al., 1980a).
Removal of human plasma chylomicrons from the circulation is
extremely rapid, since chylomicrons have a half life of about 5 minutes
(Grundy et al., 1976; Grundy, 1978).

Cholesterol incorporated into chy-
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lomicrons injected into rats was rapidly taken up by the liver with at
least 93% of the injected cholesterol found in the liver within 1 ·hour
after injection (Goodman, 1962).

Another study also using rats found

after 10 minutes only 20% of the chylomicron triglycerides in the liver
although, 80% of the injected cholesterol incorporated into chylomicrons
was found in the liver, (Redgrave, 1970).

These results were duplicated

in sheep and dogs (Bergman et al., 1971), indicating that extrahepatic
lipoprotein lipase removed triglyceride prior to uptake by the liver of
the chylomicron shell which contained the remaining esterified cholesterol core.

Humans with extrahepatic lipoprotein lipase deficiency have

very high levels of triglycerides within chylomicrons, which are not
taken up the liver.

This would be consistent with the proposed specif-

icity of hepatic lipoprotein lipase (Nicoll et al., 1980) and suggests
that a change must be made in the chylomicron molecule by extrahepatic
lipase as triglyceride is removed and a chylomicron remnant is formed.
The change in the chylomicron molecule may be the loss of apo C as triglyceride lipolysis occurs, since apo C may inhibit chylomicron binding
to the hepatic lipoprotein receptor (Shelburne et al., 1980; Windler et
al., 1980a). Receptor mediated rapid uptake of lipoproteins containing
apolipoproteins B and or Eby the liver (Brown et al., 1981) will be
discussed further (see section II.C.4. LDL Catabolism).
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3. VLDL Catabolism and LDL
Formation
Triglyceride rich VLDL formed and released from the liver, circulates in the plasma and is acted upon by extrahepatic and hepatic lipoprotein lipase which decreases the triglyceride content of VLDL, causing
an increase in VLDL density.

VLDL forms intermediate density lipopro-

tein (IDL), which has a hydrated density between 1.006-1.019 g/ml.

The

continued action of lipoprotein lipase on IDL results in the production
of LDL with a density between 1.019-1.063 g/ml.

This precursor product

relationship of VLDL and LDL was found by the injection of labeled VLDL
into humans and rats (Eisenberg et al., 1973a; 1973b).

Apolipoprotein B

was found to be produced in the liver and intestine of the rat
(Schonfeld et al., 1978) and is a component of chylomicrons, VLDL and
LDL (Schaeffer et al., 1978b). The apolipoprotein composition of LDL is
almost completely apo B (Schaefer et al., 1978b), therefore as VLDL
loses triglyceride by the action of lipoprotein lipase the apo B component of VLDL remains in the plasma, but each LDL particle becomes more
concentrated with apo B (Eisenberg et al., 1973a; 1973b).

Moreover, in

vitro incubation of VLDL with lipoprotein lipase rich plasma produced
IDL particles (Eisenberg et al., 1975).

Also, the conversion of VLDL to

LDL was found to be a one way process, since injection of labeled LDL
failed to show any labeled VLDL in human plasma (Langer et al., 1978).
The interaction of VLDL with lipoprotein lipase in humans was
found to be less efficient than lipoprotein lipase interaction with chylomicrons (Grundy et al., 1976; Grundy, 1978), since the half life for
plasma VLDL was determined to be 1-3 hours, which is much longer than
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that for chylomicrons (Bilheimer et al., 1972; Sigurdsson, et al.,
1975).

However, ape B from rat plasma VLDL was cleared more rapidly

from rat plasma than human plasma VLDL from human plasma, but the same
precursor product relationship exists between VLDL and LDL in both rat
and human (Faergeman et al., 1975).

The bulk of rat VLDL appears to be

removed directly from the circulation by specific hepatic receptors
before VLDL can be fully catabolized to LDL (see section II.C.4. LDL
Catabolism), which would partially explain why the LDL concentration of
rat plasma is so low (Stein et al., 1974).
4.

LDL Catabolism
The fractional catabolic rate of LDL in humans is dependent on LDL

clearance rather than LDL formation, since it was found that increases
in LDL appear to be due to problems in catabolism rather than increases
in LDL production (Sigurdsson et al., 1976).

In vitro analysis has

shown that fibroblasts when incubated with plasma lipoproteins derive
all their cholesterol from LDL (Brown et al., 1974a).

Moreover, a spe-

cific cell surface receptor that binds LDL with high affinity and specificity was found in cultured fibroblasts
Goldstein et al., 1974a; 1976).

(Brown et al., 1974b;

The specificity of the lipoprotein

receptor found in cultured fibroblasts has been determined to be for the
apolipoproteins E and B, which are major components of LDL, VLDL and
chylomicrons (Innerarity et al., 1978; Mahley et al., 1977c).

Electron

microscopic analysis demonstrated that LDL bound to the lipoprotein
receptor migrated to a coated pit on the cell surface (Anderson et al.,
1976; 1977a; 1977b; Orci et al., 1978) which contained 50-80% of the LDL
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receptors and appears to be specialized for rapid endocytosis.

The

receptor bound lipoprotein was ingested through absorptive endocytosis
following which, the internalized LDL was incorporated into endocytotic
vesicles that fused with lysosomes, where the protein component of LDL
was degraded into amino acids and released into the cell culture medium
(Goldstein et al., 1974a; 1975).

The cholesteryl esters of LDL were

hydrolyzed by a lysosomal acid lipase (Brown et al., 1975b) and the
unesterified cholesterol was transferred to the cellular compartment
where it was found associated with cell membranes (Brown et al., 1975c).
Unesterified cholesterol originating from LDL also suppressed HMG Co A
reductase (Brown et al., 1973) and activated ACAT facilitating reesterification of cholesterol within the cell (Brown et al., 1975a; Goldstein
et al., 1974b).

In addition, the LDL receptor was found to be regulated

by feedback inhibition, so that when fibroblasts were incubated with
LDL, the LDL receptor concentration per cell decreased (Brown et al.,
1975d).

The fibroblasts in the normal state preferred cholesterol from

LDL, since HMG Co A reductase was normally suppressed (Brown et al.,
1975c). Therefore, based primarily on in vitro studies of cultured
fibroblasts it has been suggested that the primary function of plasma
LDL is the transport of cholesterol to peripheral tissues to fulfill the
tissue's cholesterol requirements (Brown et al., 1981).

Moreover, using

membrane binding studies on bovine tissue high affinity LDL receptors
similar to those found in cultured fibroblasts were found on the membranes of the adrenal gland, ovary, liver, kidney, myocardium, spleen,
brain, erythrocytes, pancreas, thymus, skeletal muscle, testes, lung,
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jejunum, ileum and adipose tissue (Kovanen et al., 1979a), evidence that
this LDL receptor, also referred to as the classical LDL receptor is
found in almost every tissue of the body.
An alternative pathway for LDL degradation has been found to be

the scavenger pathway, which has low affinity binding, nonspecific
uptake and is dependent on plasma lipoprotein concentration (Goldstein
et al., 1974a).

The scavenger pathway appeared to be involved in non-

specific pinocytosis and is believed to degrade about 15% of human
plasma LDL daily (Goldstein et al., 1977b).

However, the scavenger

pathway did not appear to remove normal LDL from the plasma, but was
able to remove LDL which was exogenously modified to be more electronegative by acetylation or maleylation of isolated LDL using organic chemical means.

In other words, the scavenger pathway was found to remove

LDL which had lysine residues experimentally modified by acetylation or
maleylation, thereby increasing LDL's electronegativity (Brown et al.,
1980).

Acetylation of LDL probably does not occur in vivo (Goldstein et

al., 1979) however, LDL isolated from human lymph has been found to be
more electronegative than plasma LDL (Reich! et al., 1973; 1975).

More-

over, LDL incubated with cultured endothelial cells were found to be
more electronegative and had enhanced uptake by incubated macrophages
(Henriksen et al., 1981).

In addition, in vivo administration of the

exogenously modified LDL particles resulted in an increased uptake into
rat liver endothelial cells as compared to nonmodified native LDL molecules which were taken up primarily by liver parenchymal cells
(Nagelkerke et al., 1984).

The nature of any in vivo modification of
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LDL has yet to be determined.

Another macrophage receptor has been

found distinct from the acetylated LDL receptor, which binds LDL complexed with dextran sulfate.
to the receptor in the

However, since dextran sulfate will bind

absence of LDL, the receptor site appears to be

selective for dextran sulfate rather than LDL (Basu et al., 1979).
Initially, the scavenger cell pathway was found exclusively in
cultured macrophages whereas the classical LDL receptor pathway was
found exclusively in parenchymal and connective tissue (Brown et al.,
1980).

Monocytes incubated in vitro exhibited the characteristics of

the classical LDL receptor pathway, but as the monocytes matured they
expressed scavenger pathway activity indicating both receptors may exist
on the same cell type (Fogelman et al., 1981).

Since macrophages are

derived from monocytes (Wheater et al., 1979) it is possible that as
monocytes mature and leave the circulation they differentiate into
macrophages and lose the ability to bind LDL by the classical receptor
mechanism, although using immunocytochemical procedures cultured macrophages were observed to express both the classical and scavenger receptor pathways (Traber et al., 1983).

Recently, bovine endothelial cells

were demonstrated to possess both classical LDL and scavenger receptor
pathways (Baker et al., 1984; Stein et al., 1980).

However, human

endothelial cells may lack LDL scavenger receptors, since endothelial
cell do not appear to have lipid deposits, when examined in humans with
classical LDL receptor deficiencies (Buja et al., 1979).

Lipid laden

cells known as foam cells (see section V.C.2. LDL and Cholesterol) found
in humans suffering from classical LDL receptor deficiencies were found
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to be derived from smooth muscle cells or macrophages (Cookson, 1971)
with at least 80% derived from macrophages (Vedeler et al., 1984).
These foam cells were found to be distributed in tissues throughout the
body, including the stromal cells of the thymus, spleen, skin, kidney
and also in the aortic and mitral valves (Buja et al., 1979).

The chief

source of lipoprotein receptors in the body for both the classical
receptor and the scavenger receptors appears to be the liver (Kovanen et
al., 1979a), with about 75% of the body's classical LDL receptor present
in the liver (Bilheimer et al., 1984; Spady et al., 1983).

The liver

parenchymal cells which are the hepatocytes (Leeson et al., 1981) contain the classical LDL receptors, whereas the Kupfer cells contain the
scavenger LDL receptors (Brown et al., 1980).

As previously mentioned,

rat liver endothelial cells also appear to have the scavenger cell
receptors (Nagelkerke et al., 1984).
The classical LDL lipoprotein receptor pathway

has a limit to the

amount of cholesterol it will take up due to feedback control on LDL
receptors, whereas the scavenger pathway has no limit and appears to be
the chief pathway for LDL degradation in humans with an effective lipoprotein receptor deficiency (Goldstein et al., 1977a; 1977b).

Moreover,

massive accumulation of cholesteryl ester has been found to occur in
mouse macrophages incubated in vitro and might account for the widespread deposition of LDL-derived cholesteryl esters found in the macrophages of humans suffering from an effective lipoprotein receptor deficiency (Goldstein et al., 1979).

Humans suffering from an effective

lipoprotein receptor deficiency have what is known as familial hypercho-
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lesterolemia, also known as hyperlipoproteinemia type Ila, which may be
due to a lack of classical LDL lipoprotein receptors, inability of LDL
to bind to classical lipoprotein receptors or to an inability of the
classical lipoprotein receptor LDL complex to be internalized into the
cell (Anderson et al., 1977b; Brown et al., 1974b; Goldstein et al.,
1976).

This condition results in extremely high plasma cholesterol lev-

els and humans suffering from this disorder have a greater potential for
developing coronary artery disease (see section V.C.2. LDL and Cholesterol).
5.

HDL Synthesis
HDL synthesis and secretion have been demonstrated in the small

intestine and in the liver of humans and rats (Green et al., 1978; 1979;
Hamilton et al., 1976; Marsh, 1974; 1976; Noel et al., 1974; Roheim et
al., 1966).

The contributions of the intestine and the liver to HDL has

been difficult to determine, even though there is a difference in the
apolipoprotein pattern of nascent HDL from each source.

HDL from the

intestine contains newly synthesized ape A-I and small amounts of ape E
and ape C, while HDL from the liver has a high ape E content, but little
ape A-I and apo C (Felker et al., 1977; Hamilton, 1976; Imaizumi et al.,
1978a; 1978b; Marsh, 1976; Wu et al., 1979).

HDL secreted from perfused

liver is disc shaped composed of proteins, phospholipids and cholesterol
with almost no cholesteryl ester (Hamilton, 1976).

The discoidal HDL

particles may be formed from triglyceride rich lipoproteins by the
actions of lipoprotein lipase following their secretion from the liver
and intestine, since VLDL incubated in vitro with lipoprotein lipase
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yields particles similar to HDL (Patsch et al., 1978).

Moreover, tri-

glyceride rich lipoproteins have been proposed to be a plasma source of
HDL due to extrahepatic lipoprotein lipase, which decreases triglycerides from the core of VLDL or chylomicrons shrinking the lipoprotein
molecule.

The surface of the triglyceride rich lipoproteins, containing

apolipoproteins and phospholipids would then bud off,

due to the

decreased size of the core which it surrounds forming nascent high density lipoproteins (Tall et al., 1978).

In addition, this would explain

the inverse relationship found between HDL concentration and VLDL concentration (Nikkila et al., 1978; Tall et al., 1978).

Further plasma

metabolism of HDL involves the enzyme lecithin:cholesterol acyltransferase (LCAT).
6.

LCAT
Lecithin:cholesterol acyltransferase, EC 2.3.1.43 (Nomenclature

Committee, 1979) abbreviated as LCAT is a plasma enzyme responsible for
the conversion of unesterified cholesterol to esterified cholesterol
(Glomset, 1962).

Lecithin and unesterified cholesterol in

~he

presence

of LCAT produce esterified cholesterol and lysolecithin, the fatty acid
from lecithin forming an ester linkage with the 3
cholesterol.

~

hydroxyl group of

The source of the fatty acid of the cholesteryl ester is

from the C-2 position of lecithin.
LCAT has been shown to be sensitive to sulfhydryl group blockers
like sodium p-hydroxymercuribenzoate (PHMB) or p-chloromercuribenzoate
(PCMB) (Hellerman et al., 1943), which act as reversible inhibitors of
cholesterol esterification (Glomset, 1962).

The mercurial sulfhydryl
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group blocker inhibit the enzyme by forming a mercaptide with the cystine sulfhydryl group.

The process can be reversed with a thiol donat-

ing substance such as mercaptoethanol.

The reaction using PCMB as the

thiol blocker on a protein (P) and the reverse reaction using a thiol
donating agent (RSH) would proceed as follows:
a. P-SH + Cl-Hg-C H COONa
6 4
b. P-S-HgC H COONa + RSH
6 4

4

4

P-S-HgC H COONa + HCl
6 4
P-S-H + R-S-HgC H COONa
6 4

(Benesch et al., 1962; Hamilton, 1960).

p-Chloromercuriphenylsulfonic

acid or p-chloromercuriphenylsulfonate (PCMPS) as shown in figure 2,
another mercurial thiol blocking agent (Velick, 1953) used to inhibit
LCAT activity (Glomset et al., 1970) is an analogue of PCMB with a sulfate

group

that

(Vansteveninck

enhances
et

al.'

the

molecule's

1965).

An

aqueous
LCAT

solubility

inhibitor

5,5'-dithiobis-2-nitrobenzoic acid (DTNB) (Stokke et al., 1971), which
binds to thiol groups (Ellman, 1959), has been found to bind to two of
four half cysteine residues found to be associated with the LCAT molecule, indicating that the SH group of at least one of two cystines may
be at the active site and that a disulfide cross linked cysteine is
probably present within the LCAT molecule (Chong et al., 1983).

Large

quantities of lysolecithin have also been found to inhibit LCAT activity
(Fielding et al., 1972a), but with the addition of albumin LCAT activity
returns to normal probably due to loss of lysolecithin from albumin
binding (Aron et al., 1978).
At least two protein cofactors present in the plasma appear to
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enhance LCAT activity and they have been identified as apo A-I and a
subfraction of the apo C family.

Moreover, both protein cofactors have

been found to be associated with lipoproteins, particularly HDL (Aron et
al., 1978; Fielding et al., 1972b; Kostner, 1978).

LCAT has been shown

to act preferentially with HDL (Glomset, 1970), while LDL and VLDL
seemed not to have an effect on LCAT activity, although recently LCAT
has been demonstrated to have some activity with LDL (Barter, 1983).
The HDL particle secreted from the perfused liver has been found to be a
good substrate for LCAT (Hamilton, 1976) and these nascent HDL particles
also appear to be similar to those found in the plasma of patients with
LCAT deficiency (Forte et al., 1971).

In addition, HDL , the denser of
3

the HDL subtractions which can be isolated by ultracentrifugal techniques appeared to be the preferred LCAT substrate in humans (Fielding et
al., 1971), whereas HDL

2

appeared to inhibit the LCAT reaction (Fielding

et al., 1971; Fielding et al., 1972a; Pinon et al., 1980), although LCAT
does not appear to be affected by the ratios of apo
HDL subfractions.
complex with HDL

3

A~I

to apo A-II in

Moreover, studies have indicated that LCAT may form a
and VHDL (Fielding et al., 1980; Jahani et al., 1981).

LCAT incubated in vitro with apo A-I and cholesterol liposomes caused
LCAT to be inhibited by the accumulation of cholesteryl esters (Chajek
et al., 1978), which could explain why LCAT prefers cholesteryl ester
poor HDL

3

and is inhibited by cholesteryl ester rich HDL . The Vmax of
2

LCAT activity was found to be 2.4-4 times greater for HDL
after incubating plasma with different mixtures of HDL

2

3

than HDL ,
2

and HDL

Km for HDL 3 was 43-60 nmol/ml and 167-391 nmol/ml for HDL2 .

3

and the

A pre-
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dictive model formulated on the basis of the kinetic studies showed that
at physiological concentrations HDL

2

could act as a competitive inhib-

itor of the cholesterol esterification reaction displacing the effective
substrate HDL

3

by the less effective substrate HDL

2

(Barter et al.,

1984).
In vivo esterification of cholesterol by LCAT in man has been
estimated to be about 0.12 micromoles per ml plasma per hour (Glomset,
1962; Nestel et al., 1967).

An in vitro comparison of rat LCAT activity

to human showed the initial rate of cholesterol esterification in the
rat was approximately four times that of the human (Frolich et al.,
1975).

However, it is not clear whether this difference is related to

substrate concentration, enzyme or enzyme cofactors, since the comparison was not performed on the same substrate.

Another difference between

human and rat cholesterol metabolism was found to be that in the human
the enzyme most responsible for plasma esterification of cholesterol is
LCAT whereas in the rat both plasma LCAT and the liver intracellular
enzyme ACAT are responsible for the cholesteryl esters found in plasma
lipoproteins (Glomset, 1970).

This will be discussed more thoroughly

later (see section III.B.1. Cholesteryl Ester Transfer and Exchange).
7.

HDL Metabolism
The half life of HDL in the plasma is on the order of five to six

days (Brown et al., 1981).

Most cells utilize the cholesterol from LDL

via the LDL receptor pathway for cholesterol needs, however in rat adrenal and gonadal tissue, HDL may be the source of exogenous cholesterol
and may regulate sterol synthesis in those tissues (Andersen et al.,
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1979).

Rat adrenal cells incubated with HDL and LDL took up cholesterol

two to three times more from HDL than LDL.

Moreover, HDL-cholesterol

uptake was enhanced when ACTH was given to the rats before adrenalectomy, but LDL-cholesterol uptake was unaffected (Gwynne et al., 1976).
It has been suggested that the uptake of HDL-cholesterol is a receptor
mediated saturable process different from the LDL receptor pathway,
since only the cholesterol carried by the HDL particle and not the HDL
particle itself has been shown to be taken up by the cell (Gwynne et
al., 1980).

In addition, rat adrenal steroids have been demonstrated to

be derived from both HDL and LDL, but in the human only from LDL has
adrenal cholesterol uptake been demonstrated (Brown et al., 1979).

Cul-

tured cells from rat ovaries obtained cholesterol exclusively from HDL
for the production of progesterone whereas, estrogen synthesis was unaffected by lipoproteins present (Weinstein et al., 1980).

High affinity

binding of HDL has been demonstrated in the rat testes, for which VLDL
competed but LDL did not.

Moreover, the binding of HDL to the gonadal

tissue showed a two fold increase, when human chorionic gonadotropin was
added without an increase in affinity (Chen et al., 1980).

Evidence has

been given for the existence of a lipase in the adrenals of rats and
humans similar in nature to hepatic lipoprotein lipase (Jansen et al.,
1981).

It has been proposed that hepatiC lipase favors the hydrolysis

and removal of phospholipids from HDL.

This increases the relative

amount of unesterified cholesterol on the surface area of the HDL particle, which would facilitate the influx of unesterified cholesterol into
those cells which had hepatic lipoprotein lipase like activity.

Since
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lipoprotein lipase activity similar to hepatic lipase has been found on
the adrenals of humans and rats as well as the ovaries of rats, this
could explain the specific uptake of HDL-cholesterol in those tissues
(Jansen et al., 1980).
Specific lipoprotein receptors as mentioned previously (see section II.C.4.

LDL Catabolism) have an affinity for HDL containing apo E,

although there may be a qualitative and or quantitative difference
between the rat and human LDL receptor (Drevon et al., 1981).

The lipo-

protein receptor for LDL, which has been found on rat fibroblasts and
smooth muscle cells has an affinity for in decreasing order:

chylomi-

cron remnants, VLDL, LDL and HDL (apo E containing lipoproteins).

More-

over, these affinities are increased if the lipoproteins are cholesterol
enriched (Innerarity et al., 1980).

Due to the long half life of HDL

without apo E it is unlikely that a specific lipoprotein receptor exists
for HDL as it does for LDL.

LDL, VLDL and HDL

c

were found to affect

cultured swine aortic smooth muscle cell· HMG Co A reductase activity in
a concentration related response, yet HDL could not lower the enzyme's
activity more than 25% (Assman et al., 1975).

In addition, no high

affinity binding of HDL has been detected, although low affinity uptake
has been noted in fibroblasts probably due to nonspecific pinocytosis
(Miller et al., 1977).

Also, the binding of HDL was tinaffected by.incu-

bation with fibroblasts from patients with familial hypercholesterolemia
(Miller et al., 1978), further proof that HDL does not compete with LDL
for binding on the classical lipoprotein receptor.
HDL has been postulated to remove cholesterol from the surface of
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cells assisted by the actions of LCAT.

LCAT could continuously create

space on the surface of the HDL molecule for unesterified cholesterol to
accumulate as the esterif ied cholesterol was internalized into the core
of the molecule and in this way HDL would attract more unesterified chalesterol from cell surfaces (Glomset et al.,

1973).

It has been

reported that the uptake of cellular unesterified cholesterol by HDL is
determined by the rate of desorption of cholesterol out of the cell membrane into the aqueous phase surrounding the cell as well as the distance of diffusion to HDL (Phillips et al., 1980).

The rate of choles-

terol efflux from cells may also be modulated by apolipoprotein A-I
(Fielding et al., 198lb). fforeover, macrophage hydrolysis of cholesteryl
esters and excretion into the medium was found to be dependent on chalesterol acceptors present in the incubation medium, particularly HDL
(Ho et al., 1980).

Therefore HDL probably acts as a cholesterol scaven-

ger lipoprotein, accumulating cholesterol from the surface of cells and
apparently does not compete with LDL for receptor binding either through
the classical lipoprotein receptor pathway or the scavenger lipoprotein
receptor pathway.
D.

Rat Lipoprotein

1. Composition Compared to
~
No other species outside of humans has been studied more extensively as to their lipoprotein content and metabolism as the rat.

Many

remarkable similarities can be found between rat and human lipoproteins,
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especially in the structure of the apolipoproteins and also some
disparities can be found such as the lipoprotein and apolipoprotein distribution (Chapman, 1980).

Comparison of HDL apolipoproteins between

rat and human using SDS polyacrylamide gel electrophoresis appeared to
indicate that the major HDL apolipoprotein, A-I, in both species was
identical in terms of electrophoretic mobility.

Apo A-II however, was

found to be a minor component of rat serum HDL and a major component of
human serum HDL (Swaney et al., 1974).

Apo A-IV and arginine-rich apo-

lipoproteins were first found in rat HDL and not human HDL, however apo
A-IV has since been found in human VLDL (Beisegel et al., 1979).

Apo

A-II appears to be in monomeric form in the rat as well as in other species including the rabbit and monkey, whereas it is in dimeric form in
the human.

The minor apo C proteins found in HDL and VLDL are homolo-

gous to those of the human (Herbert et al., 1974).

Arginine rich lipo-

protein also known as apo E (Smith et al., 1978) has been found in the
human as a minor component of HDL and a major component of VLDL and chylomicrons (Havel et al., 1973c). In contrast, rat apo E appears to be a
major constituent of the HDL subfraction HDL

1

and VLDL (Quarfordt et

al., 1978; Weisgraber et al., 1977).
Data on rat lipoprotein composition is very inconsistent and varies with strain, diet, and methods used for isolation (Chapman, 1980).
Table 2 indicates the composition of rat lipoprotein as compared to
human lipoprotein using similar isolation techniques.

Ultracentrifugal

separation of rat plasma demonstrated that LDL had a density range
between 1.040-1.050 g/ml, and an HDL/LDL overlap which occurred between
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densities 1.050-1.063 g/ml (Lasser et al., 1973), in contrast to human
HDL which has a more distinct separation between HDL and LDL (Chapman,
1980).

No lipoprotein was found in the density fraction between

1.006-1.030 g/ml of normal rats however, rats fed a high cholesterol
diet had lipoproteins which appeared in the 1.006-1.030 g/ml fraction,
whereas lipoproteins decreased in the density 1.070-1.210 g/ml fraction
(Lasser et al., 1973).

Ultracentrifugal separation of rat plasma VLDL

(density less than 1.006 g/ml), LDL (density 1.006-1.040 g/ml) and HDL
(density 1.063-1.210 g/ml) followed by agarose gel electrophoresis indicated that the lipoproteins had homogenous bands with HDL migrating in
the prealbumin region. It was also found upon ultracentrifugation of rat
plasma that in the density range between 1.040-1.063 g/ml LDL and HDL
cross contaminate (Koga et al., 1969).

Besides the differences in the

major lipoprotein fractions between rat and human, a difference is
apparent between rat and human HDL subfractions.

Initially, rat HDL was

subfractionated into density components corresponding to human HDL
HDL

3

by preparative ultracentrifugation.

Both HDL

2

and HDL

acterized by negative staining and electron microscopy.

3

2

and

were char-

Rat HDL

2

iso-

lated between the densities 1.063-1.125 g/ml appeared to be homogeneous
spherical particles, whereas rat plasma HDL

3

appeared to be heterogene-

ous in size and shape (Pasquali-Ronchetti et al., 1975).

In contrast,

using rate zonal ultracentrifugation for isolating rat plasma HDL subfractions only HDL

1

and HDL

2

subfractions could be identified and no

subfraction corresponding to human HDL

3

appeared (Oschry et al., 1982).

Currently, the evidence indicates that the rat has only two HDL subfrac-
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tions as compared to three for the human.
2. Rat Plasma Lipoprotein
Elect;;phoretic Patterns
Paper electrophoresis of rat plasma using a Sudan black B stain
revealed alpha, beta and prealbumin lipoprotein bands among the 5 major
plasma protein bands.

An alpha

2

band which appeared in rat serum after

a high cholesterol diet was found to be unstable, due to changes which
occurred in the band upon storage of the hypercholesterolemic samples
(Watson, 1961).

Agarose gel electrophoresis of rat whole plasma com-

bined with a Sudan black B stain also appeared to suggest a prealbumin
lipoprotein band, however in this system lipid-stained bands migrated
consistently farther than their corresponding amide black proteinstained bands (Johansson et al., 1976).

Human plasma alpha

1

lipoprotein

also separated by agarose gel electrophoresis appeared to have the same
electrophoretic mobility as albumin, with the lack of electrophoretic
resolution between albumin and alpha

1

lipoprotein possibly being due to

nonspecific albumin staining (Johansson et al., 1976; Schjeide et al.,
1963).

In addition, agarose starch gel electrophoresis of rat plasma

using a combined oil red 0 and fat red 7B "total" lipid stain also
appeared to suggest bands which had prealbumin, alpha , prebeta and beta
1
electrophoretic mobility
alpha

1

(Chalvardjian, 1971).

The prealbumin and

bands appeared to correspond to HDL, since after ultracentrifugal

fractionation of the plasma, these two bands had a density range greater
than 1.063 g/ml, while the prebeta band corresponded to VLDL, and the
beta band corresponded to LDL.

However, no attempt was made to deter-
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mine the

actual cholesterol content of

the prealbumin-migrating

lipoprotein band visualized by a "total" lipid stain.
3. Metabolism and Response to
Hypercholesterolemia
Lipoprotein composition may change with dietary status.

However,

the cholesterol to protein ratio for HDL did not change in rats fed high
cholesterol diets, indicating that the amount of cholesterol found in
the rat plasma HDL fraction reflects the number of HDL particles present.

In contrast, the rat plasma LDL cholesterol to protein ratio

increased in rats fed a high cholesterol diet suggesting more cholesterol was being carried by less protein, therefore plasma LDL-cholesterol concentration appears not to be as good an indicator of the total
number of plasma LDL particles in the cholesterol fed rat as the plasma
HDL-cholesterol concentration is.

Yet without changing the amount of

cholesterol in the diet, the cholesterol to protein ratios for all rat
plasma lipoproteins remained constant, therefore plasma lipoprotein-cholesterol concentrations may directly relate to plasma lipoprotein concentrations (Frnka et al., 1974).

Dietary induced hypercholesterolemia

produced lipoprotein profile changes in the rat including the appearance
of two different lipoprotein fractions, a VLDL with beta electrophoretic
mobility and an HDL of lower density referred to as HDL
1977a). HDLc has been found to have an alpha

2

c

(Mahley et al.,

mobility using paper and

agarose gel electrophoresis and was found within the density range
·between 1.006-1.02 g/ml, yet HDL
teins of alpha

1

c

lacked apo B. Moreover, HDL lipopro-

mobility and arginine rich apolipoprotein decreased in
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the density 1.08-1.210 g/ml fraction while HDL
were fed high cholesterol diets.

c

increased, when rats

LDL and VLDL became the principle cho-

lesterol carrying rat plasma lipoproteins after dietary induced hypercholesterolemia (Mahley et al., 1977a).
A lipoprotein designated HDL

1

was found by ultracentrifugally

fractionating normal rat plasma in the density between 1.02-1.063 g/ml.
In addition, HDL
sis.

HDL

1

1

was separable from LDL by Geon Pevikon electrophore-

was found to be the normal rat's equivalent to HDLc present

in the hypercholesterolemic rat (Weisgraber et al., 1977).

HDL

1

has a

high arginine rich apolipoprotein content which when injected into normal rats finds its way to HDL, but in hypercholesterolemic rats is more
predominant in beta VLDL, LDL and HDL .
c

HDL

c

production following high

dietary cholesterol feeding has been demonstrated in other species
besides the rat, including the dog and human (Mahley, 1978).
III.

INTRAVASCULAR TRANSFER OF LIPOPROTEIN LIPIDS

A. Lipoprotein-Unesterified Cholesterol Transfer

1.

Equilibration
Unesterified cholesterol was found to equilibrate between plasma

lipoproteins during an in vitro 37 °C incubation within 2-5 hours, which
was observed using incubations of rat plasma perfused through the liver.
However, unesterified cholesterol would not equilibrate between plasma
lipoproteins when rat plasma was incubated at 4 °C. Moreover, unesterified cholesterol was found to exchange between all rat plasma lipoproteins as did triglycerides and phospholipids, but rat plasma esterified
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cholesterol was not observed to exchange between plasma lipoprotein.
(Roheim et al., 1963). Human cord blood incubated at 37 °C with HDL and
LDL as the only lipoproteins present, demonstrated a net mass transfer
of unesterified cholesterol from LDL to HDL (Sniderman et al., 1978).
2. LCAT's Relationship to
Unesterified Cholesterol
Transfer
Net transfer of unesterif ied cholesterol between plasma lipoproteins does not appear to occur when LCAT is inhibited (Fielding et al.,
198la; Perret et al., 1983), yet a time lag of 2-5 hours is required for
unesterif ied cholesterol concentrations to equilibrate between the lipoproteins.

The transfer of unesterified cholesterol to HDL is probably

due to LCAT activity creating an unsaturated HDL particle with respect
to unesterified cholesterol, allowing more unesterified cholesterol to
accumulate on the HDL particle (Perret et al., 1983).

Therefore, the

time lag for equilibration of unesterif ied cholesterol between plasma
lipoproteins incubated in vitro when LCAT was inhibited must reflect the
time it would take for the relatively unsaturated HDL particles to reach
saturation with respect to unesterified cholesterol.

The transfer of

unesterified cholesterol is believed to be a passive process whether
between plasma lipoproteins or between cells and lipoproteins (Glomset
et al., 1966; 1973; Phillips et al., 1980), however apo A-I the major
apolipoprotein component of HDL appears to promote sterol efflux from
the cell surf ace of fibroblasts during an in vitro incubation (Fielding
~al.,

1981b).

The combination of HDL being the preferred substrate

for LCAT activity and apo A-I promoting sterol efflux could account for
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the passive transfer of unesterified cholesterol to the HDL molecule in
vitro as well as in vivo, when LCAT is active .

.c-------

B.

Lipoprotein-Cholesteryl Ester Transfer

1. Cholesteryl Ester Transfer
and Exchange
Rat plasma cholesteryl ester turnover was found to be dependent on
the fatty acid moiety and the lipoprotein class, unlike human plasma
where cholesteryl ester turnover is similar for all cholesteryl esters.
This is due to the marked heterogeneity between cholesteryl esters of
all rat lipoproteins as compared to the homogeneity of human plasma
lipoprotein-cholesteryl esters (Gidez et al., 1967).

An in vivo study

on humans performed using labeled mevelonate suggested a process exists
by which cholesteryl esters equilibrate between plasma lipoproteins.
However, some heterogeneity was found to exist between the cholesteryl
ester composition of each human plasma lipoprotein class, indicating
that the same mechanism operates to equilibrate the cholesteryl ester
content of human plasma lipoprotein fractions, but at a different rate
(Goodman, 1964).

Unesterified cholesterol and phospholipid decreased

with a concomitant increase in cholesteryl esters after a 36 hour in
vitro incubation of human plasma.

In addition, triglycerides increased

in HDL while cholesteryl ester decreased during the incubation suggesting that a transfer and exchange of cholesteryl ester for triglycerides
occurred between other lipoproteins and HDL (Rehnborg et al., 1964).
Moreover, the cholesteryl ester content of human plasma VLDL increased,
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while the cholesteryl ester content of LDL and HDL decreased after a 16
hour incubation at 37 °C when LCAT was inhibited. At the same time, VLDL
triglycerides were shown to decrease, while LDL and HDL triglycerides
increased (Nichols et al., 1965).
An exchange of cholesteryl esters between HDL and LDL was demonstrated to occur when human cord blood was fractionated and incubated
with HDL and LDL alone, but no evidence of cholesteryl ester transfer
was observed.

Cholesteryl ester exchange was determined by the movement

of labeled cholesteryl ester from one lipoprotein to another without a
concomitant change in cholesteryl ester concentration, while cholesteryl
ester transfer was determined by changes in lipoprotein-cholesteryl
ester concentration.

However, VLDL was not included in the incubation

medium of this study limiting the ability to determine whether lipoprotein-cholesteryl ester transfer could occur between HDL and VLDL
(Sniderman et al., 1978).

In contrast, net transfer of cholesteryl

esters from HDL to VLDL was found when tritiated cholesterol dissolved
in HDL was administered to rabbits in vivo, while lipoprotein-cholesteryl ester exchange was not observed to occur (Barter et al., 1979b).
The sources for human plasma VLDL cholesteryl esters were established to
be both the liver and the plasma in humans (Barter, 1974a; 1974b), then
it was determined that the plasma source.of VLDL cholesteryl esters was
HDL (Barter, 1976).
It was established by using ultracentrifugal techniques coupled
with radioisotopic labeling of cholesteryl esters that rat plasma lacked
significant cholesteryl ester transfer activity as compared to other
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species (Barter et al., 1978).

Many species appear to have the ability

to transfer esterified cholesterol between plasma lipoproteins with the
exceptions being the rat, dog and pig (Ha et al., 1982).

The reported

lack of cholesteryl ester transfer activity in rat plasma could explain
the heterogeneity found between the cholesteryl ester composition of the
rat's plasma lipoproteins as compared to the homogeneous cholesteryl
ester composition of human plasma lipoproteins due to the exchange and
transfer of cholesteryl esters between lipoproteins.

Since VLDL is syn-

thesized in the liver the cholesteryl ester composition of rat plasma
VLDL is determined by the liver and plasma HDL-cholesteryl ester composition is determined by plasma LCAT activity.
2.

Lipid Transfer Factor
Due to the lack of lipoprotein-cholesteryl ester transfer in some

species and not in others and to the energy requirements needed to
remove cholesteryl ester from the core of the lipoprotein molecule, a
plasma transfer factor was postulated to exist, which could perform the
plasma lipoprotein-cholesteryl ester transfer process (Goodman, 1964;
Nichols et al., 1965).

The rabbit fed a high cholesterol diet was found

to have a plasma fraction of density greater than 1.25 g/ml which could
stimulate plasma lipoprotein-cholesteryl ester transfer or exchange and
LCAT activity was proportional to lipoprotein-cholesteryl ester transfer, although cholesteryl ester transfer still occurred when LCAT was
inhibited (Zilversmit et al., 1975).

Moreover, a cholesteryl ester

exchange protein was isolated in the density greater than 1.210 g/ml
plasma fraction of rabbit plasma which could be demonstrated to.exchange
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labeled cholesteryl ester between rabbit LDL and bovine HDL.

In con-

trast to the density greater than 1.25 g/ml plasma fraction, the plasma
fraction denser than 1.210 g/ml seemed only responsible for exchange of
cholesteryl ester between LDL and HDL, while LCAT

had no relationship

to exchange activity (Pattnaik et al., 1978).
The possibility arose that a previously described apolipoprotein,
apo D, might be the cholesteryl ester transfer protein, since the transfer protein isolated by one group of investigators seemed to have the
same isolation and electrophoretic characteristics as apo D (Chajek et
al., 1978).

However, a more purified lipid transfer protein did not

have the characteristics of any previously described apolipoprotein,
including apo D (Morton et al., 1982).

A transfer complex isolated from

human plasma had HDL substrate specificity, but it could not be established whether this complex which contained LCAT and HDL was an artifact
of ultracentrifugation (Fielding et al., 1980).
shown that HDL

3

However, it has been

and VHDL incubated with·LCAT supply cholesteryl esters

for transfer to VLDL.

Furthermore, it was suggested that an HDL /LCAT
3

complex exists producing by LCAT activity a smaller lipoprotein which
may be transferred to acceptor lipoproteins which could account for
lipoprotein-cholesteryl ester transfer (Rose et al., 1982).
Plasma LCAT activity, although not.necessary for lipoprotein·-cholesteryl ester exchange was proportional to cholesteryl ester transfer
activity in the hypercholesterolemic rabbit.

Therefore, the more cho-

lesteryl ester present in plasma the more exchange or transfer of cholesteryl ester between lipoproteins occurred (Zilversmit et al~, 1975).
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Plasma lipoprotein-cholesteryl ester transfer from HDL to VLDL and
chylomicrons was demonstrated when LCAT was inhibited, while no cholesteryl ester transfer could be observed from HDL to LDL (Marcel et al.,
1981). However when LCAT activity was present, a net mass transfer of
cholesteryl ester from HDL to LDL and VLDL occurred, which was only limited by the concentration of the cholesteryl ester acceptors, LDL and
VLDL, present in the incubation medium (Chajek et al., 1978).

Since LDL

was recently shown to support a limited amount of LCAT activity (Barter,
1983), this may account for the observed transfer of cholesteryl ester
from HDL to LDL, because esterification of unesterified cholesterol and
its incorporation into LDL may appear to be transfer if LCAT is not
inhibited.

Transfer of plasma lipoprotein-cholesteryl esters from HDL

to VLDL appeared to be more rapid than cholesterol esterif ication by
LCAT in rabbit plasma.

However, lipoprotein-cholesteryl ester transfer

or exchange in human plasma occurs at about the same rate as cholesterol
esterification (Nestel et al., 1979).

Moreover, HDL

3

the subfraction

for which LCAT is most specific in human plasma (Fielding et al.,
1972a), appears to have the most lipoprotein-cholesteryl ester transfer
activity (Greener et al., 1984).

In addition, the cholesteryl ester

content of VLDL and chylomicrons could be due to the activity of LCAT
and lipoprotein-cholesteryl ester transfer activity in those species
which have a lipoprotein-cholesteryl ester transfer factor (Marcel et
al., 1980).

Therefore, the evidence indicates that the ultimate source

of cholesteryl esters for transfer in the human is LCAT (Schwartz, et

al., 1982).
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Cholesteryl ester exchange has been observed between lipoproteins
and phospholipid vesicles, but only between HDL and the vesicles, since
LDL and VLDL could not promote exchange, when incubated alone with the
phospholipid vesicles (Pattnaik et al., 1979).

Cholesteryl ester trans-

fer from HDL to vesicles was found to require the density greater than
1. 210 g/ml fraction of either human or rabbit serum and cholesteryl
ester transfer was also found to occur with either HDL , HDL or HDL
1
2
3
(Young et al., 1981). LDL and VLDL incubated together appeared to
exchange cholesteryl ester between each other, but no transfer of cholesteryl esters was observed (Chajek et al.,

1978).

In contrast,

another study demonstrated that lipoprotein-cholesteryl ester transfer
may occur between LDL and VLDL (Barter et al., 1980).

The probability

of a transfer protein picking up esterified cholesterol in human plasma
for HDL versus VLDL versus LDL is 28.9:4.65:1 (Barter et al., 1982b),
which would explain the preference for obtaining cholesteryl ester for
transfer from HDL (Chajek et al., 1980).·

Moreover, this would suggest

that the lipoprotein-cholesteryl ester transfer protein may be nonspecific (Barter et al., 1982a).
C.

Lipoprotein-Triglyceride Transfer

Exchange of cholesteryl ester for triglyceride between lipoproteins was first demonstrated in human plasma samples incubated without
LCAT inhibition (Rehnborg et al., 1964).

Further investigation indi-

cated that lipoprotein-triglyceride and cholesteryl ester transfer may
be independent since lipoprotein triglyceride transfer can be inhibited
by thiol group blockade, whereas lipoprotein-cholesteryl ester transfer
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is not (Hopkins et al., 1980; 1982).

However, using purified lipid

transfer protein isolated from human plasma, both lipoprotein-cholesteryl ester and triglyceride transfer could be demonstrated (Morton et
al., 1982).

Moreover, others believe that lipoprotein-triglyceride and

cholesteryl ester transfer may be linked to phospholipid transfer or
exchange (Ihm et al., 1980; 1982).

Whether a single factor or lipid

transfer complex -exists for the transfer of both lipoprotein-cholesterol
and triglyceride remains to be established.

Although early studies have

shown that a lipoprotein-triglyceride exchange occurs between rat lipoproteins (Roheim et al., 1963), no evidence of significant triglyceride
transfer could be observed in rat plasma as compared to human and rabbit
plasma (Barter et al., 1979a; 1979d).
D.

Lipoprotein-Phospholipid Transfer

Phospholipid exchange was demonstrated during in vitro incubations
of rat plasma (Roheim et al., 1963).

Exchange of phospholipid for unes-

terified cholesterol was also observed between rat chylomicrons and
human HDL by what was postulated to be a passive process, initiated by
collisions between the two particles (Lippiello et al., 1983).

In con-

trast, exchange of phosphatidyl choline was found to be enhanced by a
partially purified phospholipid transfer factor as was shown by an in
~

incubation of unilamellar liposomes with human plasma HDL (Darnen

et al., 1982).

HDL has been shown to have a high capacity for phospha-

tidylcholine uptake and that membrane transfer can occur from phosphatidylcholine vesicles to HDL (Jonas, 1979), however with the addition of a
density greater than 1.21 g/ml fraction of plasma the phosphatidyl cho-
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line transfer to HDL was markedly enhanced possibly due to alteration in
the membrane, facilitating transfer (Tall et al., 1983b).

Proteins

facilitating the transfer of phosphatidyl choline and cholesteryl ester
from HDL to LDL were partially purified from human plasma and the protein or proteins responsible for both transfer processes coeluted at
every purification step.

In addition, the rat was found to have a pro-

tein, which facilitated lipoprotein-phospholipid transfer, but not lipoprotein-cholesteryl ester transfer indicating that the two processes may
be handled by at least two different proteins (Ihm et al., 1980).

This

was confirmed, when two protein fractions were isolated from human
plasma each having the separate ability of either lipoprotein-cholesteryl ester or phospholipid transfer (Tall et al., 1983a).

It has been

suggested that the lipoprotein-phospholipid transfer factor exists in a
complex with LCAT and lipoprotein-cholesteryl ester exchange protein in
human as well as in rat plasma (Ihm et al., 1982), even though rat
plasma has very little lipoprotein-cholesteryl ester transfer activity
(Barter et al., 1978).

This would be consistent with evidence that the

rat may have a plasma substance which inhibits the lipoprotein-cholesteryl ester transfer factor (Morton et al., 1981).
E.

Rat Lipoprotein-Cholesteryl Ester Transfer

The transfer of cholesteryl ester between HDL and lower density
lipoproteins has previously been reported to occur in rat plasma at
extremely low rates when compared to other species such as rabbits and
humans (Barter et al., 1978; 1979b; 1979c; Oschry et al., 1982).

A

plasma inhibitor to the lipoprotein-cholesteryl ester transfer factor
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bas been demonstrated in the rat which may account for the low rates of
lipoprotein-cholesteryl ester transfer observed between rat plasma HDL
and VLDL (Morton et al., 1981).

Recently, two HDL subfractions that

were isolated from rat plasma by HDL gradient ultracentrifugation were
found to display cholesteryl ester transfer activity employing an in
~

assay.

Rat plasma cholesteryl ester appeared to be transferred

from a less dense HDL subfraction to a denser HDL subfraction, both isolated by density gradient ultracentrifugation (Jansen et al., 1983).

In

contrast, two rat plasma HDL subfractions isolated by zonal ultracentrifugation, did not show any cholesteryl ester transfer activity in vitro.
However, in vivo, transfer of cholesteryl ester between these two HDL
subfractions was observed, with the transfer occurring from the denser
HDL subfraction to the less dense HDL subfraction when the denser HDL
subfraction containing radioactively-labeled cholesterol was administered to rats (Eisenberg et al., 1984).

The conflicting observations of

these two reports regarding cholesteryl ester transfer between various
rat plasma HDL subfractions may be due to differences in lipoprotein
compositions resulting from separation of lipoprotein fractions employing ultracentrifugal techniques (Lindgren et al., 1979).
IV.

ESTROGENIC REGULATION OF LIPOPROTEIN RECEPTORS
A.

Hypolipidemic Effect of Estradiol on Rats
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1. Hypocholesterolemia and
bipoprotein Clearance
In vivo administration of 17 a-ethinyl estradiol to rats has ·produced marked hypocholesterolemia.

Estrogen treatment lowered plasma

cholesterol levels by 90%, while plasma apolipoproteins were lowered as
well (Davis et al., 1978).

Estrogen treatment was found to cause a com-

plete disappearance of LDL in rat plasma.

Moreover, the liver was the

organ responsible for the uptake and degradation of LDL in estrogen
treated animals as was demonstrated by injecting labeled LDL into rats
treated with estrogen (Hay et al., 1971).

This was confirmed when the

rate of LDL clearance was found to decrease in functionally eviscerated
rats as compared to controls, when prior to evisceration both groups had
augmented LDL clearance due to ethinyl estradiol treatment (Chao et al.,
1979).
2. Specific Lipoprotein
Receptor Induction
LDL uptake by rat liver in vivo appeared to resemble the uptake
seen in vitro by specific LDL receptors found in fibroblasts, since the
liver membranes removed from ethinyl estradiol treated rats showed a
marked binding preference for LDL over HDL, required calcium for binding, failed to bind LDL which had been modified and the binding capability was destroyed by pronase, all characteristics of the classical LDL
binding receptor observed in fibroblasts (Kovanen et al., 1979b).

Fur-

ther characterization of the binding properties of the liver membranes
of ethinyl estradiol treated rats revealed a specificity for apo B and
apo E containing lipoproteins (Windler et al.,

1980b).

Conversely
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female rats, which were ovariectomized showed a marked increase in
plasma cholesterol, triglycerides and apolipoproteins B, E and C.

The

main reason for the increase was found to be due to an increase in LDL
and HDL in the ovariectomized rat (Van Lenten et al., 1983).

The

increases in those lipoproteins were probably due to the decrease in
uptake of apo E containing HDL and apo B containing LDL by lipoprotein
receptors which were reduced, because of the loss of estrogen stimulated
production.
B.

Sex Hormones and Human Lipoprotein Catabolism

1. Oral Contraceptives and
Estrogen Replacement
It has long been known that premenopausal women have a lower risk
of developing coronary heart disease than men and that risk increases to
the same as men after menopause (Barr et al., 1955).

Since estrogen

appears to produce a marked hypocholesterolemia in rats, it is interesting to postulate a protective role for estrogen in the human female by
increasing lipoprotein-cholesterol clearance and reducing the risk of
coronary heart disease.

Studies on women given estrogen replacement

therapy following menopause and on women given oral contraceptives have
yielded information on the influence of sex hormones on lipoprotein
metabolism.

Premenopausal women have higher plasma HDL levels than men

(Levy et al., 1966) and plasma HDL has been inversely correlated with
the risk of developing coronary artery disease (Gordon et al., 1977; see
section V. C. 3.

HDL-cholesterol).

Women on estrogen

therapy have
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increased HDL levels (Cauley et al.,

1983)., but women on combined

estrogen-progesterone therapy do not (Cheung et al., 1977).

A reduced

plasma HDL level was found in women taking contraceptives (Arntzenius et
al., 1978), which may be due to progesterone content, since it was found
that HDL increases with the amount of estrogen and decreases with the
amount or potency of progesterone administered (Bradley et al., 1978;
Farish et al., 1983).

Elevated plasma apo A-I values occur in humans

with high plasma estrogen levels, whether the estrogen is from exogenous
or endogenous sources (Albers et al., 1976).
however,

Myocardial infarction risk

increases with the use of oral contraceptives and that

increased risk has been found to continue after contraceptive use ceases
in long term users (Slone et al., 1981).

Women taking oral contracep-

tives were found to have a death rate 40% greater than those who had
never taken them and the excess deaths were found to be due to circulatory system disease, mostly from excessive clotting (Royal College of
General Practitioners, 1981).

Moreover,. lowering the estrogen content

of contraceptive pills was found to lower the incidence of thromboembelie disease (Bottiger et al., 1980a).
2. Estrogen and Male
Susceptibility to Myocardial
Infarction
While estrogens may have a protective effect toward coronary
artery disease in women possibly by increasing their HDL-cholesterol
levels, it has been found that men with myocardial infarction have
higher plasma estrogen levels than those who do not have an infarction
(Phillips et al., 1983).

In contrast, testosterone was found to have a
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significant positive correlation with plasma HDL in adult men (Heller et
al., 1981b), yet no significant correlation could be found between testosterone or estrogen and male patients who had previous myocardial
infarctions (Heller et al., 1981a).

Unfortunately, this study was not

controlled for drug usage nor time following the infarction, since some
patients included in the study had their infarction eleven years prior
to the time their steroid hormones were evaluated.

Another year long

study on adolescent boys determined an increase in plasma testosterone
occurred with a decrease in plasma estrogen, which corresponded to an
increase in plasma triglycerides and LDL-cholesterol, while HDL-cholesterol decreased (Laskarzewski et al., 1983).

The lipid changes however,

may be an age related phenomenon unassociated with the change in hormone
levels.
The cause of estrogen's protective nature regarding myocardial
infarction in women and the increased risk in men is unknown at present.
A recent research news report in Science magazine (Kolata, 1983)
received four different opinions of this problem from four researchers.
One postulated that estrogen increased the development of atherosclerosis, which seems unlikely due to the decrease in risk of coronary artery
disease associated with the raising of HDL-cholesterol levels as seen in
women taking estrogen contraceptives (Cauley et al.,· 1983).

Another

postulates that estrogen increases blood clotting, which would agree
with results seen in the contraceptive studies (Bottiger et al., 1980a;
Royal College of General Practitioners, 1981). The other two researchers
feel that estrogens either increase the work load of the heart or cause
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coronary vasospasms leading to myocardial infarction.

1.

V.

ATHEROSCLEROSIS

A.

Arteriosclerosis

Definition
Arteriosclerosis is a disease of blood vessels characterized by a

thickening and hardening of the blood vessel walls with a loss of elasticity, which occurs most frequently in arteries.

Atherosclerosis is

the most common form of arteriosclerosis, characterized by the localized
accumulations of lipid containing material within or beneath the intimal
surfaces of blood vessels.
2.

Development
Atherosclerosis is believed to progress from fatty streaks, which

occur in childhood resulting from the deposition of lipids mostly in the
form of unesterif ied cholesterol or cholesterol oleate in the smoothmuscle cells and macrophages of the arterial intima.

An increased num-

ber of smooth-muscle cells and an increased amount of connective tissue
surround and cover the deposit of cholesterol-rich lipid in the lining
of the lumen of the artery.

The connective tissue and smooth muscle

cells surrounding the cholesterol-rich- lipid core is known as a fibrous
plaque, however not all fatty streaks develop into fibrous plaques and
there is considerable controversy as to whether the fatty streak is
actually the initial condition from which the fibrous plaque develops.
As atherosclerosis progresses, the fibrous plaque enlarges and undergoes
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complex changes, becoming vascularized from both the lumen and the
media.

The fibrous plaque's lipid core also increases in size and

becomes calcified.

The intimal surface may disintegrate and ulcerate or

the blood vessels may rupture and hemorrhage into the plaque.

The ulti-

mate result of the atherosclerotic process is that the lumen of the
blood vessel becomes blocked, decreasing blood flow to the tissue the
vessel supplies (Report of the Working Group on Arteriosclerosis, 1981).
B.

Theories of Atherosclerotic Development

1. Lipid Infiltration
Hypothesis
The lipid infiltration hypothesis suggests that lipids filter
through the endothelial lining of the artery and accumulate in the
intima of the artery.

High plasma lipid levels would therefore cause an

increase in the passive diffusion of lipid between the junctions of the
endothelial cells with a subsequent increase in the lipid concentration
of the arterial intima.

Plasma proteins, including lipoproteins have

been demonstrated to penetrate the intact endothelium, therefore lipoprotein lipid could be deposited within the intima and initiate the atherosclerotic process (Bratzler et al., 1977; Reich! et al., 1973).
Moreover, the theory is supported by the 'experimental evidence that atherosclerotic lesions can be induced by feeding high fat, high cholesterol diets to experimental animals (Camejo et al., 1973; Kramsch et
al., 1981; Mahley et al., 1974; Mahley, 1978; Shore et al., 1974), since
high cholesterol diets increase the plasma cholesterol levels of certain
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animal species promoting the deposit of lipid within the intima of
arteries.

This hypothesis however, does not explain why atherosclerotic

lesions do not appear at random, but appear more frequently at areas of
stress in the arterial tree, particularly within the coronary arteries
(Ross, 1979).
2. Response to Injury
Hypothesis
The response to injury hypothesis suggests that some form of
injury occurs to the endothelial cells lining the lumen of the artery.
The protective endothelial barrier could be altered in some way as to
increase permeability toward lipoproteins and lipids, which in part
agrees with the lipid infiltration hypothesis, but assumes an underlying
cause for the increase in lipid permeability.

Alternatively, the postu-

lated damage could be so severe as to remove the endothelial cells and
cause platelet aggregation at the site of injury.

Platelet release of

substances including platelet derived growth factor (PDGF), would cause
the focal migration of smooth muscle cells to the site of injury and
their subsequent proliferation.

Plasma lipid carried by lipoproteins,

particularly LDL would have easier access to the area affected and lipid
accumulation would ensue.

Chronic injury to the area would promote the

progression of the lesion and if the factor leading to injury was temporary the process could be reversed and the lesion regress (Ross, 1979).
No direct evidence has demonstrated that initiation of the atherosclerotic lesion is due to loss of the endothelial lining, however experimentally induced atherosclerotic lesions have been produced by damaging the
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endothelial lining mechanically,
temperature, pH and osmolarity.

by irradiation, or by changes in
Other factors implicated as causes for

damaging the endothelial tissue in humans are endotoxins, hyperlipidemia, antigen-antibody complexes, carbon monoxide, viral infection and
hemodynamic stress (Grundy, 1983).

Hypertension has also been impli-

cated as a factor increasing the risk of developing atherosclerosis in
humans.

Experimental models of hypertension have demonstrated intracel-

lular enzymatic changes affecting cholesterol metabolism, therefore the
initial injury caused by undue vessel stress due to hypertension could
lead to enzyme modification of lipid metabolism, increasing deposition
of cholesteryl esters within the cell and initiating the atherosclerotic
process (Hayashi et al., 1982).
3.

Monoclonal Hypothesis
The monoclonal hypothesis assumes that atherosclerosis is a pro-

liferative disease.

The hypothesis suggests that the proliferative

smooth muscle cells in the atherosclerotic lesions are derived from a
single progenitor cell, therefore the lesions are similar to a benign
neoplasm (Ross, 1982).

The hypothesis is based on the observation that

a single isoenzyme of glucose-6-phosphate dehydrogenase EC 1.1.1. 49
(Nomenclature Committee, 1979) was present
in lesioned arteries, whereas
.
.
normal arteries had a mixture of the two isoenzymes (Benditt et al.,
1973).

This does not necessarily mean that the lesion arises from one

cell, but could mean that one cell type is more proliferative than the
other.

r
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C.

1.

Lipoproteins and Atherosclerosis

VLDL and Triglyceride
The atherogeneity of VLDL the major triglyceride containing lipo-

protein of human plasma is as yet unresolved (Grundy, 1983; Riemersma,
1984).

The results of epidemiological studies determining whether tri-

glyceride and VLDL levels correlated to the presence or severity of atherosclerotic disease have been inconsistent.

A recent study has shown a

greater amount of triglycerides and VLDL-triglycerides in patients suffering from coronary artery disease as compared to normal age matched
controls.

A fat tolerance test performed on all subjects in the study

indicated the patients with coronary artery disease cleared triglycerides from the plasma slower than the normal control subjects (Tollin et
al., 1984).

The study was undertaken to confirm a previous project,

which had demonstrated a positive correlation between serum triglyceride
concentration and the presence of coronary artery disease (Bottiger et
al., 1980b).

Moreover, VLDL-cholesterol concentration has been shown to

be a good predictor of coronary artery disease in humans over 50 years
of age (Whayne et al., 1981).
Al though many studies have shown that patients with coronary
artery disease tend to have high plasma triglyceride levels, when other
factors were considered the significance of high serum triglycerides as
a predictor of the risk of obtaining coronary artery disease disappeared.

The Framingham study demonstrated upon univariate analysis of

the data that serum triglyceride was significantly correlated with coro-
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nary artery disease in women, however using multivariate analysis no
significant correlation was found (Gordon et al., 1977).

Serum trigly-

cerides as determined in the Framingham study were not consistently
found to be a significant factor
(Castelli et al., 1977).

in coronary heart disease risk

Apolipoprotein B, a major component of VLDL as

well as LDL was determined in a human population, which had suffered
from previous myocardial infarction and compared to a human population
with hypertriglyceridemia.

Higher ape B concentrations were found in

those patients with previous myocardial infarction and in the hypertriglyceridemia patients with symptoms of coronary artery disease, than in
patients with hypertriglyceridemia and no symptoms of coronary artery
disease.

Serum triglycerides although high in both populations, were

not as important predictors of coronary artery disease as the ape B concentration (Sniderman et al., 1982).
Studies attempting to link serum triglyceride levels to the severity of coronary artery disease in humans· have also suffered from inconsistencies.

VLDL-triglyceride has been found to be significantly corre-

lated with the severity of coronary artery disease, while serum
triglyceride results were inconclusive (Jenkins et al., 1978).

Other

studies have indicated that serum triglycerides have no discriminating
function at all as to severity of coronary artery disease (Noma et· al.,
1983; Riesen et al., 1980; Vander Heiden et al., 1984).
HDL-cholesterol, which will be discussed shortly has been negatively correlated with coronary artery disease (Gordon et al., 1977)
and has been negatively correlated with VLDL-triglyceride concentration
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(Gordon et al., 1977; Miller et al., 1975; Schaeffer et al., 1978a).
Hypertension, a primary risk factor for development of atherosclerotic
disease is related to body mass as is plasma triglyceride concentration.
Moreover, epidemiological studies indicate that triglyceride levels
appear to be related to cholesterol concentration.

Therefore, plasma

triglycerides are related to factors which are in turn related to the
risk in humans of developing atherosclerotic disease, but plasma triglyceride levels alone are not necessarily related to coronary artery disease.

No persuasive evidence could be found in the Western Collabora-

tive Group study or in a twenty year review of published epidemiological
reports that triglycerides
(Hulley et al., 1980).

are involved in coronary heart disease

On the other hand, a mechanism has been proposed

whereby VLDL could be involved

in the atherosclerotic process.

Zilversmit (1973) has suggested that lipoprotein lipase by its location
on the cell surface and its actions on VLDL creates a lipoprotein parti.cle with a high cholesterol content in close proximity to the cell surface, thus increasing the likelihood of cholesterol being taken up into
the intima.

It has also been suggested that the liberation of free

fatty acids by lipoprotein lipase's action on VLDL triglycerides creates
a disturbance in the endothelial lining increasing the permeability of
·the artery, allowing LDL or the newly ·formed VLDL remnant ready access
to the intimal layer of the artery (Hulsmann et al., 1975).
The epidemiological evidence thus far accumulated appears to indicate that serum triglycerides and VLDL triglycerides may not play a primary role in the induction of atherosclerotic lesions.

However, epide-
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miological studies are based on lipid levels determined at a particular
time on a particular day and are unrelated to processes involved in
actual lipid metabolism.

VLDL may play an important secondary role in

atherogenesis as the precursor to LDL (Eisenberg et al., 1973a) or by
VLDL's inverse relationship to HDL (Miller et al., 1975).

VLDL's con-

tribution to the generation of atherosclerotic disease may not be
clearly understood until consideration is given to the plasma lipid metabolic processes, which can not be determined in epidemiologic studies.
2.

LDL and Cholesterol
Recently the atherogeneity of human plasma total cholesterol has

been demonstrated by the Lipid Research Clinics Program (1984a; 1984b).
The program had completed a study showing that drug therapy which
decreased plasma total cholesterol concentrations in patients suffering
from hypercholesterolemia was responsible for a decrease in the incidence of coronary heart disease and coronary artery disease.

The plasma

total cholesterol was found to be directly proportional to the LDL-cholesterol level.

Since LDL is the major cholesterol carrying lipoprotein

in the human, the reduction in plasma total cholesterol found in this
study was found to be due to a reduction in plasma LDL-cholesterol.
This study has confirmed what has been implied since the 1950's, that
LDL elevation in human plasma was strongly correlated with atherosclerosis (Gofman et al., 1954).
Epidemiological studies have shown in almost all cases a positive
correlation between the risk of developing either coronary heart disease
or coronary artery disease and the plasma concentration of

LDL~choles-
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terol.

The Framingham study (Gordon et al., 1977; Castelli et al.,

1977) had found significant positive correlations between

LDL-chol~s

terol and coronary heart disease, but the Framingham study when adjusted
for age did not find a significant relationship between plasma total
cholesterol and coronary heart disease, as was also true for the
Stockholm study (Bottiger et al., 1980b).
Although LDL-cholesterol has been found to be a significant predictor of coronary heart disease, determination of human plasma LDL-cholesterol concentration may be an even better predictor of coronary
artery disease severity.

Plasma LDL-cholesterol and ape B concentra-

tions have been found to be the best predictors of human coronary artery
disease severity in several studies (Noma et al., 1983; Riesen et al.,
1980; Sniderman et al., 1982; Vander Heiden et al., 1984).

All of these

studies demonstrated a positive correlation between plasma LDL-cholesterol concentration and ape B concentration and the degree of angiographically measured coronary heart disease.

Moreover, the ape B con-

centration appeared to be the best discriminator of coronary disease
severity, particularly in a study, which used subjects who had plasma
total cholesterol levels below 265 mg/dl (Whayne et al., 1981).
Since LDL carries 70% of human total plasma cholesterol and atherosclerotic disease is due to the

depo~i~

of cholesteiyl esters within

the arterial wall it has been assumed that LDL-cholesterol is the primary lipoprotein involved in the human atherogenic process.

The LDL

receptor pathway however, as described by Goldstein and Brown (1977a) is
a nonatherogenic pathway, because LDL receptors are down regulated by
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cholesterol

accumulation preventing

cells

from

taking

up

more

cholesterol than they need (see section II.C.4. LDL Catabolism). Yet,
atherosclerosis has been found to occur when human plasma LDL-cholesterol concentration increases due to either inherited lipoprotein receptor defects or environmental factors.

The increased LDL-cholesterol may

be taken up in cells by phagocytosis via the scavenger cell pathway,
which is not regulated by cholesterol uptake, thus cholesterol can accumulate in the scavenger cells to a tremendous extent forming the foam
cells seen in atherosclerotic lesions (Brown et al., 1980; Goldstein et
al., 1977b; Packard et al., 1983).
Clearly epidemiological and experimental evidence supports the
atherogenic potential of LDL-cholesterol, although the epidemiological
evidence for plasma total cholesterol as a risk factor for atherogenesis
is not as convincing.

One area of LDL and atherosclerotic research

which needs to be addressed on the molecular level is the phagocytosis
of unmodified LDL (see section II.C.4. LDL Catabolism), since the scavenger pathway does not appear to recognize normal LDL, but only a modified more electronegative LDL (Brown et al., 1980).

Therefore, in vivo

LDL modification prior to phagocytosis has yet to be completely understood.

Moreover, the relationship of other risk factors to atherogene-

sis and LDL metabolism must also be explored to determine what LDL's
function is in atherosclerotic lesion production.
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3.

HDL-cholesterol
Many biological systems have balances, like feedback inhibition,

to prevent excesses from occurring.

LDL, which appears to be an athero-

genic lipoprotein would hopefully be balanced by a nonatherogenic, protective lipoprotein.
protein.

Studies have indicated that HDL may be that lipo-

A relationship between alpha

1

lipoprotein-cholesterol (HDL)

and reduced risk of obtaining atherosclerosis was demonstrated in the
1950's (Barr, 1951).

It was also noted that a high plasma total choles-

terol concentration was related to a high plasma beta lipoprotein-cholesterol (LDL) concentration but low alpha

1

lipoprotein-cholesterol con-

centration was a more consistent predictor of atherosclerotic disease.
However, it was not until 1975 that interest was rekindled in alpha

1

lipoprotein, when a study using subjects with plasma cholesterol levels
less than 250 mg/dl found that the HDL-cholesterol levels were significantly lower in those patients with coronary artery disease than those
without coronary artery disease (Miller et al., 1975).

Epidemiological

studies have consistently shown that HDL-cholesterol is negatively correlated to the risk of obtaining coronary heart disease (Castelli et
al., 1977; Gordon et al., 1977).

Moreover, the major apolipoprotein of

HDL, ape A-I may be an even better discriminator of coronary artery disease than HDL-cholesterol (Maciejko, et al., 1983).
Despite HDL-cholesterol's discriminant power in predicting the
incidence of atherosclerotic disease, HDL-cholesterol does not appear to
be a good predictor of the severity of atherosclerotic disease (Noma et
al., 1983).

Apo A-I, ape B, ape A-II, TC and LDL-C were found to be
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good discriminators of severity of coronary artery disease,
HDL-cholesterol was not (Riesen et al., 1980).

but

Interestingly, apo A-I

and HDL-cholesterol have been found to be very closely correlated
(Maciejko et al., 1983), therefore the discriminating power of apo A-I
as compared to HDL-cholesterol should be similar, which was not indicated in the study by Riesen and coworkers.

Moreover, another study has

demonstrated that HDL-cholesterol concentration is a good discriminator
of atherosclerotic disease severity (Jenkins et Al., 1978), therefore
the discriminatory power of HDL-cholesterol as a predictor of atherosclerotic disease severity is still controversial.
Virtually every epidemiological study demonstrates a negative correlation between human plasma HDL-cholesterol concentration and coronary
artery disease or coronary heart disease.

People involved in aerobic

exercise have a lower incidence of coronary heart disease than the rest
of the population and more HDL-cholesterol than sedentary people or
those who exercise anaerobically (Clarkson et al., 1981; Hartung et al.,
1980).

People in areas free of coronary heart disease have higher HDL-

cholesterol concentrations than people in areas of high incidence for
coronary heart disease (Walker et al., 1978).

Consumption of alcohol

has been shown to be associated with a decreased risk of obtaining coronary heart disease (Dyer et al., 1980; Klatsky et al., 1974).

Moreover,

alcohol consumption has been associated with an increase in plasma HDLcholesterol concentration (Haskell et al., 1984; Thornton et al., 1983).
Although these studies do not necessarily imply a direct link between
HDL-cholesterol and atherosclerotic risk, they are suggestive that HDL
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plays an important role in the prevention of atherosclerotic disease.
The protection HDL-cholesterol appears to provide from atherosclerosis has been postulated to be due to HDL acting as a cholesterol seavenger (see section II.C.7. HDL Catabolism).

In vitro studies have

shown HDL is able to attract the unesterif ied cholesterol from tissue
membranes (Fielding et al., 1981b).

LCAT for which HDL has been demon-

strated to be the preferred substrate (Fielding et al., 1971), esterifies cholesterol on the surface of the HDL molecule and the esterif ied
cholesterol is stored in the hydrophobic core of the HDL molecule allowing room for the accumulation of more unesterif ied cholesterol on the
surface (Glomset et al., 1973).

Cholesterol has been postulated to be

cleared from the cells by this mechanism, although no direct in vivo
evidence has proven this.

Removal of cholesterol from human plasma may

be dependent on HDL uptake by the liver or more probably by cholesteryl
ester transfer to lower density lipoproteins (see section III.B.1. Cholesteryl Ester Transfer and Exchange) which ultimately results in the
increase of cholesteryl esters within LDL, which are then removed
through the LDL receptor pathway (Brown et al., 1981).
Presently, the factors which are known and can be determined to
account for the risk in humans of developing coronary artery disease may
be able to predict the disease only 50% o"f the time (Crouse, 1984)."

The

focus of the search for better predictors of coronary artery disease is
on the constitutive fractions of lipoproteins and coagulation factors
leading to thrombi, which can block the arteries.
tors

Other possible fac-

including dietary and psychological studies are also being
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explored.

Lipoprotein concentrations have limited value as a diagnostic

tool in those patients showing symptoms of coronary artery disease, but
the great value may come as a predictive index for the potential of
developing such disease and the continued elaboration of the functional
roles of lipoproteins will lead to the ultimate understanding of the
atherosclerotic disease process and its cure (Blackburn, 1983).
D.

1.

Species Susceptibility to Atherosclerosis

Rat Atherosclerosis
Proliferative lesions have been found to occur in rat arteries

when subjected to stress or damage, but these lesions do not mimic atherosclerotic lesions since they are lipid poor, unless the rat's plasma
cholesterol is artificially elevated either by a high cholesterol diet
or injection of cholesterol rich lipoproteins (Bishop,

1980).

Simi-

larly, spontaneous arteriosclerotic lesions which appear in the rat do
not stain for lipid and are more prevalent in the female.

The occurance

of these proliferative lesions was positively correlated to the frequency of breeding indicating there may be a hormonal influence to the
proliferative disease (Wexler, 1964).
2.

Diet
The rat is very resistant to dietary induction of atherosclerotic

lesions (Bishop, 1980).

Atherosclerotic lesions in rats similar to

those seen in humans however, have been produced by feeding rats high
cholesterol diets including bile acids and inducing hypothyroidism with
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propylthiouracil or irradiation (Fillies et al., 1956; Malinow et al.,
1954; Wissler et al., 1954).

The rat's resistance to dietary induced

atherosclerotic lesions is similar to that of the dog, which must also
be made hypothyroid with a high cholesterol diet to induce atherosclerotic lesions (Mahley et al., 1977d).

Another animal fairly resistant to

dietary induction of atherosclerotic lesions is the mouse (Beher et al.,
1963), whereas species that are susceptible to dietary induced atherosclerotic lesions include, rabbits, monkeys, swine and possibly humans
(Camejo et al., 1973; Kr ams ch et al., 1981; Mahley, 1978; Ross, 1979;
Shore et al., 1974).
3. Hypothyroidism
Hypothyroidism in the human has been found to cause a hyperlipidemia characterized by high plasma cholesterol levels, whereas thyrotoxicosis produces the opposite effect on plasma cholesterol and LDL levels
(Mishkel et al., 1977; Walton et al., 1965).

Thyroid hormones affect on

cholesterol concentration of the plasma may be related to LDL receptors
as it has been observed from in vitro studies on human skin fibroblasts

-

---

that thyroxine stimulates the growth of LDL receptors (Chait et al.,
1979).

The increase in extrahepatic lipoprotein receptors would

increase LDL catabolism in vivo and thus lower the plasma cholesterol
concentration.
Experimentally induced hypothyroidism in rats has been found to
affect the apo E and apo B composition of rat plasma lipoproteins.
Moreover, both apo E and apo B concentrations increase by 100% after
propyl thiouracil induced hypothyroidism, with a concomitant increase in
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plasma cholesterol of 50-100% and a 20-40% decrease in plasma triglycerides.

The decrease in rat plasma triglycerides was believed to be due

to an increase in lipoprotein lipase activity, whereas the increase in
rat plasma cholesterol was due to a decrease in LDL and VLDL remnant
removal (Dory et al., 1981).

Hypothyroid rats on a high cholesterol

diet produced qualitative and quantitative differences in the plasma
lipoprotein profile as compared to euthyroid rats on the same high cholesterol diet.

Plasma apo E concentrations decreased in the cholesterol

fed euthyroid rats as compared to an increase in the hypothyroid cholesterol fed rats.

In addition, HDL

c

and beta migrating VLDL appeared in

the hypothyroid cholesterol fed rat plasma, whereas neither lipoprotein
was found in the plasma of euthyroid cholesterol fed rats.

Apo B and

plasma cholesterol were increased in both rat groups, but more so in the
hypothyroid rats (DeLamatre et al., 1981).

These data suggest that the

hypercholesterolemia induced by hypothyroidism is qualitatively different from dietary induced hypercholesterolemia.
4. Miscellaneous
Atherosclerotic Factors
HDL , the lipoprotein which appears after cholesterol feeding (see
c

section II.D.3. Metabolism and Response to Hypercholesterolemia) may be
involved with the atherosclerotic process, since HDL

c

appears in ·all

species studied when hypercholesterolemia has been induced (Mahley,
1978).

On the other hand, the atherosclerotic process was shown to be

inhibited in monkeys fed lanthanum with a high cholesterol atherogenic
diet, therefore it was postulated that calcium, for which lanthanum is
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an antagonist,

is an integral part of the atherosclerotic process

(Kramsch et al., 1981).

Platelet derived growth factor (PDGF) has _also

been suggested as the initiator of the proliferative disorder associated
with atherosclerotic lesions (Ross,

1979).

Epinephrine administered

with thyroxine and triiodothyronine was found to produce arteriosclerotic lesions in the rabbit, which was unrelated to any hypertensive
effect (Oester, 1959).

Currently, it would appear that no one event or

factor may be responsible for the initiation and progression of the atherosclerotic lesion.

The list of primary risk factors for atheroscler-

otic disease in humans includes, hyperlipidemia, hypertension, smoking
and diabetes mellitus, with numerous possible secondary risk factors
also implicated toward developing coronary artery disease (Grundy,
1983).

Animal models of atherosclerotic disease have provided a great

deal of information toward understanding the initiation and progression
of atherosclerotic lesions.

In addition, animal models have provide

insights into lipoprotein metabolism and its relation to atherosclerotic
disease.

Animal models designed to investigate lipoprotein metabolism

and atherosclerotic progression in response to the known and proposed
risk factors can ultimately lead to the prevention of atherosclerotic
disease.

CHAPTER II

RESEARCH OBJECTIVES
High density lipoprotein-cholesterol (HDL-C) has been implicated
as a protective factor against atherosclerotic disease (Gordon et al.,
1977; Miller et al., 1975).

Since the rat is known to have a very large

proportionate amount of HDL-C (Chapman,

1980; Frnka et al.,

1974;

Narayan, 1971) and is also relatively resistant to the experimental
induction of atherosclerotic disease (Chapman, 1980; Fillies et al.,
1956; Mahley et al., 1977a; Wissler et al., 1954), this animal would
appear to be an excellent model to study the relationship of high density lipoproteins to atherosclerosis.

Unfortunately, many studies which

have utilized several different methods for determining plasma lipoprotein-cholesterol concentrations of the rat have yielded inconsistent
results as indicated in a review by Chapman (1980).

The coupling of an

enzymatic determination of cholesterol (Allain et al., 1974) with cellulose acetate electrophoresis (Cobb et al., 1978) has made possible a
rapid and specific separation and analysis of human plasma lipoproteincholesterol fractions, the ratios of which are currently being employed
as risk factors for the development of human atherosclerosis.

However,

such a method has not been previously investigated with regard to the
rat.

The dissertation studies were therefore designed to compare the

cellulose acetate electrophoretic plasma lipoprotein-cholesterol profile
79
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of the rat and other experimental animals to that of the human.

The

presently reported studies were also designed to compare HDL-C levels in
the rat determined by cellulose acetate electrophoresis to HDL-C levels
obtained by polyanion precipitation techniques (Burstein et al., 1960;
Kestner, 1976; Manual of Laboratory Operations, 1974).

Therefore, the

first part of this dissertation describes the technique by which we have
characterized the cellulose acetate electrophoretic lipoprotein-cholesterol profile of the rat and its comparison to other experimental animals.

These studies have led to the discovery of a lipoprotein unique

to rat plasma and has been named by this laboratory for its electrophoretic mobility as prealbumin lipoprotein (PAL).
The second part of this dissertation deals with cholesterol movement between rat plasma lipoproteins and the subsequent discovery of a
lipoprotein catabolic product possibly responsible for rat plasma cholesterol clearance.

In addition, this dissertation also describes a new

technique for determining the unesterified cholesterol (UC) concentration of plasma lipoprotein fractions separated by cellulose acetate
electrophoresis.

The presently described method for analyzing plasma

lipoprotein-UC combined with the usual method for analyzing plasma lipoprotein-total cholesterol (TC) allows for the calculation of plasma
lipoprotein-esterified cholesterol (EC) from the difference between
plasma lipoprotein-TC and plasma lipoprotein-UC values.

This new tech-

nique allowed us to characterize the in vitro movement of cholesterol
between plasma lipoproteins more thoroughly.

The transfer of choles-

teryl ester between high density lipoprotein (HDL) and lower density
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lipoproteins has previously been reported to occur in rat plasma at
extremely low rates when compared to other species such as rabbits and
'
humans (Barter et al., 1979c; Barter et al., 1978; Oschry et al., 1982).
Recently however, two HDL subfractions that were isolated from rat
plasma by HDL gradient ultracentrifugation were found to display cholesteryl ester transfer activity employing an in vitro assay.

Rat plasma

cholesteryl ester appeared to be transferred from a less dense HDL subfraction to a denser HDL subfraction, both isolated by density gradient
ultracentrifugation (Jansen et al., 1983).

In contrast, two rat plasma

HDL subfractions isolated by zonal ultracentrifugation did not show any
cholesteryl ester transfer activity in vitro.

However in vivo, transfer

of cholesteryl ester between these two HDL subfractions was observed
with the transfer occurring from the denser HDL subfraction to the less
dense HDL subfraction when the denser HDL subfraction containing radioactively-labeled cholesterol was administered to rats (Eisenberg et al.,
1984).

The conflicting observations of these two reports regarding cho-

lesteryl ester transfer between various rat plasma HDL subfractions may
be due to differences in lipoprotein compositions resulting from separation of lipoprotein fractions
(Lindgren et al., 1979).

employing ultracentrifugal techniques

It has been suggested that electrophoretic

techniques for isolation of plasma lipopr.otein fractions may be superior
to ultracentrifugal methods because of the distortions leading to lipoprotein degradation resulting from ultracentrifugation (Lindgren, 1980).
As determined from the first part of these dissertation studies,
two of four rat plasma lipoproteins separated using the technique of
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cellulose acetate electrophoresis combined with an enzymatic stain for
total cholesterol (Cobb et al., 1978), were characterized as HDL subfractions and named according to their cellulose acetate electrophoretic
mobilities as prealbumin lipoprotein

(PAL) and alpha

1

lipoprotein.

Side-by-side cellulose acetate electrophoretic comparisons between rat
whole plasma and the rat plasma HDL fraction isolated in the density
range between 1.063-1.210 g/ml by sequential ultracentrifugation (Havel
et al., 1955), as well as the rat plasma HDL supernates obtained by manganese heparin precipitation (Manual of Laboratory Operations, 1974),
and dextran sulfate precipitation (Kestner, 1976) confirmed that rat
plasma prealbumin lipoprotein-cholesterol (PAL-C) and alpha

1

lipoprotein

(a L-C) separated by cellulose acetate electrophoresis were HDL-C sub1
fractions.

The other two rat plasma lipoproteins isolated by cellulose

acetate electrophoresis were alpha

2

lipoprotein-cholesterol (a L-C) cor2

responding to VLDL-C and beta lipoprotein-cholesterol CeL-C) corresponding to LDL-C.

Studies presented in the second part of this disserta-

tion were designed to investigate whether the two rat plasma high
density lipoprotein subfractions, PAL and a L, were involved in the
1
clearance of cholesterol from rat plasma, thereby playing a possible
role in the rat's relative resistance to dietary-induced atherosclerotic
disease (Chapman, 1980; Fillies et al., 1956; Mahley et al., 1977a;
Wissler et al., 1954).

CHAPTER III

METHODS
I.

SERUM COLLECTION

Samples of blood were obtained from the abdominal aorta of adult
male Sprague-Dawley rats ranging from 60-90 days of age (Holtzman Co.,
Madison, WI) under light ether (Mallinckrodt, St. Louis, MO) anesthesia
(Grice, 1964).

Samples of rabbit blood were obtained from the ear vein

of adult male New Zealand white rabbits (Langshaw Farms, Augusta, MI).
Samples of mouse blood were obtained from neck vessels following decapitation of adult male Cox Swiss mice (Lab Supply Co., Indianapolis, IN).
Samples of monkey blood were obtained from the femoral vein of phencyclidine-anes thet ized adult male Rhesus monkeys (Primate Imports, New
York, NY) courtesy of Dr. Randall from the department of Physiology.
Samples of dog blood were obtained from the femoral artery of ethrane
and nitrous oxide-anesthetized adult male dogs (Notsinger Kennels, St.
Joseph, IL) courtesy of Dr. Thomas from the department of Physiology.
Samples of human blood were obtained from the cubital vein of normal
healthy adult male volunteers drawn while in a sitting position.

All

blood was collected in a sterile B-D vaccutainer tube with no additives
(Becton, Dickenson and Co., Rutheford, NJ).

The blood was placed in an

ice bath, allowed to clot for 1 hour and then centrifuged at 1,000 x g
for 15 min at 4 °C in an International refrigerated centrifuge.
83

The

84
upper layer of serum was withdrawn and either placed in an ice bath for
immediate analysis or frozen at -20 °C for analysis done at a later
time.
II.

SERUM AND PLASMA TOTAL CHOLESTEROL DETERMINATION

Serum or plasma total cholesterol levels were measured using an
enzymatic method (Allain et al., 1974).

Twenty microliters of serum or

plasma were added to 1 ml of cholesterol reagent (Beckman Instruments
Inc.) containing 1.6 mmol/l 4-aminoantipyrine, 21.2 mmol/l phenol,
50,000 IU/l peroxidase, 500 IU/l cholesterol oxidase and 440 IU/l cho-

lesterol esterase in pH 7.5 phosphate buffer with chelate ions.
were mixed and incubated for 10 min at 37 °C.

Samples

Absorbance was determined

at 500 nm using a Beckman DU-8 spectrophotometer.

Cholesterol concen-

trations were determined by comparison to a standard curve or by using a
Beer Lambert constant.

The assay was linear from 5 mg/dl to 500 mg/dl

of cholesterol.
III.

LIPOPROTEIN-CHOLESTEROL AND PROTEIN DETERMINATION
A.

Lipoprotein-cholesterol Electrophoresis

Electrophoresis was carried out according to the method of Cobb
and Sanders (1978) on Titan III cellulose acetate plates (Helena Laboratories, Beaumont, TX) that were soaked overnight for optimal resolution
in pH 8.8, 0.077 ionic strength tris-barbital buffer (Helena Laboratories).

Two microliters of serum or plasma were applied to the plate.

The plate was electrophoresed at 180 volts for 25 min.

Ten min prior to

the end of the electrophoresis period, half of a second cellulose ace-
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tate plate which had soaked for at least 15 min in 0. 5 M, pH 6. 7
phosphate buffer (Helena Laboratories) and blotted was then covered with
enzymatic total cholesterol-staining reagent (Helena Laboratories) which
was reconstituted with 1.5 ml of distilled water prior to electrophoresis.

The electrophoresed sample plate was then cut in two, one half of

which was layered carefully on top of the reagent plate and excess
reagent and air bubbles removed, making a sandwich of the two half
plates.

The sandwiched plates were placed between two preheated devel-

opment weights and incubated on top of a Helena Laboratories microevaporator hood for 25 min at 37 °C, following which the two plates were separated and the sample plate dried and examined under transmitted light
for orange-colored lipoprotein-cholesterol bands.

The orange-colored

lipoprotein-cholesterol bands were densitometrically scanned at 500 nm
in a Beckman DU-8 spectrophotometer with an attached densitometer.
Lipoprotein-cholesterol concentrations were calculated by multiplying
the relative percent of each lipoprotein·fraction, as obtained by densitometric scanning, by the total serum or plasma cholesterol concentration.
B.

Protein Staining

Half of the original sample plate containing duplicate samples of
serum was stained for protein with Ponceau S (Briere et al., 1964).

At

the end of electrophoresis half of the sample plate was placed in 100 ml
of Ponceau S protein stain (Helena Laboratories) for six minutes.

The

Ponceau S stained plate was then placed in 100 ml of 5% acetic acid
three times for two minutes each with agitation.

After the acetic acid
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washes the Ponceau S stained plate was placed in 100 ml of absolute
methanol (J. T. Baker Co., Phillipsburg, NJ) twice for two minutes each
with agitation to dry the plate.

Finally the Ponceau S stained plate

was cleared in a solution consisting of 71 ml absolute methanol, 25 ml
glacial acetic acid (DuPont de Nemoirs Co., Wilmington, DE) and 4 ml of
Clear Aid (Helena Laboratories) for seven and a half minutes.

The Pon-

ceau S stained plate was then held vertically for one minute to remove
excess clearing agent and then dried.

The red-colored protein bands

were densitometrically scanned at 525 nm in a Beckman DU-8 spectrophotometer with an attached densitometer.
C.

"Total" Lipid Staining

"Total" lipid staining was also initially performed on electrophoresed serum samples as a comparison to the total cholesterol stained
samples.

The electrophoresed serum samples on the cellulose acetate

plate were placed in a well containing 35 ml of oil red 0 stain (Helena
Laboratories) to which 10 ml of one normal sodium hydroxide was added
drop by drop with agitation five minutes prior to the end of electrophoresis.

The electrophoresed cellulose acetate plate was soaked in the

oil red 0 stain at room temperature for one hour, following which the
stained plate was rinsed in water for a few seconds.

The oil red 0

stained cellulose acetate plate was then wiped with cotton, placed in
100 ml of absolute methanol for 10 seconds, followed by 15 seconds in
100 ml of distilled water.

After the water wash the plate was placed

for 5-10 minutes in clearing solution consisting of 25 ml methanol and
100 ml of glycerol (Mallinckrodt).

The oil red 0 stained

pl~te

was
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removed from the clearing solution, blotted twice and five minutes later
sprayed with Lipe Spray (Helena Laboratories) to fix the stain.

The

red-colored lipid bands were scanned densitometrically at 525 nm in a
Beckman DU-8 spectrophotometer with an attached densitometer.
IV.

ULTRACENTRIFUGAL ISOLATION OF RAT SERUM LIPOPROTEINS
~

~-

-~~

Ultracentrifugal isolation of the rat serum HDL fraction was performed according to the method of Havel, Eder and Bragdon (1955).

The

serum of two rats each was pooled from 12 rats total, making six serum
samples from which HDL was isolated.

One tenth ml of 5% EDTA (Baker)

was added to every 10 ml of rat serum used.

A stock salt solution of

density 1.346 g/ml was made using 15.3 g sodium chloride (Baker) and
35.4 g potassium bromide (Mallinckrodt) and making it up to 100 ml with
distilled water.

The density of the serum was adjusted to 1.063 g/ml by

the following formula:

(A x Y) + (B x Z)

= (A

+ B)X

where A is the volume of serum or serum infranate used, B is the volume
of stock salt solution, Y is the nonprotein solvent density of serum or
serum infranate, Z is the density of the stock salt solution and X is
the desired nonprotein solvent density of the sample.

The density

adjusted serum was place in a 10.4 ml capacity, polycarbonate, ultracentrifuge bottle (Beckman Instruments Inc.)

and centrifuged using a type

40 rotor in a Beckman Model L ultracentrifuge at 40,000 rpm for another
24 hours at 15 °C. The top two ml of supernate representing the density
less than 1.063 g/ml fraction was removed and the remaining infranate
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was washed in a density 1.063 g/ml salt solution and recentrifuged for
another 24 hours.

Following the removal of the density less than 1.063

g/ml fraction from the serum, the infranate was adjusted to a density of
1.210 g/ml by adding a concentrated salt solution of NaCl and KBr (density 1.346 g/ml) according to the formula as mentioned above.

The sam-

ple was mixed and centrifuged using a type 40 rotor in a Beckman Model L
ultracentrifuge at 40,000 rpm for another 24 hours at 15 °C. The top 1.0
ml of the supernate representing the HDL fraction (density 1.063-1.210
g/ml) was removed, washed with a density 1.210 g/ml salt solution and
centrifuged at 40,000 rpm for 24 hours.

Again the top 1 ml of the

supernate was removed and the final washed 1.063-1.210 g/ml density HDL
fraction was dialyzed using tubing (Spectrum Medical Ind.

Inc., Los

Angeles, CA) which was prewashed in distilled water for one hour.

Dia-

lysis was performed overnight at 4 °C against 15 liters of 0.15 M NaCl
solution containing 0.05% EDTA and then electrophoresed on a cellulose
acetate plate as described above.

One experiment was performed in which

the density 1.063 infranate was dialyzed as described above without
adjusting the density to 1.210, therefore the infranate represented the
density greater than 1.063 g/ml plasma fraction.
V.

POLYANIO~IC

A.

PRECIPITATION -OF --RAT ----SERUM LIPOPROTEINS

Manganese Heparin Precipitation

Manganese heparin precipitation of rat serum lower density lipoproteins was performed using a modification of the Lipid Research Clinics Program Method (Manual of Laboratory Operations, 1974).

A 0.1 ml

aliquot of HDL reagent containing 1,012 mmol/l manganese chloride and
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2,000 U/ml heparin (Worthington Diagnostics, Freehold, NJ) was added to
1.0 ml of serum.

The sample was vortexed 5 sec, placed in an ice bath

for 30 min and then centrifuged at 1,000 x g for 30 min at 4 °C. The
supernate containing the HDL-cholesterol was removed, analyzed for total
cholesterol, dialyzed overnight at 4 °C against 0.15 M NaCl containing

o. 05%

EDTA and then electrophoresed on a cellulose acetate plate as

described above.
B.

Dextran Sulfate Precipitation

Dextran sulfate precipitation of rat serum lower density lipoproteins was performed according to the method of Kestner (1976).

A 0.05

ml aliquot of dextran sulfate reagent containing 20 g/l dextran sulfate
(Dow Diagnostics Co., Indianapolis, IN) was added to 1.0 ml of serum.
Following mixing, 0.1 ml of magnesium sulfate reagent containing 1.1
mol/l magnesium sulfate (Dow Diagnostics Co.) was added and the mixture
allowed to stand at room temperature for 5 min, after which it was centrifuged at 1,000 x g for 10 min at 4 °C. The supernate containing the
HDL cholesterol was removed, analyzed for total cholesterol and then
electrophoresed on a cellulose acetate plate as described above.
VI.

RAT PLASMA COLLECTION

Male Sprague Dawley rats

betwee~

tlie ages of

60~90

days

obt~ined

from Holtzman Co. (Madison, WI) were fed a diet of rat chow from Ralston
Purina Co. (St. Louis, MO) ad libitum and had free access to water.

The

rats were on a light-dark cycle of 12 hours light from 0600-1800 and 12
hours dark from 1800-0600 for 2 weeks prior to the collection of blood.

90
samples of blood were obtained from the abdominal aorta of rats under
light ether anesthesia (Grice, 1964) employing vaccutainer tubes containing EDTA (Becton Dickenson, Rutheford, NJ).

The tubes containing

the blood were inverted several times and immediately placed in an ice
bath, following which the blood was then centrifuged at 1500 x g for 30
minutes at 4 °C. The upper layer of plasma was collected and either
placed in an ice bath for immediate analysis or frozen at -20 °C for
analysis done at a later time.
VII.

PLASMA INCUBATION

Each plasma sample was initially divided into three 1 ml portions:
the first 1 ml portion of plasma was subdivided into 3 individual aliquots, each being placed in a 400 microliter stoppered micro test tube
and immediately frozen at -20 °C for non-incubated t

0

samples so that

there would only be a single thaw per sample prior to each analysis.
The second 1 ml portion of plasma was placed in a small test tube containing 0.8 mg of p-chloromercuriphenylsulfonic acid (PCMPS), a lecithin: cholesterol acyltransferase (LCAT) inhibitor

(Glomset et al.,

1973) (Sigma Chemical Go., St. Louis, MO), while the third 1 ml portion
of plasma was placed into an empty test tube.

A 250 microliter aliquot

of the second and third 1 ml portions of plasma was drawn into a siliconized Natelson blood collecting pipet, tightly sealed at both ends and
then incubated at 37 °G for 4 hours.

After the incubation period the

pipettes were placed in an ice bath for 5 minutes and the incubated
plasma then subdivided into 3 individual aliquots, each being placed in
a 400 microliter stoppered micro test tube and immediately frozen at -20
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VIII.
A.

4

hour samples.

PLASMA UNESTERIFIED CHOLESTEROL DETERMINATION

Enzymatic Determination of Unesterified Cholesterol

1. Quinoneimine Dye
Generation
A method derived from the method developed by Allain and company
(1974) was tested by this laboratory and compared with a commercial kit
for the enzymatic determination of unesterified cholesterol and a gas
chromatographic method for unesterified cholesterol determination.
Unesterified cholesterol reagent was prepared fresh as needed and consisted of 5. 0 mM sodium chelate (Sigma), 2. 0 mM 4-aminoantipyrine
(Sigma), 30, 000 U/ liter horseradish peroxidase type I

(Sigma), 150

U/liter cholesterol oxidase (Sigma), 20 mM phenol (Mallinkrodt) and 0.17
mM polyethyleneglycol-8000 (Sigma), prepared in a 0.1 M, pH 6.7 phosphate buffer.

Fifty microliters of plasma, standard or water (reagent

blank) were added to test tubes containing one ml of the unesterified
cholesterol reagent.

The tubes were mixed and incubated at 37 °C for 20

minutes after which they were placed in a room temperature water bath
for 5 minutes.

Quinoneimine was generated in direct proportion to the

amount of unesterified cholesterol present.

Absorbance was determined

at 500 nm using a Beckman DU-8 spectrophotometer.
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2.

Lutidine Dye Generation
Plasma unesterified cholesterol levels were measured by an enzy-

matic method (Beutler et al., 1976).

Two hundred microliters of rat

plasma were added to 2.5 ml of cholesterol color reagent (Boehringer
Mannheim Co., Indianapolis, IN), mixed, then divided into two equal aliquots.

One aliquot received 10 micro liters of cholesterol oxidase

(Boehringer Mannheim) and the other aliquot was used as a sample blank.
The aliquots were covered, mixed and incubated at 37 °C for one hour.
Lutidine dye was generated in direct proportion to the amount of unesterified cholesterol present.

Absorbance was determined at 405 nm using

a Beckman DU-8 spectrophotometer.
B.

Gas Chromatographic Determination of Cholesterol

Both plasma unesterified and total cholesterol were determined by
gas chromatography (Macgee et al., 1973). Twenty mg of 5 a-cholestane
(Sigma), used as an internal standard, were dissolved in 1 ml diethylether and 20 ml of tetramethylammonium hydroxide (MCB, Cincinnati, OH)
and then diluted to 100 ml with isopropanol (Mallinckrodt).

This solu-

tion known as TMH-i was used for total cholesterol determination.

For

unesterified cholesterol determination, 10 mg of 5 a-cholestane were
dissolved in 1 ml diethylether and diluted to 100 ml with isopropanol.
Two hundred microliters of TMH-i solution were added to 13x100
screw cap pyrex tubes.

Two hundred microliters of the internal standard

solution for the determination of unesterified cholesterol were added to
separate tubes.

Fifty microliters of plasma were added to each tube and

mixed for 10 sec.

The tube containing plasma and TMH-i solution was
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placed in a heating block set at 70-80 °C for 15 min. The tube was then
removed and 300 microliters of ethylacetate (Baker) added to the tube
for the determination of unesterified cholesterol and the TMH-i tube.
All tubes were mixed for 15-30 sec then centrifuged for 4 min at 500 x g
at room temperature.

One to two microliters of the clear upper phase

were injected into a Varian 3740 gas chromatograph with a flame ionization detector containing a 4 ft. silanized glass column packed with 3%
OV17 and HP chrom W 100/120 support (Varian, Co. Sunnyvale, CA).

The

injector temperature was 300 °C, the column temperature was 250 °C and
the detector temperature was 350 °C. Unesterified and total cholesterol
were both determined by calculating the peak height ratio of cholesterol
to the internal standard.

The resultant ratio was divided by the ratio

obtained in a similar manner from a cholesterol standard solution which
had been treated in the same manner as the plasma samples undergoing
analysis.

The cholesterol/internal standard peak height ratio deter-

mined from the plasma sample divided by -the cholesterol/internal standard peak height ratio of the standard solution multiplied by the concentration of the standard solution equals the concentration of
cholesterol in the plasma sample.
D.

Esterified Cholesterol and LCAT Activity Determination

The plasma esterified cholesterol level was calculated as the difference between the plasma total and plasma unesterified cholesterol
concentrations.

Rat plasma LCAT activity was determined by the percent

decrease in unesterified cholesterol concentration from the initial
unesterified cholesterol concentration after a 4 hour 37 °C in vitro
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incubation (Stokke et al., 1971; Patsch et al., 1976).
IX.

LIPOPROTEIN-UNESTERIFIED AND ESTERIFIED CHOLESTEROL
A.

Lipoprotein-unesterified Cholesterol Staining

Electrophoresis was carried out as previously described.

Ten min-

utes prior to the end of the electrophoresis period, a cellulose acetate
plate which had been soaked for at least 15 minutes in 0.5 M, pH 6.7
phosphate buffer, was removed from the buffer and blotted.

The blotted

plate was then covered with 1.5 ml of an enzymatic cholesterol-staining
reagent similar to the total cholesterol-staining reagent, but lacking
cholesterol esterase, therefore this reagent stained only the unesterified cholesterol of plasma lipoproteins separated by cellulose acetate
electrophoresis.

The enzymatic unesterified cholesterol reagent which

was freshly prepared in our laboratory contained 1.0 U/ml cholesterol
oxidase (Sigma), 100 U/ml horseradish peroxidase Type I (Sigma), 20.0 mM
sodium cholate (Sigma), 4.0 mM 4-aminoantipyrine (Sigma) and 50.0 mM
phenol (Mallinkrodt Inc. Paris, KY) in 0.5 M sodium phosphate buffer, pH
6.7.

The electrophoresed plate was carefully layered on top of the

reagent plate and excess reagent and air bubbles were removed making
sandwiches of the plates.

The sandwiched plates were then placed

between two preheated development plates and incubated on top of a
Helena Laboratories microevaporator hood for 25 minutes at 37 °C.

After

the incubation, the sample plate was separated from the reagent plate,
dried and examined under transmitted light for orange-colored lipoprotein-unesterif ied cholesterol bands.

The orange-colored lipoprotein-un-

esterified cholesterol bands were scanned at 500 nm employing a Beckman

r
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DU-8 spectrophotometer with an attached densitometer.
B.

Lipoprotein-Esterified Cholesterol

Plasma lipoprotein-total cholesterol electrophoresis and plasma
lipoprotein-unesterified

cholesterol electrophoresis

combined with

plasma total and unesterified cholesterol determinations result in mg/dl
values for the total cholesterol (TC) content of each rat plasma lipoprotein fraction which included both unesterified cholesterol (UC) and
esterified cholesterol (EC), as well as the unesterified (UC) content of
each plasma lipoprotein fraction.

In addition, the esterified choles-

terol (EC) content of each plasma lipoprotein fraction was obtained from
the difference between total cholesterol (UC + EC) and unesterified cholesterol (UC) values.
X. ESTROGEN INDUCED HYPOCHOLESTEROLEMIA
The effect of an increased plasma cholesterol clearance on rat
plasma lipoprotein-cholesterol fractions· separated by cellulose acetate
electrophoresis was studied following the induction of lipoprotein
receptor production by 17 a-ethinyl estradiol (Windler et al., 1980b).
Adult male rats were administered either 17 a-ethinyl estradiol (Sigma)
dissolved in propylene glycol (Sigma) or propylene glycol alone in daily
subcutaneous doses for four days.
5.

All rats were then sacrificed on day

Two rats received 0.05 mg/kg of 17 a-ethinyl estradiol daily, four

rats received 0.5 mg/kg of 17 a-ethinyl estradiol daily, four rats
received 1. 0 mg/kg of 17 a-ethinyl estradiol daily, and four rats
received 2.5 mg/kg of 17 a-ethinyl estradiol daily.

Five rats received
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amounts of propylene glycol equivalent to that which was administered to
the 17 a-ethinyl estradiol-treated rats.
their food and water intake measured.

Rats were weighed daily _and
Collection and incubation of

plasma samples from adult male rats treated with 17 a-ethinyl estradiol
was performed as previously mentioned.
XI.
A.

STATISTICS

Mean, Standard Deviation and Standard Error

The most commonly used parameter to describe the central character
of data is the mean (x) (Remington et al., 1970) which is the average
value of all numbers (x) within an experimental population (n).

To cal-

culate the mean the resultant values of the data collected for the
entire experimental population (n) are summed then divided by n:
n

x

= 1:
. I
1=

x./n.
i

The standard deviation (s) is used to describe the dispersion of
data around the mean in the same units as the mean.

This statistic is

derived from the measure of variability known as the variance.

The var-

iance is the average squared deviation of the measurements from their
mean, while the standard deviation is the square root of the variance:
n
- 2
~
s = (1: (x.-x) /(n-1))
1
i=l

The standard error to the mean (S.E.M.) is calculated by dividing
the standard deviation (s) by the square root of the experimental population (n):
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S.E.M. = s/(n) .
Whereas the standard deviation is a useful statistic for describing the
variability of the measurement, the standard error is used to establish
a confidence interval for the true mean of a population and is useful
for comparison of means to each other (Marks, 1982).

B. Linear Regression
Linear regression is used to determine the relationship of one
variable to another.

A correlation coefficient of 1, means the vari-

ables show a strong positive correlation, whereas a correlation coefficient of -1, means the variables show a strong negative correlation and
a correlation of O, means there is no correlation between the two variables.

Linear regression analysis chooses as the best estimate a line

for the data points by the least squares procedure (Remington et al.,
1970).

The algebraic equation for a line is:
y = mx + b

where m is the slope of the line and b is the intercept at the y axis.
The slope of the line is estimated by summing the products of all variables x and y and subtracting from that the product of the sums of all x
and the sums of all y divided by n.

This result is divided by the

square of sums of all x which is then divided by n and subtracted from
the sum of all x squared:
n
n
n
n
n
2
2
m = ((I x.y.)-(I (x.)I (y.))/n)/(I x.)-(I x.) /n.
1 1
1
1
1
1
i=l
i=l
i=l
i=l
i=l
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The y intercept is estimated by the following formula:
n

n

b = (I yi-mI xi)/n.
i=l
i=l
Finally the correlation coefficient is described by
r
where s
of y.

x

= m(s x /s y )

is the standard deviation of x and s

y

is the standard deviation

The significance of r can be estimated by calculating its t sta-

tistic as follows:

2
2 ~
t = (r (n-2)/(1-r ))
The t value is compared to the values in a table of critical values for
t with n-2 degrees of freedom for a two-tailed test.

The coefficient of

2
determination is r , which describes the amount of variation in the
response variable measurement that can be explained by the fitted
regression line.

Therefore, a correlati-0n coefficient of 0.5 yields a

coefficient of determination of 0.25 meaning that the model explains 25%
of the variability in the response variable measurements (Marks, 1982)
C.

Paired Student's t-test

The paired t-test is used when two samples of data are obtained
from the same subject (Remington et al., 1970).

Plasma incubated four

hours was compared to the fresh sample using the paired t-test.
statistic was determined as follows:
t

= d/sd

The t
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where dis the mean difference between the paired observations and scris
the standard error of the mean difference
D.

a.

Analysis of Variance

Analysis of variance CANOVA) was designed to compare more than two
factor levels in a single test.

This is necessary since multiple sta-

tistical testing decreases the overall significance level of the test
(Marks, 1982).

The increase in the overall significance level (OSL) can

be determined from the following formula:
OSL = 1-(1-p)

k

where k is the number of independent tests and p is the level of significance.

It can readily be seen that a statistical test used with a sig-

nificance level (p) equalling 0.05 and only one comparison the OSL will
remain at 0.05, but if three comparisons are made then the OSL increases
to 0.14 and with four comparison to 0.26.

Therefore, multiple testing

increases the likelihood of rejecting the null hypothesis when it is
true.

The formula for one way ANOVA is as follows:
n 2
2
n n 2
n 2
F=((r T./n.-T /n)/(k-1))/((r r x .. -ccr T./n.)/(n-k))
i=l 1 1
i=li=l 1J i=l 1 1

where k is the number of populations sampled, j is the index of the
observation within samples, i is the index of sampled populations, n. is
1

the number of observations in sample i, n is the total number of obser·
· t h e J·th ob servat1on
'
· t h e 1'th samp 1e, T 1s
' t h e sumo f
va t ions,
x .. 1s
1n
1J

all observations, T. is the sum of the observations in sample i.
1

The

degrees of freedom (df) in the numerator is k - 1 and in the denominator

100
is n - k (Remington et al., 1970).

The F statistic is calculated and

compared to values in a table for the level of significance.

If the

level of significance is less than 0.05 then there is a significant difference between the means which were being compared, but the test will
not determine which means were different.

E.

Duncan's New Multiple Comparison Test

The ANOVA determined whether a difference existed between compared
means and the Duncan's New Multiple Range Test was designed to determine
which means were different with a constant overall significant level.
Using the Duncan's test the difference between means must exceed a critical value to be considered significantly different.

The critical value

is determined using the mean squared error obtained from the analysis of
variance, the number of samples (n) and the value q, which is obtained
from a table.

The value q is dependent on the mean squared error

degrees of freedom (v), the level of significance (a) and the number of
steps (r) each mean is from the mean to which it is being compared.

The

formula for the critical difference (CD) is as follows:
CD

= q a;r;v

(MSE/n) ~ .

The MSE is the denominator of the ANOVA equation with degrees of freedom
of n-k (Kirk, 1982).

/

CHAPTER IV

RESULTS
I. COMPARISON OF -RAT
- PLASMA LIPOPROTEIN AND PROTEIN PROFILES

Figure 3 presents a comparison of the cellulose acetate electrophoretic migration of adult male rat serum proteins stained for total
cholesterol and for protein.

Four orange-colored cholesterol-staining

lipoprotein bands were detected in the serum of adult male rats and have
been named according to their plasma protein-staining electrophoretic
mobilities.

Beta lipoprotein-cholesterol, abbreviated as a1-c, had a1-

globulin mobility corresponding to low density lipoprotein (LDL) and
accounted for an average of 13.6% of the total plasma lipoprotein-cholesterol.

Alpha

2

lipoprotein-cholesterol, abbreviated as a L-C, had
2

a -globulin mobility corresponding to very low density lipoprotein
2
(VLDL) and accounted for 5.1% of the total plasma lipoprotein-cholesterol.

Alpha

1

lipoprotein-cholesterol,

abbreviated as

a L-C had
1

a -globulin mobility corresponding to high density lipoprotein (HDL) and
1
accounted for 55.9% of the total plasma lipoprotein-cholesterol.

A

fourth band was found to migrate faster than rat albumin with prealbumin
mobility accounting for the remaining 25.4% of the total plasma lipoprotein-cholesterol, and has been presently named as prealbumin lipoprotein-cholesterol and abbreviated as PAL-C.
Figure 4 compares a "total" lipid stain (oil red 0) to the spe-
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cific enzymatic cholesterol stain both performed after cellulose acetate
electrophoresis.

The cholesterol stain offers sharper resolution

between the lipoprotein bands without staining albumin as appeared to
occur with the "total" lipid stain.

Moreover, quantitation of lipopro-

tein-cholesterol could be performed using the enzymatic cholesterol
stain, whereas the "total" lipid stain was semiquantitative at best.
However, the "total" lipid stain did offer the advantage of staining
lipoproteins containing high concentrations of triglycerides such as
chylomicrons, which usually have a very low cholesterol content and
could not be seen by a specific cholesterol stain.
Overnight-fasting of adult male rats did not affect the relative
percentages of the presently obtained lipoprotein-cholesterol profile.
However, the resolution of PAL-C was markedly influenced by the amount
of time the cellulose acetate plate was presoaked in tris-barbital
buffer as shown in figure 5.

It was found that overnight soaking of the

cellulose acetate plate was necessary for the optimal resolution of
PAL-C from a L-C.
1

Although it is not clear as to why the resolution was

improved by increased soaking time, it is possible that the cellulose
acetate plate's absorptivity changes upon prolonged soaking which could
improve the resolution between PAL-C and a L-C bands found in rat
1
plasma.
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II. SPECIES COMPARISON
Figure 6 presents the comparative distribution of plasma lipoprotein-cholesterol fractions separated by cellulose acetate electrophoresis in normal adult male rat, mouse, rabbit, dog, monkey and human serum
samples.

PAL-C found in rat serum was not present in serum samples of

the adult mouse, rabbit, dog, monkey or human, indicating that PAL may
be a new plasma lipoprotein with a cellulose acetate electrophoretic
mobility faster than albumin.

The present data also suggest that PAL

may be a plasma lipoprotein that may be unique to the rat.

All the spe-

cies studied except the human were found to have higher amounts of a L-C
1

compared to their amounts of eL-C present.
Serum lipoprotein-cholesterol values in terms of mg/dl of the various normal adult nonfasting animals studied by cellulose acetate electrophoresis are given in table 3.

The concentration of PAL-C and

in adult male rat serum was found to be 15 ± 4 (±

S.D.)

a L-C
1

and 33 ± 7

mg/dl, respectively. The sum of PAL-C and a L-C of the adult male rat
1
was found to be 81.4% of the total serum cholesterol concentration which
appears to agree with previous reports in the literature for the total
amount of rat serum high density lipoprotein-cholesterol as determined
by ultracentrifugal separation of lipoproteins (Frnka et al., 1974;
Havel et al., 1955; Hanninen et al., - 1978; Narayan et al., 1968;
Narayan, 1971).

One of the currently-used coronary artery disease risk

ratios obtained by dividing the LDL-cholesterol (LDL-C) concentration by
the HDL-cholesterol (HDL-C) concentration (Gordon et al., 1977) was
found to be lowest for those species least responsive to diet-induced
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atherogenesis (rat, mouse and dog) and highest in those species (rabbit,
monkey and human) most prone to diet-induced atherogenesis (Beher et
al., 1963; Camejo et al., 1973; Kramsch et al., 1981; Mahley et al.,
1974; Mahley, 1978; Ross, 1979; Shore et al., 1974).

In addition, the

adult male human was also found to differ markedly from the experimental
animals studied with regard to another currently-employed coronary
artery disease risk ratio (Gordon et al., 1977), having a serum total
cholesterol to HDL-cholesterol ratio almost three times as great as the
other species.
III.

PAL:

A HIGH DENSITY LIPOPROTEIN

Figure 7 characterizes PAL-C and a L-C separated by cellulose ace1
tate electrophoresis as rat plasma high density lipoprotein-cholesterol
employing ultracentrifugation (Havel et al., 1955).

Only two cholester-

al-staining bands were found to occur in the high density fraction(l.063-1.210 g/ml) of normal adult rat serum separated by ultracentrifugation.

These two bands had cellulose acetate electrophoretic

mobilities corresponding to PAL-C and a L-C, indicating that both belong
1
to the HDL-cholesterol fraction of rat plasma.

Moreover, figure 8 dem-

onstrates essentially the same comparison of the denser plasma fraction
(greater than 1.063 g/ml) to whole serum indicating that PAL and a L are
1
both high density lipoproteins.

However, the dialyzed plasma fraction

with a density greater than 1.063 g/ml demonstrates better resolution
between the PAL and a L bands than the rat plasma fraction separated
1
between the densities 1.063-1.210 g/ml.

This could be due to the stabi-

lizing influence of albumin, which improved the electrophoretic resolu-
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tion of plasma proteins when paper was used as a support medium (Lees et
al., 1963). Confirmation that PAL and a L were high density lipoproteins
1
of the adult rat was achieved by using two different polyanionic precipitation methods (Kestner, 1976; Manual of Laboratory Operations, 1974).
The manganese heparin supernate containing the high density lipoprotein
fraction of rat plasma was dialyzed prior to cellulose acetate electrophoresis in order to remove the manganese, since manganese interferes
with the enzymatic cholesterol reagent (Steele et al., 1976; Thompson et
al., 1981).

Dialysis of the dextran sulfate supernatant fraction con-

taining the high density lipoprotein fraction of rat plasma prior to
cellulose acetate electrophoresis was found to be unnecessary.

Two cho-

lesterol-staining bands were also found to occur in both the 1,000 x g
manganese heparin high density lipoprotein supernate and the 1,000 x g
dextran sulfate high density lipoprotein supernate, with electrophoretic
mobilities corresponding to PAL-C and a L-C, as shown in figures 9 and
1
10.

These results offer additional evidence that both PAL-C and a L-C
1

belong to the HDL-C fraction of rat plasma. It is also interesting to
note that albumin is present in the HDL supernates of both precipitation
methods and the resolution of PAL from a L is equivalent to that of the
1
density greater than 1.063 g/ml plasma fraction indicating that albumin
may be a factor in the increased resolution of PAL from a L using cellu1
lose acetate electrophoresis.
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IV.

METHOD COMPARISON

Figures 11 and 12 show that a positive correlation using linear
regression analysis exists between rat serum HDL-C levels determined by
cellulose acetate electrophoresis and rat serum HDL-C levels determined
by either the manganese heparin precipitation method or by the dextran
sulfate precipitation method.

The total HDL-C concentration for the

cellulose acetate electrophoretic method was obtained by adding the
PAL-C and a L-C concentrations.
1

Figure 13 demonstrates that the best

correlation exists between the two precipitation techniques as would be
expected.

Although the three methods demonstrated a statistically sig-

nificant positive correlation, figure 14 shows that statistically significant differences in absolute HDL-C levels in identical samples of
adult male rat serum were obtained by each method.

Statistical compari-

sons were made using an analysis of variance and Duncan's new multiple
range test.

Mean values for

adult male rat HDL-C concentration

obtained by cellulose acetate electrophoresis were 44 ± 2 mg/dl
S.E.M.), with the mean PAL-C being 12 ± 1 mg/dl and the

(±

mean a L-C
1

being 32 ± 2 mg/dl. In contrast, mean values for the HDL-C concentration
obtained by manganese heparin precipitation and

dextran sulfate precip-

itation were 34 ± 2 and 27 ± 2 mg/dl respectively. Not only did both
polyanionic precipitation methods yield statistically significant different values from those obtained by the electrophoretic method, but
both polyanionic precipitation methods yielded statistically significant
different values from each other.
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V.

RAT PLASMA LIPOPROTEIN-CHOLESTEROL MOVEMENT

Figure 15 shows a progressive decrease in a L-TC concentration
1
along with a progressive increase in PAL-TC concentration during a 4
hour incubation of adult rat plasma at 37 °C. At the end of the 4 hour
incubation period, PAL-TC had increased from 25.0% to 63.2% of the
plasma lipoprotein-cholesterol while alL-TC had decreased from 51.9% to
21.4% of plasma lipoprotein-cholesterol.

No statistically significant

change in plasma total cholesterol was observed during the 4 hour in
vitro incubation period.

These data indicated a marked movement of

total cholesterol from a L to PAL during the in vitro incubation period.
1

Figure 16 depicts the changes in the lipoprotein profile as demonstrated
densitometrically both at 1 hour and 4 hours after incubation at 37 °C.
Although not clearly seen in figure 16, table 4 demonstrates that incubation of rat plasma appears to affect the electrophoretic mobility of
eL and to some extent the mobility of a L as eL moves toward the a L
2
2
region. e1 increases its mobility by 25 .·8% whereas a L electrophoretic
2
mobility increased by 11.9%. PAL and a L mobility were unaffected by the
1
incubation.

Interestingly, the addition of 2.0 ml'I PCMPS a known LCAT

inhibitor (Glomset et al., 1970) increased the mobility of eL slightly,
but not significantly, while after a 4 hour 37 °c in vitro incubation e1
mobility does not differ significantly from the initial mobility as compared to the fresh sample containing 2.0 mM PCMPS.

However, eL electro-

phoretic mobility increased significantly in the sample containing PCMPS
when compared to the fresh sample with no additives.

It is possible

that LCAT may be responsible for the increase in electrophoretic mobil-
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itY of 6L, but PCMPS, which is a relatively nonspecific sulfhydryl group
inhibitor (Vansteveninck et al., 1965) could have affected other plasma
enzymes or the LDL molecule specifically, preventing the increased
mobility that was seen after a four hour in vitro incubation of rat
plasma.

The observed increase in 6L electrophoretic mobility and lipo-

protein-cholesterol movement between lipoproteins was an indication that
a dynamic process continued to exist in plasma incubated in vitro at
physiological temperatures and was an indication of possible problems
that could occur if a plasma sample was not analyzed immediately after
being taken or steps are not taken to inhibit either lipoprotein-cholesterol movement or increased lipoprotein electronegativity.

Moreover, it

was an indication that a process could be occurring in vivo affecting
rat plasma lipoprotein-cholesterol composition and lipoprotein integrity, which we attempted to study by in vitro incubations.
Figure 17

indicates that statistically significant changes

occurred in plasma lipoprotein-UC concentrations in 3 out of 4 rat
plasma lipoprotein fractions during a 4 hour 37 °C in vitro incubation
of plasma.

The decrease in a L-TC concentration appears to
1

be due to a

change in a L-UC which decreased by 202 ± 5 nmol/ml plasma/4 hr since
1
a L-EC remained unchanged.
1

The increase in

amounted to 295 ± 18 nmol/ml plasma/4
increase in PAL-UC of 75 ± 16

PAL-TC concentration which

hr appears to be due to both an

nmol/ml plasma/4 hr and an increase in

PAL-EC of 220 ± 21 nmol/ml plasma/4 hr. In addition, 6L-UC was found to
decrease by

41 ± 10 nmol/ml plasma over the 4 hour incubation period,

while 6L-EC remained unchanged.

The observed loss of UC from 6L and a L
1
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together with the concomitant increase in PAL-EC suggested that either
the UC of aL was first transferred to a L, where the UC was esterified
1
by LCAT to EC which was then transferred to PAL or on the other hand,
the UC of aL and a L was transferred directly to PAL, where the UC was
1
then esterified.

These two possibilities were therefore investigated by

inhibiting the esterification of rat plasma by the addition of 2.0 mM
PCMPS, a known LCAT inhibitor (Glomset et al., 1970).
VI. LIPOPROTEIN-CHOLESTEROL MOVEMENT WITH
LCAT
-- INHIBITION
Confirmation that rat plasma UC esterification is inhibited by the
addition of PCMPS was obtained by the following observations.

In the

absence of PCMPS, rat plasma UC was found to decrease by 38. 4 ± 4. 4%
following a 4 hour 37 °C in vitro incubation of plasma.
of 2. 0 mM PCMPS however, rat

In the presence

plasma UC was found to decrease by only

3.3 ± 0.8% under identical conditions.

Figure 18 shows that in the

presence of 2.0 mM PCMPS, instead of a loss of UC from a L occurring in
1
incubated rat
in

plasma, there was a 44 ± 13 nmol/ml plasma/4 hr increase

a L-UC, along with a loss of 41 ± 5 nmol/ml plasma/4 hr in the aL
1

fraction, demonstrating that rat plasma SL-UC concentrations decreased
by the same amount during a 4 hour incubation period of plasma both in
the presence or absence of 2.0 mM PCMPS.

These results indicated that

UC was transferred from SL to a L since the amount of a L-UC increase
1
1
was equal to the SL-UC decrease over the 4 hour incubation period in
LCAT-inhibited plasma.

In addition, these data also suggested that fol-

lowing the transfer of UC from SL to a L in rat plasma incubated without
1
2.0 mM PCMPS, the transferred UC was then esterified, and the resulting
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EC either transferred to PAL or alternatively, a L itself might have
1
been partially catabolized to PAL, causing the presently observed
increased concentration of PAL-EC.
A cholesteryl ester transfer factor may be present in rat plasma
since

PAL-EC decreased by 59 ± 34 nmol/ml plasma/4 hr while a L-EC
1

increased by 93 ± 39 nmol/ml plasma/4 hr in adult rat LCAT inhibited
plasma following a 4 hour 37 °C in vitro incubation.

This suggested

that cholesteryl ester transfer may occur between the two rat plasma HDL
subfractions from PAL to a L, but does not appear to be physiologically
1
significant since it was only observed in LCAT inhibited plasma.

How-

ever, it may be significant that the increase of 14% in rat plasma
a L-EC in the presence of 2.0 mM PCMPS observed in the present studies
1
was similar to the increases in VLDL cholesteryl ester found in rat
plasma incubated under similar conditions as previously reported using
ultracentrifugation to separate lipoproteins in order to assay for lipoprotein-cholesteryl ester transfer activity

(Barter et al., 1978).

These data indicate that rat plasma may possess a lipoprotein-cholesteryl ester transfer factor inhibitor as has previously been reported to
be present in the rat and other species lacking significant lipoproteincholesteryl ester transfer activity (Morton et al., 1981).
The a L fraction was the only lipoprotein fraction of rat plasma
2
whose cholesterol concentration did not appear to be affected by the 4
hour 37 °C in vitro incubation.

The a L-TC concentration did not sig2

nificantly change nor did the a L-EC or a L-UC concentration in adult
2
2
male rat plasma incubated either in the absence or presence of 2. 0 mM
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pCMPS,

indicating that

LCAT had no effect

on a L-cholesterol
2

concentration.
Figures 19 and 20 present changes in esterified to unesterified
cholesterol ratios of lipoprotein fractions separated by cellulose acetate electrophoresis following a 4 hour 37 °C in vitro incubation of
adult male rat plasma in the presence and absence of 2.0 mM PCMPS.

The

EC/UC ratio of alL increased by 500% in plasma incubated in the absence
of PCMPS because of a decrease in UC without any change in EC as shown
in figure 17.

The EC/UC ratio of eL showed a statistically significant

increase after incubation of rat plasma both in the presence and absence
of 2.0 mM PCMPS because of a decrease in eL-UC without any change in the
eL-EC concentration.

a L appeared to have a relatively constant EC/UC
2

ratio throughout the in vitro incubation.

The observed increase in the

EC/UC ratio of a L incubated rat plasma is most likely due to LCAT
1
esterification of a L-UC.
1

However, inasmuch as the a L-EC concentration
1

was found to be unchanged during the incubation period, this suggests
that the EC generated by LCAT activity must in some way have been incorporated into PAL, which was the only lipoprotein fraction in which a
significant increase in EC concentration occurred when rat plasma was
incubated without PCMPS.
It is possible that the incorporation of EC from a L into PAL may
1
be due to a specific transfer of EC from a L to PAL, but this would not
1
explain the subsequent increase in UC necessary to keep the EC/UC ratio
of PAL constant during the incubation period.

In addition, the EC

transfer from a L to PAL, was not demonstrated in LCAT-inhibited plasma,
1
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although LCAT inhibition by PCMPS does not appear to affect the transfer
of cholesteryl esters between plasma lipoproteins of other species (Ha
et al., 1982).

Another explanation of our data may be that PAL is the

preferred substrate for rat plasma LCAT and that UC from both a L and BL
1
is passively transferred to PAL, where it is then esterified by LCAT.
That BL may be passively transferred is suggested since there is no evidence for an energy requiring process or transfer protein in order that
unesterified cholesterol may be moved from one lipoprotein to another.
However, when PCMPS was added to rat plasma causing an inhibition of
LCAT, a transfer of UC did occur from BL to a L. It has been previously
1
reported that equilibration of UC between plasma lipoproteins is slow
relative to LCAT activity.

If LCAT is inhibited, then the preferred

LCAT substrate may be relatively unsaturated with respect to UC, and in
order to regain equilibrium, UC would have to be transferred to the preferred LCAT substrate to achieve relative saturation and equilibrium
with the other plasma lipoproteins (Perret et al., 1983).

It would

therefore be expected that if PAL were the preferred rat LCAT substrate,
then UC should have been transferred from BL to PAL to establish equilibrium once LCAT is inhibited.

The data however, suggests that a L and
1

not PAL is the preferred substrate for rat LCAT activity, since a L
1
receives BL-UC as presently demonstrated in LCAT-inhibited rat plasma.
Still another explanation of our data is that in the rat, PAL is a catabolic product of a L, the a L in some way splitting to form a PAL parti1
1
cle containing a specific amount of UC and EC.

Further investigation of

this possibility was therefore performed using the technique of obtain-
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ing rats with hypocholesterolemia that is induced by the in vivo
administration of 17 a-ethinyl estradiol (Davis et al., 1978).
VII.

RAT PLASMA LIPOPROTEIN-CHOLESTEROL CLEARANCE

Adult male rats administered subcutaneous doses of 17 a-ethinyl
estradiol dissolved in propylene glycol did not differ significantly
from rats receiving only propylene glycol with regard to body weight or
food intake.

Figure 21 shows that the plasma total cholesterol concen-

trations of rats receiving 17 a-ethinyl estradiol were markedly lower
than vehicle control rats.

The plasma total cholesterol of adult male

rats administered 0.05 mg/kg of 17 a-ethinyl estradiol daily was significantly lower after 5 days than the control group by an average of
50.9%.

Rats receiving daily doses of 0.5 mg/kg of 17 a-ethinyl estra-

dial had 73.6% lower plasma cholesterol levels after 5 days than control
rats.

Rats receiving daily doses of 1.0 mg/kg of 17 a-ethinyl estradiol

had 90.6% lower plasma cholesterol than control rats and those rats
receiving daily doses of 2.5 mg/kg of 17 a-ethinyl estradiol had 81.1%
lower plasma cholesterol values at 5 days compared to control rats.
Figure 22 presents the effects of in vivo administration of 17
a-ethinyl estradiol on lipoprotein-total cholesterol concentrations
before and after a 4 hour 37
plasma.

°c in vitro
---

incubation of adult male rat

The lower plasma cholesterol values observed after 17 a-ethinyl

estradiol administration are primarily reflected in the values of PAL-TC
and eL-TC. The lowest dose of 17 a-ethinyl estradiol (0.05 mg/kg daily
for 4 days) resulted in PAL-TC levels that were 96.7% lower than control
rats and eL-TC levels that were 92. 9% lower than control rats._ Both
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PAL-TC and 6L-TC apparently disappeared from the plasma of rats receiving 0.5 mg/kg and higher doses of 17 a-ethinyl estradiol, whereas a L-TC
1
and a L-TC remained present at all doses of 17 a-ethinyl estradiol even
2
though both a L-TC and a L-TC
1
2

showed decreased levels.

The cholesterol

present in the plasma of adult male rats administered 0.5 mg/kg and
higher of 17 a-ethinyl estradiol therefore appeared to be carried exclusively by a L and a L.
2
1

Only PAL-TC reappeared following a 4 hour in

vitro incubation of those plasma samples in which PAL-TC was previously
not detected as a result of an in vivo 17 a-ethinyl estradiol administration. In addition, a concomitant decrease in a L-TC was found to
1
occur in incubated plasma of rats administered 0.5 mg/kg and higher 17
a-ethinyl estradiol.

Unlike PAL-TC, 6L-TC could not be detected in

incubated plasma of rats administered 0.5 mg/kg and higher 17 a-ethinyl
estradiol either before or after a 4 hour 37 °C in vitro incubation.
The fact that PAL-TC reappeared in the plasma of 17 a-ethinyl estradioltreated rats after a 4 hour in vitro incubation at 37 °C and that a L-TC
1
decreased during the same incubation with LCAT remaining active suggests
that PAL of the rat may be a product of plasma a L catabolism and that
1
a L is the preferred substrate for rat LCAT activity, as summarized in
1
figure 23.

In addition, a L-cholesterol appears to be linked to LCAT
1

activity since PAL-cholesterol concentrations did not change as drastically when rat plasma was incubated at 37 °C in the presence of PCMPS,
an LCAT inhibitor, which is summarized in figure 24.

However, statisti-

cally significant changes in the cholesterol concentration of a L, PAL
1
and 6L still occur.

These changes appear to reflect the processes of
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unesterified and possibly esterified cholesterol transfer.

PAL-TC

decreased due to a decrease in PAL-EC while a L-TC increased as a result
1
of both an increase in UC and EC.
result of a UC decrease.

In addition 6L-TC decreased as a

The increase in a L-UC was the same as the
1

6L-UC decrease indicating that the UC most probably came to a L from 6L.
1
The EC drop in PAL with a concomitant increase in a L-EC indicated that
1
transfer of EC may have occurred from PAL to a L under these conditions.
1
Moreover, the present data suggest that PAL, like 6L, may be cleared by
hepatic lipoprotein receptors of the rat since both PAL-TC and 6L-TC
appear to be rapidly removed from rat plasma following the induction of
lipoprotein receptor production by 17 a-ethinyl estradiol.

l

CHAPTER V

DISCUSSION
I.

CELLULOSE ACETATE LIPOPROTEIN-CHOLESTEROL ELECTROPHORESIS

Resolution of plasma lipoproteins by paper electrophoresis has
been greatly improved by employing a barbital-albumin buffer (Lees et
al., 1963).

However, paper electrophoresis of plasma lipoproteins gen-

erally requires 16 hours for completion.
support medium

Cellulose acetate used as a

for electrophoresis is capable of excellent resolution

of plasma lipoproteins without the requirement of albumin in the buffer,
within 15-45 minutes (Beckering et al., 1970; Chin et al., 1968;
Fletcher et al., 1970).

Accurate quantitation of electrophoretically-

separated plasma lipoproteins with nonspecific "total" lipid stains has
been difficult, because of each lipoprotein's differing affinities for
such stains (Fletcher et al., 1970).

Such commonly used lipid stains as

Sudan black B, preferentially stain unsaturated sterol esters and unsaturated triglycerides, whereas unesterified cholesterol and phospholipids are stained negligibly or not at all (Schjeide et al., 1963).
Moreover, the various cholesteryl esters and triglycerides have different staining affinities for Sudan black B, dependent upon their particular fatty acids.

Oil red 0, which is another commonly used "total"

lipid stain, stains cholesteryl esters more intensely than Sudan black
B, but its staining is also dependent on the cholesterol ester's degree
116
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of fatty acid saturation.

In addition,

oil red 0 also stains

triglycerides as well as albumin, but does not stain phospholipids or
unesterified cholesterol.

Recently a cellulose acetate electrophoretic

technique, which combines an enzymatic staining procedure for total cholesterol (Allain et al., 1974) has been developed for determining human
plasma

lipoprotein-cholesterol concentrations

which are

currently

employed as risk factors for human atherosclerotic disease (Cobb et al.,
1978). . The method of quantitating human plasma lipoproteins using
enzymes specific for cholesterol is more precise and accurate as opposed
to "total" lipid staining.
Ultracentrifugation and poly anionic

precipitation techniques,

although commonly used for human plasma lipoprotein fractionation, may
hot be ideal methods for the analysis of rat plasma lipoprotein-cholesterol concentrations.

Ultracentrifugation may lead to lipoprotein deg-

radation and loss of lipoprotein-cholesterol in the rat (Fainaru et al.,
1977; Marcel et al., 1981) as well as the loss of apolipoproteins from
HDL in the human (Hojnacki et al., 1978; Lindgren et al., 1979).
Another drawback to ultracentrifugation is the time involved in separating lipoprotein fractions, which can take up to a week to accomplish
(Havel et al., 1955).

A major problem with precipitation methods is

that although the various lipoprotein density classes can be sequentially precipitated, the resolution between lipoprotein classes is so
close that a portion of the lipoprotein class which is desired in solution may also occur in the precipitate (Burstein et al., 1970).

In a

study comparing various precipitation techniques to sequential ultracen-
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trifugation (Warnick et al., 1979a; 1979b), a good correlation was found
between the methods however,

differing HDL-cholesterol levels were

obtained depending on which method was used.

This would indicate that

the various precipitation techniques are not equivalent and can lead to
significant differences in HDL-C quantitation.

Another problem with

precipitation techniques is the inadvertent precipitation of HDL containing apolipoprotein E along with the apolipoprotein B-containing
lipoproteins (Mahley et al., 1977b).
Cellulose acetate electrophoresis coupled with an enzymatic cholesterol stain offers several advantages over other methods for measuring the distribution of rat plasma lipoprotein-cholesterol.

The cellu-

lose acetate electrophoretic method utilizes only 2 µl of serum
which permits multiple sampling from the same animal.

In contrast, both

the polyanion precipitation and ultracentrifugal methods require several
ml of serum.

The cellulose acetate electrophoretic method has been

presently found to fractionate rat plasma into four lipoprotein-containing cholesterol bands, compared to only three lipoprotein bands which
have been observed in rat serum employing paper electrophoresis (Mahley
et al., 1977a; Watson, 1961).

Polyanion precipitation methods yield

only two fractions, namely HDL-C in the supernate and lower density
lipoprotein-cholesterol consisting of both VLDL-C and LDL-C as a precipitate.

In addition, the present data indicates that polyanion precipi-

tation methods employing rat serum resulted in a loss of 29-40% of the
HDL-total cholesterol.
This dissertation describes a new method for the determination of
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unesterified cholesterol in plasma lipoprotein fractions.

The reagent

we used was derived from the enzymatic technique for the measurement of
plasma total cholesterol (Allain et al., 1974) and the method was
derived from that for lipoprotein-total cholesterol analysis by cellulose acetate electrophoresis (Cobb et al., 1978).

The unesterified cho-

lesterol reagent was used to determine the UC concentrations of rat
plasma and compared favorably to two established techniques for the
determination of plasma UC (Beutler et al., 1976; Macgee et al., 1973)
with identical results observed for all methods employed.

We have used

this method to describe the plasma cholesterol metabolism of the rat in
an in vitro assay.

This method has great potential for the study of

cholesterol metabolism not only in the rat but other experimental systems as well including the human.

The advantages of electrophoretic

separation and specific cholesterol staining techniques include, small
sample requirments, high resolution, short assay time, greater accuracy
and precision and fewer artifacts as compared to other methods for
plasma lipoprotein fractionation, such as ultracentrifugation or polyanionic precipitation (Fainaru et al., 1977; Hojnacki et al., 1978; Kunitake et al., 1982; Lindgren et al., 1979; Mahley et al., 1977b; Marcel
et al., 1981; Warnick et al., 1979a; 1979b).
II.

COMPARISON OF SPECIES PLASMA LIPOPROTEIN-CHOLESTEROL

Plasma lipoprotein-cholesterol ratios for various animal species
have been obtained employing cellulose acetate electrophoretic separation of lipoproteins coupled with an enzymatic cholesterol stain.

The

LDL-C/HDL-C ratios were presently found to be markedly higher in the
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rabbit, monkey and human, species known to be more prone to experimentally-induced atherosclerotic lesions (Camejo et al., 1973; Kramsch et
al., 1981; Mahley, 1978; Ross,

~

1979; Shore et al., 1974), than the
~

~

LDL-C/HDL-C ratios of the rat, mouse and dog, which are species less
prone to induced atherosclerotic lesions (Beher et al., 1963; Fillies et
al., 1956; Mahley et al., 1974; 1977b; Mahley, 1978; Wissler et al.,
1954).

The total cholesterol to HDL-C ratio was also found to be higher

in those species most prone to induced atherosclerotic lesions, although
the species differences between the total cholesterol/HDL-C ratios
appear to be less marked than the species differences between the
LDL-C/HDL-C ratios.

Human epidemological evidence has shown that the

LDL-C/HDL-C ratio is positively correlated to the risk of developing
atherosclerotic disease (Gordon et al., 1977), therefore it is possible
that a high LDL-C/HDL-C ratio may be an important indicator of species
susceptibility to the experimental-induction of atherosclerotic disease.
III.

PAL:

~UNIQUE

RAT PLASMA

L~POPROTEIN

The present data employing cellulose acetate electrophoresis combined with an enzymatic cholesterol stain clearly demonstrates for the
first time that adult male rat plasma contains a rapidly-moving cholesterol-containing high density lipoprotein with an electrophoretic mobility equivalent to prealbumin.

Previous electrophoretic studies of rat

plasma apparently have not demonstrated prealbumin lipoprotein due to
either differences in the electrophoretic medium or due to the semiquantitative nature of the "total" lipid stains employed (Fletcher et al.,
1970; Schjeide et al., 1963).

Agarose gel electrophoresis of rat plasma
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HDL following ultracentrifugal separation demonstrated a single lipidstaining band whose migration appeared to include the prealbumin region
(Koga et al., 1969).

Agarose gel electrophoresis of rat whole plasma

combined with a Sudan black B stain also appeared to suggest a prealbumin lipoprotein band, however in this system lipid-stained bands
migrated consistently farther than their corresponding amido black protein-stained bands (Johansson et al., 1976).

Human plasma alpha

1

lipo-

protein also separated by agarose gel electrophoresis appeared to have
the same electrophoretic mobility as albumin, with the lack of electrophoretic resolution between albumin and a L possibly being due to non1
specific albumin staining (Johansson et al., 1976; Schjeide et al.,
1963).

In addition, agarose-starch gel electrophoresis of rat plasma

using a combined oil red 0 and fat red 7B "total" lipid stain also
appeared to suggest bands which had prealbumin, alpha , prebeta and beta
1
electrophoretic mobility (Chalvardj ian, 1971).
alpha

1

The prealbumin and

bands appeared to correspond to HDL, since after ultracentrifugal

fractionation of the plasma, these two bands had a density range greater
than 1.063 g/ml, while the prebeta band corresponded to VLDL, and the
beta band corresponded to LDL.

However, no attempt was made to deter-

mine the actual cholesterol content of the prealbumin-migrating lipoprotein band visualized by a "total" lipid stain.

Moreover, a side-by-side

electrophoretic comparison of total lipid-stained and protein-stained
plasma was not performed using the agarose-starch gel electrophoretic
technique and moreover, the prealbumin lipid-staining band was visualized from albumin by the difference in albumin's staining color.

The
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agarose-starch gel method combined with a "total" lipid stain is quite
semiquantitative with densitometric analysis being extremely difficult
due to albumin interference.

On the other hand, the present studies

employing cellulose acetate electrophoresis combined with an enzymatic
cholesterol stain allow for the easy distinction between prealbumin
lipoprotein and albumin, as well as an accurate comparative quantitation
of the cholesterol concentration of prealbumin lipoprotein and other rat
plasma lipoproteins.
Based on the smaller cholesterol content of PAL, as indicated in
table 3, this high density lipoprotein fraction of rat plasma obtained
by cellulose acetate electrophoresis may be similar to the HDL

1

subfrac-

tion isolated from rat plasma by rate zonal ultracentrifugation (Eisenberg et al., 1984) or by density gradient centrifugation (Jansen et al.,
1983), which would therefore make a L obtained by cellulose acetate
1
electrophoresis similar to HDL

2

isolated by centrifugation. One problem

with this interpretation is the rapid electrophoretic mobility of PAL on
cellulose acetate, since apolipoprotein E-containing lipoproteins have
been found to migrate in the a -globulin region using paper electro2
phoresis, and HDL

1

of the rat has been reported to have a high apolipo-

protein E-content (Mahley et al., 1977a; Weisgraber et al., 1977).

How-

ever, rat plasma PAL isolated by

may

celltilo~e

acetate

el~ctrophoresi~

contain other apolipoproteins besides apolipoprotein E, which might
enhance its electrophoretic mobility.
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IV.
The lipid rich

FAST BETA LIPOPROTEIN

a fraction

of human plasma was shown to be sensi-

tive to storage and temperature since

a globulin

electrophoretic mobil-

ity increased when stored for long periods (Armstrong et al., 1947).
similar study demonstrated that within 36 hours human plasma
acquires a

2

globulin electrophoretic mobility. However, the

A

a globulin
i~crease

in

mobility can be prevented for at least 10 days by storage at 0-4 °C or
by heating the serum at 50 °C for 3 hours (Hoch et al., 1954), which
would indicate that a plasma enzyme was probably involved in this electrophoretic transformation.

More evidence of enzymatic involvement was

indicated when the increase in

a1

electrophoretic mobility was inhibited

by sodium bromoacetate or heating at 58 °C as demonstrated using paper
electrophoresis with a "total" lipid stain after a 72 hour 37 °C incubation of either horse or human serum (Tayeau et al., 1956).

We have

redemonstrated this increase in beta lipoprotein electrophoretic mobility for the first time in rat plasma and have shown that PCMPS a known
sulfhydryl group inhibitor (Velick, 1953) also inhibits the increased
electrophoretic mobility of

a1

after a 37 °C in vitro incubation.

The increased mobility of

a lipoprotein

at first may have seemed

trivial, an artifact of incubation, but in light of recent findings as
to the increased uptake of electronegative LDL by the scavenger pathway
(Brown et al., 1980), this change in mobility may have some influence on
the pathogenesis of atherosclerosis. Human plasma

a

lipoprotein was

shown to have increased electrophoretic mobility after it passed into
the lymph (Reichl et al., 1973; 1975).

Moreover, LDL incubated with
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cultured endothelial cells was found to be more electronegative and had
enhanced uptake by incubated macrophages (Henriksen et al., 1981) .. In
addition, in vivo administration of the modified LDL particles resulted
in an increased uptake into liver endothelial cells as opposed to the
unmodified LDL which was taken up by liver parenchymal cells (Nagelkerke
et al., 1984).

Therefore, it has been demonstrated that increased elec-

tronegativity of LDL can occur in vivo as well as in vitro and that a
pathway for the clearance of this more electronegative LDL exists.
Moreover, the macrophage scavenger pathway, responsible for the clearance of LDL with increased electronegativity has been implicated as a
factor leading to atherosclerotic lesions (Goldstein et al., 1979).
The mechanism for the increased mobility of LDL is not known
though several possibilities may be explored.

Heparin, an endogenously

produced substance has been shown to increase the electrophoretic mobility of lipoproteins possibly by its activation of lipoprotein lipase
(Houtsmuller, 1966) or by complexing with the LDL molecule as dextran
sulfate complexes with LDL, thus increasing LDL's negative charge and
its affinity for the macrophage receptor (Basu et al., 1979).

The pos-

sibility exists that an enzyme may be involved which is heat labile and
sensitive to sulfhydryl group inhibition.
way to degrade the LDL
negative groups.

apolipoproteins~

The enzyme could act in some

which could reveal more electro-

Another possibility could be that the enzyme degrades

the lipid content of LDL or transfers it to another lipoprotein, causing
a conformational change which could reveal electronegative groups on the
LDL molecule.

One other possibility is the transfer of apolipoproteins
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from other lipoproteins to the LDL molecule which could increase its
electronegativity.

These possibilities all remain to be explored in the

future.
V.

RAT PLASMA LIPOPROTEIN-CHOLESTEROL MOVEMENT

Esterified cholesterol transfer between HDL and VLDL particles
isolated by ultracentrifugal techniques has been found to occur during
the in vitro incubation of plasma of rabbits, humans and other animal
species (Barter et al., 1978; 1979; Ha et al., 1982; Nichols et al.,
1965; Zilversmit et al., 1975).

However, esterified cholesterol trans-

fer between plasma HDL and VLDL in rats has either not been observed
(Oschry et al., 1982) or has been reported to occur at such a low rate
as to be physiologically insignificant (Barter et al., 1978).

The pres-

ent studies suggest that movement of cholesteryl ester does occur from
a L to PAL, two high density lipoprotein fractions of rat plasma sepa1
rated by cellulose acetate electrophoresis.

In contrast, the present

data also suggest that when rat plasma LCAT was inhibited, lipoproteincholesteryl ester transfer activity may still be present, but EC movement was found to occur from PAL to a L rather than from a high density
1
lipoprotein to the very low density lipoproteins as found in other species (Ha et al., 1982).

The observed cholesteryl ester movement from

a L to PAL appears to be the physiologically significant process since
1
movement of EC in the opposite direction could only be demonstrated when
LCAT was inhibited.

The presence in rat plasma of an inhibitor to cho-

lesteryl ester transfer as has been previously reported (Morton et al.,
1981) would indicate that the significant movement of cholesteryl ester
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from a L to PAL as presently reported was most probably due to LCAT
1
activity and not to lipoprotein-cholesteryl ester transfer.
Figure 25 shows our proposed in vivo mechanism for cholesterol
clearance by circulating plasma lipoproteins in the adult male rat based
on current knowledge of rat lipoprotein metabolism and from the present
data obtained from in vitro incubation studies of rat plasma coupled
with 17 a-ethinyl estradiol-induced rat hypocholesterolemia.

It would

appear that a L is the preferred substrated for LCAT activity in rat
1
plasma similar to HDL

3

being the preferred substrate for LCAT in humans

(Fielding et al., 1971; 1972a; Jahani et al., 1981). The catabolic conversion of a L (VLDL) to 6L (LDL) by the action of lipoprotein lipase
2
(Eisenberg et al., 1973a) occurs only in vivo since the enzyme is bound
to the endothelial walls of the vasculature (Eisenberg et al., 1982) and
generally released by highly anionic compounds like heparin (Krauss et
al., 1973) and would therefore not be a factor in the present in vitro
assay.
It has been reported that the uptake of cellular UC by HDL is
determined by the rate of desorption of cholesterol out of the cell membrane into the aqueous phase surrounding the cell as well as the distance of diffusion to HDL (Phillips et al., 1980).

The rate of choles-

terol efflux from ·cells may also be modulated by apolipoprotein A-I
(Fielding et al., 1981b). The transfer of UC to HDL is probably due to

--

LCAT activity creating an unsaturated HDL particle with respect to UC,
allowing more UC to accumulate on the HDL particle (Perret et al.,
1983).

The exchange of UC between lipoproteins occurs constantly
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(Roheim et al., 1963), but seems to be temperature dependent, since at 4
0

c

no exchange of UC occurs between lipoproteins (Perret et al., 1983).

Net transfer of UC between plasma lipoproteins has been reported not to
occur when LCAT is inhibited (Perret et al., 1983; Fielding et al.,
198la; 1981b), however, a net transfer of UC between eL and a L was
1
observed during the presently reported in vitro incubation of rat
plasma.

A possible explanation for this net transfer of UC between rat

eL and a L may involve a L being relatively unsaturated with respect to
1
1
UC due to LCAT activity, with net transfer of UC from eL to a L occur1
ring in order to achieve equilibrium.

Moreover, the UC transfer from eL

to a L observed in LCAT inhibited plasma incubated for 4 hours may
1
reflect the same process indicating that esterification of UC by LCAT
occurs at a faster rate than UC can be transferred to a L to achieve
1
relative saturation, which would explain the 2-4 hours needed for equilbrium to be achieved between the UC concentrations of incubated rat
plasma lipoproteins as has been reported previously (Perret et al. ,
1983; Roheim et al., 1963).
VI.

RAT PLASMA LIPOPROTEIN-CHOLESTEROL CLEARANCE

17 a-Ethinyl estradiol has been reported to induce the production
of hepatic lipoprotein receptors that are specific for apolipoprotein B
(apo B) and apolipoprotein E (apo E) containing lipoproteins (Windler et
al., 1980b), suggesting that PAL because of its rapid clearance from the
plasma in 17 a-ethinyl estradiol-treated rats may therefore contain
either of these two apolipoproteins.

However, since PAL is a high den-

sity lipoprotein, it is more probable that PAL contains apo E rather
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than apo B (Quarfordt et al., 1978).

The fact that apo E-containing

lipoproteins have been found to migrate to the a -globulin region using
2
paper electrophoresis (Mahley et al., 1977a; Weisgraber et al., 1977)
together with the finding that PAL migrates much further when electrophoresed on cellulose acetate, suggests that PAL may contain other apolipoproteins besides apo E which enhance its electrophoretic mobility.
Apolipoprotein analysis of the cellulose acetate electrophoreticallyseparated rat plasma lipoproteins are currently being undertaken in this
laboratory to determine which apolipoproteins are associated with PAL
and a L in order to establish whether PAL and a L are similar to the
1
1
ultracentrifugally-separated less dense HDL

1

and more dense HDL

2

sub-

fractions of rat plasma. The conflicting reports of rat plasma cholesteryl ester transfer between HDL

1

and HDL

2

(Eisenberg et al., 1984; Jan-

sen et al., 1983) or between HDL and VLDL (Barter et al., 1978) may be
due to the apo E content of the lipoproteins since the apo E content has
been found to be greatly affected by ultracentrifugal isolation of lipoproteins (Fainaru et al., 1977; Kunitake et al., 1982).
The present data suggest that the clearance of rat plasma cholesterol appears to be through an HDL pathway in which a L is catabolized
1
to PAL in the plasma, with the catabolism of a L being apparently
1
related to LCAT activity.

PAL may then be removed from the plasma by

hepatic lipoprotein receptors, which can be induced by 17 a-ethinyl
estradiol (Windler et al., 1980).

This is in marked contrast to the

human in which cholesterol accumulates in LDL, as a result of cholesteryl ester transfer from HDL to VLDL (Barter et al., 1979b) with subse-
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quent metabolism of VLDL to LDL (Eisenberg et al., 1973a). LDL is then
cleared from human plasma by LDL receptors (Brown et al., 1981).

Since

HDL has been negatively correlated to the risk of developing atherosclerosis in humans (Miller et al., 1975), it is possible that the rat's
relative resistance to dietary-induced atherosclerotic lesions (Fillies
et al., 1956; Mahley et al., 1977a; Wissler et al., 1954) may be due to
a major role that the HDL subfractions, a L and PAL, may play in clear1
ing cholesterol from rat plasma.

CHAPTER VI

SUMMARY
The plasma lipoprotein-cholesterol profile of the adult male rat
was investigated using cellulose acetate electrophoresis combined with
an enzymatic stain for total cholesterol and an enzymatic stain for
unesterified cholesterol developed for these studies.

A comparison of

the electrophoretically determined serum lipoprotein-cholesterol profile
of the adult male rat with mouse, rabbit, dog, monkey and human serum
was performed.

Four cholesterol-staining lipoprotein bands were

detected in rat serum, while only three bands were present in the other
species studied.

The apparently unique lipoprotein-cholesterol band in

the rat was found to electrophoretically migrate faster than rat albumin
with prealbumin mobility and has been named prealbumin lipoprotein-cholesterol (PAL-C).

PAL-C of the rat, accounting for 25.4% of the total

serum cholesterol of the adult male rat, was shown to be an HDL fraction
employing ultracentrifugation as well as a polyanion precipitation technique.

Therefore, HDL of rat plasma is composed of both a prealbumin

and an a

1

lipoprotein fraction as can be determined by cellulose acetate

electrophoresis.
It was found using cellulose acetate electrophoresis and staining
for both total and unesterified cholesterol that following a four hour
37 °C in vitro incubation of rat plasma, the total cholesterol concen130
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trations of both PAL and a L change due to a decrease in the
1
unesterified cholesterol concentration of a L with a concomitant
1
increase in the esterif ied cholesterol concentration of PAL.

In the

presence of PCMPS, a lecithin: cholesterol acyl transferase inhibitor,
incubated rat plasma demonstrated a decrease in PAL-total cholesterol
with a concomitant increase in a L-total cholesterol.
1
net transfer of unesterified cholesterol occurred from
in the presence and absence of PCMPS.

In addition, a
~L

to a L, both
1

Hypocholesterolemia induced by

the in vivo administration of 17 a-ethinyl estradiol to rats resulted in
the disappearance of both PAL and

~L-total

cholesterol from plasma.

However, PAL-total cholesterol reappeared in rat plasma during an in
vitro 4 hour incubation at 37 °C while a L-total cholesterol decreased.
1
The present data suggest that both PAL-cholesterol and

~L-cholesterol

are cleared from rat plasma by hepatic lipoprotein receptors induced by
17 a-ethinyl estradiol and that PAL of the rat may be a product of
plasma a L catabolism.
1
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Figure 3.

A comparison between the lipoprotein-cholesterol profile and

the protein profile of rat serum as separated by cellulose acetate electrophoresis.

Following electrophoresis of duplicate 2 microliter ali-

quots of serum on different halves of the cellulose acetate plate, the
plate was cut into two equal parts.

One part was enzymatically stained

for total cholesterol and the second part stained for protein with Ponceau S.

(PAL-C is prealbumin lipoprotein-cholesterol; a L-C is alpha
1

1

lipoprotein-cholesterol; a L-C is alpha lipoprotein-cholesterol; 61-C
2
2
is beta lipoprotein-cholesterol; PA is prealbumin; A is albumin; a

1

is

alphal globulin; a2 is alpha2 globulin; el is beta! globulin; e2 is
beta

2

globulin; l is gamma globulin.)
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Figure 4. A comparison between the lipoprotein-cholesterol profile and
the lipoprotein profile of rat serum as separated by cellulose acetate
electrophoresis.

Following electrophoresis of duplicate 2 microliter

aliquots of serum on different halves of the cellulose acetate plate,
the plate was cut into two equal parts.

One part was enzymatically

stained for total cholesterol and the second part stained for "total"
lipids with oil red 0.

(PAL-C is prealbumin lipoprotein-cholesterol;

HDL-C is high density lipoprotein-cholesterol; VLDL-C is very low density lipoprotein-cholesterol; LDL-C is low density lipoprotein-cholesterol; PAL is prealbumin lipoprotein; a L is alpha
1

is prebeta lipoprotein; 61 is beta lipoprotein.)

1

lipoprotein; pre-6L
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Figure 5.

Improved resolution of PAL-C from a L-C by soaking cellulose
1

acetate plate overnight.

Two microliter aliquots of adult rat plasma

were applied to two cellulose acetate plates, one of which had been
presoaked overnight in tris-barbital buffer; the other being presoaked
for 1 hour in tris-barbital buffer.

Both plates were then electro-

phoresed in the same chamber simultaneously.

(PAL-C is prealbumin lipo-

protein-cholesterol; a L-C is alpha lipoprotein-cholesterol; a L-C is
1
2
1
alpha

2

lipoprotein-cholesterol;

~L-C

is beta lipoprotein-cholesterol.)
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Figure 6.

Comparison of the serum lipoprotein-cholesterol profiles of

the normal adult male rat, mouse, rabbit, dog, monkey and human, determined by cellulose acetate electrophoresis combined with an enzymatic
cholesterol stain.
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Figure 7.

Cellulose acetate electrophoresis of the high density frac-

tion (1.063-1.210 g/ml) of adult male rat serum obtained by ultracentrifugation.
°C

A sample of the corresponding whole serum was stored at -20

during the time required to isolate the high density fraction and

was subsequently electrophoresed on the same plate.

(PAL-C is prealbu-

min lipoprotein-cholesterol; a L-C is alpha lipoprotein-cholesterol;
1
1
a L-C is alpha lipoprotein-cholesterol; at-C is beta lipoprotein-cho2
2
lesterol.)
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Figure 8. Cellulose acetate electrophoresis of the high density fraction
(greater than 1.063 g/ml) of adult male rat serum obtained by ultracentrifugation.

A sample of the corresponding whole serum was stored at

-20 °C during the time required to isolate the high density fraction,
and was subsequently electrophoresed on the same plate.

(PAL-C is pre-

albumin lipoprotein-cholesterol; a L-C is alpha lipoprotein-choles1
1
terol; a L-C is alpha lipoprotein-cholesterol; aL-C is beta lipopro2
2
tein-cholesterol.)
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Figure 9.

Cellulose acetate electrophoresis of the dialyzed supernate

obtained after manganese heparin precipitation of adult male rat serum.
A sample of the corresponding whole serum was stored at -20 °C during
the time it took to dialyze the manganese heparin supernate against 0.15
M sodium chloride solution containing 0.05% EDTA at 4 °C, and was subsequently electrophoresed on the same plate.

(PAL-C is prealbumin lipo-

protein-cholesterol; a L-C is alpha lipoprotein-cholesterol; a L-C is
1
1
2
alpha

2

lipoprotein-cholesterol;

~L-C

is beta lipoprotein-cholesterol.)
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Figure 10. Cellulose acetate electrophoresis of the supernate obtained
after dextran sulfate precipitation of adult male rat serum.

A sample

of the corresponding whole serum was stored at -20 °C during the time
required to isolate the high density fraction and was subsequently electrophoresed on the same plate.

(PAL-C is prealbumin lipoprotein-choles-

terol; a L-C is alpha lipoprotein-cholesterol; a L-C is alpha lipopro1
2
1
2
tein-cholesterol;

~L-C

is beta lipoprotein-cholesterol.)
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Figure 11. Correlation of rat plasma high density lipoprotein-cholesterol levels determined by cellulose acetate electrophoresis versus manganese heparin precipitation method.

The line was drawn with a slope of

1.02 obtained by linear regression analysis; y-intercept=9.30.

(PAL-C

is prealbumin lipoprotein-cholesterol; a L-C is alpha lipoprotein-cho1
1
lesterol.)
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Figure 12. Correlation of rat plasma high density lipoprotein-cholesterol levels determined by cellulose acetate electrophoresis versus dextran sulfate precipitation method.

The line was drawn with a slope of

1.08 obtained by linear regression analysis; y-intercept=15.65.

(PAL-C

is prealbumin lipoprotein-cholesterol; a L-C is alpha lipoprotein-cho1
1
lesterol.)
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Figure 13. Correlation of rat plasma high density lipoprotein-cholesterol levels determined by dextran sulfate precipitation versus manganese heparin precipitation method.

The line was drawn with a slope of

0.95 obtained by linear regression analysis; y-intercept=-5.7.
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Figure 14. Comparison of rat plasma high density lipoprotein-cholesterol
(HDL-C) levels determined by cellulose acetate electrophoresis, manganese heparin precipitation and dextran sulfate precipitation.

Statisti-

cal analysis was performed using one way analysis of variance followed
by Duncan's new multiple range test.

(PAL-C is prealbumin lipoprotein-

cholesterol; a L-C is alpha lipoprotein-cholesterol.)
1
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Figure 15. Kinetic changes in adult male rat plasma lipoprotein-total
cholesterol fractions separated by cellulose acetate electrophoresis
during a 4 hour in vitro incubation of plasma at 37 °C.

(PAL-C is pre-

albumin lipoprotein-cholesterol; a L-C is alpha lipoprotein-choles1
1
terol; a L-C is alpha Jipoprotein-cholesterol; eL-C is beta lipopro2
2
tein-cholesterol.)
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Figure 16.

Comparisons of rat plasma lipoprotein-cholesterol profiles

after a 1 hour and 4 hour in vitro incubation at 37

°c.

(PAL-C is pre-

albumin lipoprotein-cholesterol; a L-C is alpha lipoprotein-choles1
1
terol; a L-C is alpha lipoprotein-cholesterol; eL-C is beta lipopro2
2
tein-cholesterol.)
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Figure 17.

Changes in lipoprotein-cholesterol fractions separated by

cellulose acetate electrophoresis following a 4 hour 37 °C
incubation of adult male rat plasma.

in vitro
--

Statistical analysis between the

initial lipoprotein-cholesterol concentrations and those after four
hours of incubation was performed using a paired Student's t-test.

(PAL

is prealbumin lipoprotein; a L is alpha lipoprotein; a L is alpha
1
2
1
2
lipoprotein;

~L

is beta lipoprotein.)
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CHANGES IN LIPOPROTEIN·CHOLESTEROL FRACTIONS SEPARATED BY CELLULOSE ACETATE ELECTROPHORESIS
FOLLOWING A 4 HOUR 37 •c IN VITRO INCUBATION OF ADULT MALE RAT PLASMA
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Figure 18.

Changes in lipoprotein·cholesterol fractions separated by

cellulose acetate electrophoresis following a 4 hour 37 °C

in vitro

~

~~

incubation of adult male rat plasma in the presence of an LCAT inhibitor
(2.0 mM PCMPS).

Statistical analysis between the initial lipoprotein-

cholesterol concentrations and those after four hours of incubation was
performed using a paired Student's t-test.

(PAL is prealbumin lipopro-

tein; a L is alpha lipoprotein; a L is alpha lipoprotein;
2
1
1
2
lipoprotein.)

et

is beta
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Figure 19.

Changes in esterified to unesterified cholesterol ratios of

lipoprotein fractions separated by cellulose acetate electrophoresis
following a 4 hour 37

°c

in vitro incubation of adult male rat plasma.

~

~~-

Statistical analysis between the initial lipoprotein-esterified cholesterol to unesterified cholesterol ratios and those after four hours of
incubation was performed using a paired Student's t-test.

(PAL is pre-

albumin lipoprotein; a L is alpha lipoprotein; a L is alpha lipopro2
2
1
1
tein;

a1

is beta lipoprotein.)
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Figure 20.

Changes in esterified to unesterified cholesterol ratios of

lipoprotein fractions separated by cellulose acetate electrophoresis
following a 4 hour 37 °C in vitro incubation of adult male rat plasma in
the presence of an LCAT inhibitor (2.0 mM PCMPS).

Statistical analysis

between the initial lipoprotein-esterified cholesterol to unesterified
cholesterol ratios and those after four hours of incubation was performed using a paired Student's t-test.

(PAL is prealbumin lipoprotein;

a L is alpha lipoprotein; a L is alpha lipoprotein;
1
1
2
2
protein.)

~L

is beta lipo-
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Figure 21.

Effect of 17 a-ethinyl estradiol on total cholesterol con-

centration of adult male rat plasma.

Rats were administered daily doses

of 17 a-ethinyl estradiol subcutaneously for 4 days and sacrificed on
day 5.

All plasma total cholesterol concentrations of rats given 17

a-ethinyl estradiol were statistically significantly lower than the control animals.

The control value represents the mean

lesterol concentration of 5 rats.

plas~a

total cho-

The 0.05 mg/kg dose of 17 a-ethinyl

estradiol represents the mean plasma total cholesterol concentration of
2 rats.

All other points represent the mean plasma total cholesterol

concentration of 4 rats.

Statistical analysis was performed using one

way analysis of variance followed by Duncan's new multiple range test.
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EFFECT OF 17 a-ETHINYL ESTRADIOL ON TOTAL
CHOLESTEROL CONCENTRATION OF ADULT MALE RAT PLASMA
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Figure 22. Effects of in vivo administration of 17 a-ethinyl estradiol
on lipoprotein-total cholesterol concentration before and

after a 4

hour 37· °C in vitro incubation of adult male rat plasma.

Rats were

administered daily doses of 17 a-ethinyl estradiol subcutaneously for 4
days and sacrificed on day 5.

Statistical analysis was performed using

one way analysis of variance followed by Duncan's new multiple range
test.
alpha

(PAL is prealbumin lipoprotein; a L is alpha lipoprotein; a L is
1
2
1
2

lipoprotein; 6L is beta lipoprotein.)
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Figure 23.

Proposed intravascular lipoprotein catabolic transformation

of adult male rat alpha
incubation of plasma.

1

lipoprotein following a 4 hour 37 °C

in vitro

Statistical analysis between the initial lipopro-

tein-cholesterol concentrations and those after four hours of incubation
was performed using a paired Student's t-test.

(PAL is prealbumin lipo-

protein; a L is alpha lipoprotein; a L is alpha lipoprotein;
2
1
1
2
beta lipoprotein.)
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PROPOSED INTRAVASCULAR LIPOPROTEIN CATABOLIC TRANSFORMATION OF ADULT MALE
RAT ALPHA1 LIPOPROTEIN FOLLOWING A 4 HOUR 37
IN VITRO INCUBATION OF PLASMA
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Figure 24. Inhibition of intravascular lipoprotein catabolic transformation of adult male rat alpha

1

lipoprotein following a 4 hour

37 °C in

vitro incubation of plasma containing an LCAT inhibitor (2.0 mM PCMPS).
Statistical analysis between the initial lipoprotein-cholesterol concentrations and those after four hours of incubation was performed using a
paired Student's t·test.

(PAL is prealbumin lipoprotein; a L is alpha
1
1
lipoprotein; a L is alpha lipoprotein; aL is beta lipoprotein.)
2
2
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2.0 mM PCMPS
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Figure 25. Proposed in vivo mechanism for cholesterol clearance by circulating plasma lipoproteins in the adult male rat.

(PAL is prealbumin

lipoprotein; a L is alpha lipoprotein; a L is alpha lipoprotein; BL is
2
2
1
1
beta lipoprotein.)
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CHAPTER VII I

TABLES
TABLE 1

DISTRIBUTION AND COMPOSITION OF LIPOPROTEINS IN VARIOUS MAMMALS*
TC

Serum
PL

Species

TC

l'[

Density <I.019 gm/ml
TC
PL Protein
TC

l'[

(mg/IOD ml)
ean va ues
young adult
human>

179 226

Density 1.019-1.063 gm/ml
TC
PL Protein
TC
l'[

fmg/100 mll

(mg/100 ml)

Density
TC PL

>1.0li~

TC

l'[

(mq/100 ml)

0.79

23

28

17

0.82

103

74

60

1.39

4CI 123

n.40

Rabbit

41

93

0.44

15

IR

14

0.83

9

11

12

O,R3

17

fiQ

n.2s

Rat

50 114

0.44

6

17

12

0.35

IO

13

17

0. 77

31

711

n.4n

Pig

106 161

0.66

8

12

10

0.67

51

37

3fi

1.4

41

102

0.40

Hamster

121 269

0.45

25

44

21

0.57

29

34

22

0.85

61

17

0.53

52

1.0

Dog

150 362

0.41

2

10

9

0.20

10

lg

Monkey

173 295

0.59

17

20

13

0.85

64

64

*From Havel ~~-· 1955. Abbreviations: TC : total cholesterol, PL: phospholipid
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176

0.35

127 325

n.~Q

206

0.39

RO
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TABLE 2

DISTRIBUTION AND COMPOSITION OF HUMAN AND RAT SERUM LIPOPROTEINS SEPARATED BY SEQUENTIAL ULTRACENTRIFUGATION*
Density
( g/ml)

Species

Cholesterol
Ester

Unesterified
Cholesterol

Total
Cholesterol

Triglyceride

Phospholipid

Protein

(Mean percent of lipoprotein weight)
Human

Chylomicrons

6.0

3.1

g_ 1

81.3

7.0

2.5

Rat

<1.006 (VLDL)

4.2

8.9

13.l

61.l

12.0

13.8

Human

<1. 019
(VLDL & IDL)

16.2

6.0

18.2

51.8

17.q

7.1

Rat

1. 006-1. 019
(IDL)

12.5

18.l

30.6

41.1

12.0

16.3

Human

l.Olg-I.063
(LDL)

39.4

7.5

46.9

9.3

23.1

20.7

Rat

1. 019-1. 063
(LDL)

15.0

1g.1

34.1

12.2

n.2

21i.5

Human

1.063-1.210
(HDL)

17.4

2.0

19.4

8. l

?6.1

41;.4

Rat

1.063-1.210
(HDL)

15.0

14.8

29.8

2.8

21i.O

41.4

*Human data from

Bragdon!!_~.,

1956 and Rat data from Pasqua 1i-Ronchetti !!_ ~·, 1975.
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TABLE 3

SERUM LIPOPROTEIN-CHOLESTEROL VALUES OF
n

Total
Cholesterol
111g/dl
(Mean t SD)

PAL-C
mg/dl
(Mean t SD)

a1L-C
111g/dl
(Mean t SD)

~MAL,

NONFASTING ANIMALS

ca 2L-C
mq/dl
(Mean t SD)

LDL-C*
llM::r

TOTAL-C*

8 t 2

0.17

1.23

Bl.-C
1119/dl
(Mean t SD)

Rol-t

33 t 7

3t 1

0

109 t 15

7t 3

11 t

s

0.10

1.16

34 t 8

0

20 t 6

J t 2

11 t J

o.ss

1.70

3

139 t 15

0

116 t 11

12 t 2

11 t 3

0.09

t.20

Adult Male
Monkey
Ser1111

3

147 t 25

0

R9 t 30

12 t

s

46 t 5

O.'SZ

1.65

Adult Male
H1111an
Ser111
(21-39 yrs)

13

183 t 47

0

44 t 9

12 t fi

127 t 4fi

3.05

4.33

Adult Male
Rat Ser111

15

59 t 11

Adult Male
Mouse Ser111

6

127 t 20

Adult Male
Rabbit
Ser111

10

Adult Male

Dog Ser111

15 t 4

• To calculate the c0111Parat1ve ratios (2), LDL-C 1s ass1111ed to be equivalent to BL-C and HDL-C ts assUllM!lf to be
equivalent to PAL-C + a1L-C.
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TABLE 4

CHANGES IN ELECTROPHORETIC MOBILITY OF ADULT MALE RAT PLASMA LIPOPROTEIN FRACTIONS FOLLOWING A FOUR HOUR 37
IN VITRO INCUBATION AND COMPARED TO RAT PLASMA INCUBATED WITH AN LCAT INHIBITOR (2.0 mM PCMPS)a.

SL

PAL

Distance from Sample Application (millimeters)
Electrophoretic Mobility
Rat Plasma t 0

27.0 ± 0.4

21.2 ± 0.2

16.0 ± 0.2

12.8 ± 0.1

Electorphoretic Mobility
Rat Plasma t4

27.1 ± 0.8

21.5 ± 0.4

17.9 ± o.5b

16.1 ± 0.4b

0.4%

1.4%

Electrophoretic Mobility
Rat Plasma t 0 with
2.0 mM PCMPS

27.0 ± 0.3

21.3 ± 0.1

16.2 ± o.2c

13.2 ± o.2c

Electrophoretic Mobility
Rat Plasma t 4 with
2.0 mM PCMPS

26.4 ± 0.3

21.0±0.3

16.0 ± o.2c

13.9 ± 0.3b,c

% Change in Electrophoretic
Mobility t4 Compared to
Rat Plasma t 0

%Change in Electrophoretic
Mobility t 4 compared to
Rat Plasma to with
2.0 mM PCMPS
a

b

c

-2.2%

-1.4%

Results are expressed as the mean± S.E.M. of 9 animals
Significantly different from Rat Plasma t 0 value p < 0.05
Significantly different from Rat Plasma t 4 value p < 0.05

11.9%

-1.3%

25.8%

5.3%

°c

,
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RAT SERUM STORAGE AND THE LIPOPROTEIN-CHOLESTEROL PROFILE

TABLE 5

STORAGE EFFECTS ON THE LIPOPROTEIN-CHOLF.STEROL CONCENTRATION OF RAT SERUM
FRESH
SERUM
PAL-C
a 1L-C
~L-C

f!L-C

SERUM STORED
4 °c, 4 HOURS

SERUM STORED
-20 °c, 4 HOURS

SERUM STORED
4 °c, 24 HOURS

SF.RUM STORED
-20 °c, 24 HOURS

2.2

12.1

:!:

3.1

11.1

:!:

2.9

12.7

:!:

3.8

12.0

:!:

3.9

21.s :1: 2.1

18.S

:!:

2.3

19.4

:!:

2.3

19.4

:!:

2.3

21.0

:!:

2.2

9.2

:!:

4.1

:!:

0.4

4.6

:!:

o.s

4.0

:!:

0.3

4.0

:!:

0.8

3.1

:!:

0.4

10.8

:!:

1.2

10.3

:!:

0.9

11.0

:!:

1.3

9.4

:!:

0.9

9.3

:!:

o.s

Values represent the mean cholesterol concentration in mg/dl
of 4 animals fasted overnight

:!:

S.E.M.

Aliquots of rat serum were analyzed for lipoprotein-cholesterol content
by cellulose acetate electrophoresis combined with an enzymatic stain
for total cholesterol immediately after serum collection, after 4 hours
at 4 °C, after 4 hours at -20 °C, after 24 hours at 4 °C or after 24
hours at -20 °C.

Results are shown in table 5 above.

None of the lipo-

protein fractions was found to be statistically different under any of
the five conditions as determined by analysis of variance.

Therefore,

the effects of serum storage on the observed phenomena as reported in
this dissertation are minor and would not necessarily affect the conclusions drawn from these studies.
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RAT PLASMA LIPOPROTEIN-CHOLESTEROL PROFILE AND THIMEROSAL

TABLE 6
EFFECTS OF A BACTERIOSTATIC AGENT ON THE LIPOPROTEIN-CHOLESTEROL CONCENTRATION
OF ADULT MALE RAT PLASMA AS DETERMINED BY CELLULOSE ACETATE ELECTROPHORESIS
BEFORE AND AFTER A FOUR HOUR 37 °c INCUBATION
RELATIVE % LIPOPROTEIN-CHOLESTEROL
PRIOR TO INCUBATION
CONTROL
PLASMA

PLASMA CONTAINING
0.015% THIMEROSAL

RELATIVE % LIPOPROTEIN CHOLES'!"F:ROL
AFTER A 4 HOUR INCUBATION AT 37 °c
CONTROL
PLASMA

PLASMA CONTAINING
0.015% THIMF.ROSAL

PAL-C

29.0

:i- 3.~

29.6

:i-

4.3

69.1 ± 3.6a

76.1 ± 3.7a

a 1L-C

47.2

:i-

1.7

45.fl

:i-

3.1

19.5 ± 2.5a

11.5

:i-

2.ha

a 2L-C

5.6

:i-

0.5

5.4

:i-

0.9

2.1

o.2a

2.0

:i-

o.1a

BL-C

18.2

:i-

1.6

19.2

:i-

1.6

9.3 ± l.4a

8.4

:i-

l.Sa

:i-

Values represent the mean :i- S.E.M. of 4 animals fasted overnight.
a Significantly different vs. non-incubated plasma using Duncan's new multiple
range test (p < 0.05)

A bacteriostatic agent, thimerosal, was added to plasma samples at a
final concentration of 0.015%.

No significant differences were observed

between non-incubated plasma with and without thimerosal or between
plasma incubated at 37 °C for 4 hours with and without thimerosal.
Apparent movement of cholesterol from a L to PAL was observed in plasma
1
incubated for 4 hours at 37 °C whether thimerosal was present or not as
indicated by table 6 above.

In addition, a similar transfer of choles-

terol from a L to PAL was observed under sterile techniques.
1

This indi-

cates that the movement of cholesterol from a L-C to PAL-C was not due
1
to bacterial contamination.
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